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ABSTRACT 
The problem of development has long been one of the key issues in biology.  With stem-cell 
therapies on the horizon, the “reverse engineering” of developmental programs promises to 
become a task of great practical significance.  We now understand the general schemes by 
which transcriptional networks regulate cellular differentiation and morphogenesis.  These 
genetic circuits function as complex state machines which, over the course of development, 
undergo sequenced transitions that bring cells to specific end states.  A variety of different 
gene-expression assays can be used to follow these transitions.  The sensitivity of the assays 
now in common use limits the resolution with which we can follow the activity of genetic-
regulatory networks.  This thesis describes two projects aimed at refining an established 
gene-profiling method, quantitative RT-PCR, so that it can be used to profile transcriptional-
network states cross-sectionally within developing cell populations at single-cell resolution.  
Two advanced qRT-PCR protocols were developed to support these projects, one based on 
microfluidic “digital PCR,” the other based on multiplexed “preamplification PCR.”  These 
protocols were used to measure transcription-factor expression in hematopoietic progenitor 
cells, and to evaluate the effects of aging on the stability of gene regulation.  In their current 
form, the digital PCR and preamplification techniques will permit the analysis of perhaps a 
few hundred to a few thousand cells in a single-cell survey.  By combining microfluidic-chip 
assays with the preamplification method, it will soon be possible to scale up to the analysis 
of many thousands of cells, while profiling many different transcription factors in each 
individual cell.  This should facilitate the modeling of the transcriptional networks which 
control cellular differentiation as we press forward into the era of “tissue engineering.” 
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Chapte r  1 
OVERVIEW 
1.1 Introduction 
Progress in stem-cell biology has raised hopes for a revolution in therapeutics, based on the 
application of tissue regeneration techniques to make up deficits arising from injury, disease, 
and old age.  A more detailed understanding of the molecular mechanisms that govern 
development will be needed before the promise of regenerative medicine can be realized.  
The broad principles underlying the action of gene regulatory networks have already been 
elucidated, and it is no longer a mystery how a fixed DNA sequence can specify the dynamic, 
conditional processes involved in cellular differentiation and morphogenesis.  Nevertheless, 
the genetic networks controlling development are highly complex, and their characterization 
remains difficult even with the most sensitive molecular assays available today.  New 
techniques will be required to gather the data needed to model these circuits and rationally 
intervene in cellular differentiation programs for the purposes of “tissue engineering.” 
Self-renewing, multipotent stem cells were first identified in the hematopoietic system, and 
hematopoiesis remains the most tractable research model for investigating cell differentiation 
in mammals.  Fluorescence-activated cell sorting (FACS) has been the principal enabling 
technology for hematopoietic studies.  The power of FACS stems from its unique ability to 
analyze cell populations cross-sectionally with single-cell resolution.  When applied to 
superficially homogeneous blood progenitor cells recovered from bone marrow, FACS 
reveals a diversity of cellular phenotypes, which present as natural clusters when cells are 
visualized in gene-expression space.  On further inquiry, many of these subpopulations have 
2 
 
emerged as intermediates in the branching path by which hematopoietic stem cells (HSCs) 
develop into the specialized cell types of the blood.  FACS has facilitated the progressive 
refinement of progenitor taxonomies, which has in turn allowed researchers to focus in on 
key molecular actors and decision points in the cellular-differentiation process. 
FACS is limited in that it surveys only membrane-protein expression, and yet we know that 
cell-fate choice is directly controlled by transcription factors acting in the cell nucleus.  The 
expression of these regulatory factors can be evaluated using a variety of standard mRNA 
assays, including qRT-PCR, SAGE, and microarray analysis, and such measurements have 
provided insight into the networks controlling hematopoiesis.  Still, conventional assays only 
give us population-average expression profiles, based on mRNA derived from thousands of 
cells, so the data they provide is necessarily conditioned by preestablished cell taxonomies.   
To analyze population structure at the transcriptional-network level, we need assays sensitive 
enough to quantitate multiple, low-abundance transcripts in single cells, and convenient 
enough to expedite the analysis of many individual cells.  This thesis describes two projects 
undertaken to improve the sensitivity and throughput of single-cell gene profiling: 
1. The first project sought to develop an assay with the sensitivity required to quantitate 
transcription factors in single cells.  FACS was used to immunophenotype and sort 
blood progenitor cells into RT-PCR buffer, and the cell lysates were then reverse 
transcribed in a conventional thermocycler.  The cDNA preps were quantitated in 
the Fluidigm Digital Array chip using a multiplexed TaqMan assay.  Inside the chip, 
each cDNA sample is subdivided into 1200 isolated compartments immediately 
before the PCR.  A scan of the fluorescence in the chip at the PCR end point gives a 
count of the number of template molecules in the sample.  Absolute expression 
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levels of the housekeeping transcript GAPDH and the hematopoietic transcription 
factor PU.1 were measured in 116 cells using this methodology. 
2. The second project measured the cell-to-cell variability of transcript levels in cells 
isolated from young and old mice, to evaluate the hypothesis that transcriptional 
regulation is destabilized with age.  Again, FACS was used to prepare single-cell 
lysates for analysis.  For this study, achieving high sample throughput was more 
important than maximizing assay sensitivity.  This motivated a different technical 
approach to cDNA quantitation, based on “preamplification PCR.” Reverse 
transcription was coupled with 15 cycles of multiplex PCR, and the “preamplified” 
cDNA was diluted and analyzed in six independent SYBR Green qPCR assays using 
a standard real-time PCR machine.  Parallel reactions on RNA quantitation standards 
were used to convert qPCR threshold-cycle readouts into absolute mRNA copy 
numbers.  A total of 324 cells were evaluated in the study (figure 1.1). 
1.2 Organization 
Chapter 2. Regulatory Coding of Lymphoid Lineage Choice by Hematopoietic Transcription 
Factors 
This chapter reviews the literature on the transcriptional control of differentiation in the 
branch of hematopoiesis which gives rise to the adaptive immune system.  
Chapter 3. Single-Cell Gene-Expression Analysis 
This chapter summarizes current methods for analyzing gene expression at the protein and 
mRNA levels, with a particular emphasis on single-cell assays. 
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Chapter 4. Thesis Methods 
This chapter explains the technical choices behind the two single-cell analysis protocols 
developed for the thesis work, and discusses their respective merits and potential. 
Chapter 5. Transcription Factor Profiling in Individual Hematopoietic Progenitors by Digital 
RT-PCR 
This chapter describes the hematopoiesis/digital PCR study.   
Chapter 6. Transcriptional Instability is Not a Universal Attribute of Aging 
This chapter describes the aging/preamp PCR study.   
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Figure 1.1. Single-cell gene-expression analysis. The 2D scatterplots summarize the mRNA copy-number data 
from the aging study.  The levels of six mRNA species were measured in 324 individual hematopoietic cells.  
Four FACS-purified cell populations were evaluated in young and old mice: hematopoietic stem cells (HSCs), 
granulocytes, naïve B-2 B cells, and naïve CD8 T cells.  Although the analysis targeted housekeeping and pan-
hematopoietic genes, the four cell populations still show distinctive expression signatures.  The levels of the 
coregulated ribosomal subunit genes Rpl5 and Rpl19 were strongly correlated within and across cell types.
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Chapte r  2 
REGULATORY CODING OF LYMPHOID LINEAGE CHOICE 
BY HEMATOPOIETIC TRANSCRIPTION FACTORS* 
Luigi A. Warren and Ellen V. Rothenberg 
 
 
2.1 Summary 
During lymphopoiesis, precursor cells negotiate a complex regulatory space, defined by the 
levels of several competing and cross-regulating transcription factors, before arriving at 
stable states of commitment to the B-, T- and NK-specific developmental programs. Recent 
perturbation experiments provide evidence that this space has three major axes, 
corresponding to the PU.1 versus GATA-1 balance, the intensity of Notch signaling through 
the CSL pathway, and the ratio of E-box transcription factors to their Id protein antagonists. 
  
                                                 
* This chapter was originally published in Current Opinion in Immunology, 15(2), 2003.  The 
references for this chapter appear in the References and Recommended Reading section. 
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2.2 Abbreviations 
bHLH basic helix–loop–helix 
CLP common lymphoid progenitor 
CMP common myeloid progenitor 
CSL CBF1, Suppressor of Hairless, Lag-1 
DC dendritic cell 
GM-CSF granulocyte-macrophage colony-stimulating factor 
HSC hematopoietic stem cell 
Id inhibitor of differentiation 
IL interleukin 
IL-7Rα IL-7 receptor α 
M-CSF macrophage colony-stimulating factor 
NK natural killer 
Notch-ICN Notch intracellular domain 
TCR T-cell receptor 
 
2.3 Introduction 
Hematopoiesis offers us an unusually revealing picture of cellular differentiation, a process 
which underpins all metazoan development. In contrast to the situation in solid tissue, blood 
cells maintain, and to a lesser extent arrive at, their terminal phenotypes cell autonomously, 
without the influence of the fate choices of neighboring cells and without requiring stable 
association with the supporting matrix. This independence of a fixed tissue geometry makes 
hematopoietic differentiation relatively simple to adapt to in vitro conditions, thereby 
facilitating inquiry into the causative factors involved in lineage choice and developmental 
program progression. Furthermore, at least ten different hematopoietic cell types are 
generated continuously throughout life from a pool of multipotent stem cells. Neither 
multipotentiality nor the processes through which individual cells winnow their options 
down towards lineage commitment are dependent on any special conditions restricted to 
embryonic states. Thus, hematopoiesis affords us our best hope of answering the 
fundamental questions of vertebrate cellular differentiation: What are the origins of 
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symmetry breaking and diversity in development? How is homeostatic control over specific 
cell-type populations achieved? How do transcription factor expression profiles encode 
lineage decisions and divide up the multitude of possible cell fates? How do differentiation 
programs unfold? What stabilizes the end states of development? 
This review focuses on the elements of the hematopoietic program that generate 
lymphocytes; that is, B cells, T cells and natural killer (NK) cells. Our concern here is with 
the early branch points leading to the three basic lymphoid career choices, and not the later 
decisions that fine-tune morphologically similar cells to highly specific immunological roles, 
such as the CD4+ versus CD8+ choice in late T-cell development. Much is known about how 
these choices activate the downstream gene expression cascades that implement B-lineage 
differentiation [1–3, 4**, 5–7], but these causal relationships are far less clear for the NK and 
T-cell lineage programs. Therefore, differentiation genes will be touched on only briefly and 
our principal interest will be the generation of developmental diversity itself. 
2.4 Developmental Choices are Defined by Combinations of Essential 
Functions 
Definitive lymphopoiesis—that is to say, production of lymphocytes in the adult organism—
begins with self-renewing, pluripotent hematopoietic stem cells (HSCs) in the bone marrow. 
These cells can differentiate into any of the cell types found in blood. One major pathway 
for lymphocyte development passes through an intermediate cell type called the common 
lymphoid progenitor (CLP), an HSC-derived cell in which the potential for development 
along the competing myeloid and erythroid pathways is shut off [8, 9]. It is controversial 
whether this is the only pathway for lymphocyte development; as reviewed elsewhere [10*], 
there is evidence for lymphoid differentiation from precursors with various combinations of 
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potentials. It could be that stochastic variation of gene expression in HSCs, either within a 
population or within an individual cell over time, correlates with future differentiation 
potential without defining a canonical series of intermediate types. Each “destination” in the 
differentiation process is defined by its own unique set of regulatory functions, but the path 
that leads to that destination may not be uniquely prescribed [11**].  
The debate over the pathways involving “CLPs” or other mooted early lymphoid precursors 
can be sidestepped by focusing on patterns of gene expression needed for arrival at each 
destination, rather than the perhaps tendentious naming of intermediate cell types. Given 
our current ignorance of the principles governing regulatory network architecture, we should 
be wary of overcommitting ourselves to a strictly hierarchical model of development. If we 
think of a gene expression profile as a vector that defines cellular state as a point in a high-
dimensional space, we can conceptualize differentiation as the tracing of a path through 
space from a stable start point to a stable end point. As the points along the way correspond 
to relatively unstable states, it is perfectly feasible that diverse trajectories link the same start 
and end. Moreover, if the regulatory network comprises subnets that are weakly coupled, so 
that they can collapse into stable patterns of gene expression more or less independently, we 
could well have a situation in which multiple quasi-stable intermediates can converge at the 
same end state (figure 2.1). 
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Figure 2.1. Alternative models for the regulatory network architecture responsible for encoding lineage 
assignment. Modularity is a prerequisite for an evolvable system. Thus, both (a) and (b) postulate that the 
network incorporates smaller “subnets” of highly coupled, cross-regulating transcription factors, which can 
assume self-stabilizing states (0,1) more or less independently. The figure shows the progressive commitment 
of three bistable subnets, starting from a completely uncommitted progenitor network. (a) In the sequenced 
subnet commitment model, the subnets stabilize in a predetermined order during development, constrained by 
genetic linkages that function as “enable” signals, subdividing developmental space in a stepwise fashion in the 
process. This picture corresponds to our traditional notion of hierarchical lineage commitment. (b) In the 
autonomous subnet commitment model, subnets can stabilize independently and asynchronously, generating a 
much more diverse population of intermediates. The attainable end states are the same for both models, but 
the number of permissible trajectories and intermediates is greater in the second scenario, as the highlighted 
transitions from the uncommitted initial state to the arbitrarily chosen end state “101” exemplify. These models 
depict idealized extreme cases, of course. Real lineage-choice networks probably exploit both design principles. 
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It is particularly important to consider this model because stem cells and immature precursor 
cells actively express genes that could serve any of several developmental fates, before they 
make absolute lineage decisions. Stem cells and multilineage precursors coexpress lymphoid 
and myeloerythroid genes in the same cells [12, 13*, 14]. Populations of CLPs and their 
myeloid counterparts (common myeloid progenitors; CMPs) still express combinations of 
genes associated with all of their potential descendents [13*, 15**–17**]. Few, if any, 
“differentiation genes” in this system are true markers of lineage commitment. Furthermore, 
the uncommitted progenitors simultaneously express many of the transcription factors that 
serve later in the differentiation pathway as specific regulators of divergent differentiation. A 
vivid precedent for the ways in which such a system can give rise to diverse cell types is 
provided by the gene regulatory networks that have been developed in detail for some 
embryonic tissues [18, 19**, 20, 21]. 
In light of these considerations, we will resist the temptation to taxonomize intermediates 
and instead concentrate on identifying the transcription factors and regulatory subnets that 
play decisive roles in channeling HSC development towards the three lymphoid fates. With 
respect to each lineage option, we can ask the following questions: What is the proximate 
causative factor determining the choice to pursue that option? How does this factor push 
development in a particular direction? What is the ultimate source of the diversity in the fate 
decision? 
2.5 PU.1- and GATA-Family Transcription Factor Levels Jointly Encode 
Lymphoid, Myeloid and Erythroid Lineage Choice 
When expressed at a high level, the Ets transcription factor PU.1 induces several 
characteristic myeloid genes, including Mac-1 (CD11b), F4/80, GM-CSF receptor and M-
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CSF receptor (CD115) [22, 23, 24**, 25]. Lack of PU.1 completely blocks macrophage 
development and impairs other myeloid development [26, 27]. However, PU.1 is also 
required for the generation of lymphoid lineages, albeit at a lower level. PU.1 knockouts lack 
B cells and are deficient in fetal thymocytes [27, 28]. At low levels—but not at high levels—
PU.1 directly induces the receptor for the canonical lymphoid cytokine, IL-7 [4**, 29]. IL-7 
receptor α (IL-7Rα) promotes both survival and proliferation of pro-B cells and pro-T cells, 
with a continuing role in mature T cells. This is likely to be a major function, if not the only 
one, for which PU.1 is needed in B-cell development, because retroviral transduction with 
IL-7Rα can rescue PU.1-/- B-cell precursors, albeit at low efficiency [4**, 29]. At least some 
of the effects of IL-7 are mediated by inhibition of apoptosis through the caspase inhibitor 
Bcl2, but there is evidence that this cytokine is more than just a survival factor [30]. PU.1 
knockouts also show defects in natural killer (NK) cell development, although these are less 
severe than the defects in the B or T lineages [31], which may be explained by their reduced 
dependency on IL-7Rα. Whether IL-7Rα is the only PU.1 target gene that is needed for T-
lineage precursors still remains to be tested. GATA-1 is a positive regulator of erythroid and 
megakaryocytic genes and is essential for erythroid development. 
When expressed at high levels, GATA-1 can participate in a mutually antagonistic 
relationship with PU.1 to influence cell fate [32–34]. PU.1 and GATA-1 can associate in the 
nucleoplasm; GATA-1 loses its DNA-binding ability andPU.1 loses its transactivation 
capacity in the resulting dimer. PU.1 can also antagonize GATA proteins through 
competitive interactions with the coactivator CBP [35*, 36]. Both PU.1 and GATA-1 are 
suspected to be positively autoregulating [37–39], and there is substantial evidence that they 
can activate the expression of transcription factors that collaborate with them in the myeloid 
and erythroid programs, respectively [38, 40, 41]. 
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It is a plausible working hypothesis that the subdivision of hematopoietic precursor potential 
into lymphoid, myeloid and erythroid compartments is governed by the mutual antagonism 
of PU.1 and GATA-1, a coupling which may be said to constitute a simple regulatory 
subnet. In this hypothesis, cells with GATA-1 in a self-sustaining high-activity state turn on 
erythroid gene batteries, while repressing the gene batteries required for the competing 
myeloid and lymphoid programs by antagonizing PU.1. When GATA-1 is in the “off” 
condition, the choice between myeloid and lymphoid programs is determined by the PU.1 
expression regime. High PU.1 expression, stabilized by positive feedback, activates the 
myeloid batteries, including myeloid cytokine receptors, while turning off IL-7Rα expression 
and disabling lymphoid program progression. Low levels of PU.1 activity could promote the 
lymphoid programs through IL-7-mediated pathways and through the absence of competing 
myeloid and erythroid gene expression. Figure 2.2 shows the proposed division of 
developmental space on the basis of PU.1 levels. 
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Figure 2.2. Hypothetical subdivision of early hematopoietic regulatory space by three transcription factors: 
PU.1, E2A/HEB and Notch. According to the model, assignment to the erythroid, lymphoid or myeloid 
compartment is encoded by the expression level of PU.1: in the absence of PU.1, precursors progress down the 
erythroid/megakaryocytic path, in the presence of high levels of PU.1 they take on myeloid fates, and between 
these two extremes, they follow lymphoid pathways. Within the lymphoid compartment, antagonism of the E 
proteins E2A and HEB by Id factors directs cells toward the NK-lineage program. When the E proteins are 
unopposed, differentiation proceeds down the B-lineage pathway, unless the T-lineage program is engaged by 
high levels of Notch activation.  
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2.6 The Origin of Diversity in Primary Hematopoietic Lineage Choice 
is Unknown 
If this model is correct it raises a question: what is the source of the diversity in the 
expression levels of the primary fate-determining genes? Given the apparent absence of any 
instructive signals from neighboring cells, the null hypothesis for the source of diversity in 
gene expression must be stochastic variation. Single-cell assays show significant 
heterogeneity in gene expression among hematopoietic progenitors within the same apparent 
class, including even the precocious low-level expression of terminal differentiation genes 
[15**]. This suggests that multipotent cells may operate in a loosely regulated regime in which 
random fluctuations in gene expression are exploited for symmetry breaking and the 
generation of developmental diversity. 
A gene expression “free for all” could supply the feedstock for a production line that turns 
out multiple differentiated cell types, but there must also be some mechanism for channeling 
individual differentiating precursors toward circumscribed functional roles. The thresholding 
implied by the winner-takes-all, dichotomous logic of the GATA-1/PU.1 subnet seems a 
plausible mechanism for effecting such a transition, but poses the problem of how a 
presumably less than stable state of intermediate PU.1 expression could funnel into a major 
lineage pathway such as lymphopoiesis. In reality, the subnet governing this choice is likely 
to be bigger than just GATA-1 and PU.1. We know that both proteins occur in small 
families and that some of their relatives, specifically GATA-2, GATA-3 and the Ets factor 
Spi-B, play overlapping and partially redundant roles in at least some of the same regulatory 
pathways [42*, 43, 44]. The net result might be a more rugged stability landscape than the 
precipice-like terrain implied by a simple GATA-1/PU.1 titration relationship. For example, 
at lower levels of expression, the combination of PU.1 and GATA-2 is stable enough to give 
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rise to the additional cell fate choice of mast cells [45], and low levels of both PU.1 and 
GATA-3 are essential for early T-cell development, although high levels of either disrupt it 
[46**]. Alternatively, complexity might reside in other transcription factors whose roles have 
yet to be characterized. 
This general model may suggest new possible explanations for the roles of some apparently 
unrelated factors. For example, the transcription factor Ikaros has long been known to be 
essential for most lymphocyte development [47], but there has been some controversy over 
its precise function. Ikaros has no definite positive regulatory targets and is suspected of 
regulating the packaging of multiple genes into open or closed chromatin states [48]. Loss of 
function of this factor has little effect on erythroid or myeloid cells but blocks lymphocyte 
development specifically in a pattern resembling loss of function of PU.1 [47]. It would be 
interesting to investigate, therefore, whether a major role of Ikaros is to stabilize the 
precarious low-PU.1 expression state that lymphocyte development depends upon. 
Finally, it is conceivable that the statistical distributions and kinetics of the fate decision 
mechanism obviate the need for a stable lymphoid progenitor expression code. Instead, a 
delay before commitment to alternative lineage programs might be sufficient. For example, if 
the average dwell time before excursions into positive feedback-stabilized GATA-1hi and 
PU.1hi regimes is long enough, a significant fraction of unstable PU.1lo precursors could be 
swept into the lymphoid program first. This diversion could be rendered irreversible by 
downstream “lockdown” in the lineage-specific programs. It is not clear whether the CLP 
intermediate itself has such lockdown mechanisms; however, in the case of B-cell 
development, Pax-5 expression clearly plays this stabilizing role [49*, 50]. In the case of T-
cell development, stabilization is linked to the shutoff of erythroid differentiation cofactors, 
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such as SCL/Tal-1, LMO-1 and LMO-2, and eventually of PU.1 (and Spi-B) itself [24**, 51, 
52]. 
2.7 The Thymus Promotes the T-Lineage Fate Choice via Notch 
Signaling 
The regulatory space that is permissive for lymphocyte development is subdivided along axes 
on the basis of Notch activity and on the balance of E-box-binding transcription factors 
with Id (for “inhibitor of differentiation”) proteins (figure 2.2).  
The regulation of differentiation and morphogenesis through Notch signaling is a recurring 
theme in a wide range of organisms and tissues. Even within hematopoiesis, Notch has 
diverse, context-dependent functions. For example, Notch signaling in the bone marrow can 
keep HSCs self-renewing [53], and the pathway also has important roles in the later, 
immunological stages of lymphocyte development [54, 55]. A large transmembrane protein, 
Notch is found in four forms in mammals, encoded by paralogous genes expressed in 
distinctive but overlapping patterns. Notch has multiple activating ligands, antagonists and 
downstream pathways. The integration of a complex set of signaling inputs with a 
developmentally specific transcription factor context underlies the multivalent character of 
Notch as a regulator. 
Despite these poorly understood nuances, it does seem clear that activation of Notch by 
ligands produced in the thymus is the determining factor in channeling lymphoid 
development away from the B-cell program and towards the T-cell program [55, 56]. We 
cannot exclude the possibility that the starting population of HSCs or multipotent 
progenitors includes subpopulations that are predisposed to thymic homing and subsequent 
T-lineage development, for example, through the expression of the appropriate adhesion 
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molecules. However, transgenically induced Notch signaling is sufficient by itself to produce 
T-lineage committed precursors in the bone marrow [57, 58*, 59, 60], whereas conditional 
knockout or inhibition of Notch1 signaling is sufficient to instigate B lymphopoiesis within 
the thymus [61–63]. 
The mechanisms by which Notch signaling induces the T-fate choice are still under 
investigation. Thymic stimulation of the Notch pathway is mediated by the binding of the 
Delta-like ligand to the Notch1 receptor. Notch signaling involves proteolytic cleavage that 
liberates the intracellular domain (Notch-ICN) as a consequence of ligand binding. Multiple 
downstream interactions are known or suspected to mediate the effects of Notch on gene 
expression, including the NF-kB pathway [64]. However, it appears that the impact of Notch 
on the T-fate choice is routed primarily through CSL (for CBF1, Suppressor of Hairless, 
Lag-1), also called recombination signal binding protein J (RBP-J), the mammalian ortholog 
of Drosophila Su(H). A ubiquitous transcriptional repressor, CSL binds to Notch-ICN, which 
incorporates a transcriptional activation domain. The CSL-Notch-ICN complex becomes an 
activator of the same genes that CSL alone would otherwise repress, creating a sharp binary 
switch in the regulatory state. Conditional knockout of CSL is sufficient to arrest T-cell 
development and divert progenitors to B-lineage fates in the thymus, while leaving myeloid 
and B development in the bone marrow untouched [65**]. 
At minimum, the Notch-ICN–CSL complex promotes T-lineage fates by initiating 
transcription of pTα [66*] and upregulating expression of the basic helix–loop–helix (bHLH) 
transcription factor, HES-1. The pTα protein helps form a “trial” T-cell receptor (pre-TCR) 
to validate TCRb chain rearrangement, and is essential for the development of mature 
TCRαβ T cells [67]. Interestingly, pTα is usually expressed in γδ T-cell development, even 
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though it has no essential functional role there. Nevertheless, although pTα plays an 
important part in advancing the T-cell development program, it seems improbable that its 
downstream effects can be felt early enough to block the B-lineage program. 
HES-1, which is also upregulated by Notch-ICN–CSL, is a bHLH protein related to 
Drosophila hairy and enhancer-of-split. It seems to function as an early T-lineage survival 
factor. It is critical for the expansion of T-lineage precursors during the first phase of TCR 
gene rearrangement [68]. However, the block to T-cell differentiation in HES-1-/- mice does 
not prevent T-lineage specification, in contrast to the situation in Notch1-/- mice. 
Overexpression of HES-1 or the related gene HES-5 in bone marrow progenitors partially 
blocks B-cell development, albeit much more weakly than Notch-ICN itself [69*]. Thus, it 
seems that HES family gene induction mediates only a subset of the effects of Notch on the 
T/B lineage choice. 
It has also been proposed that Notch signaling blocks the B-lineage differentiation program 
by antagonizing E47, an E-box transcription factor transcribed from the E2A locus [56]. 
E47 is centrally involved in B-cell commitment [3]: it participates in the regulation of 
virtually all B-cell genes, and activates EBF and in turn Pax5, the factor responsible for 
locking down the B lineage choice. However, E47 and its splice variant E12 also play 
important early roles in T commitment. The waters are muddied here by the redundancy that 
seems to exist between E2A splice variants and the closely related HEB factor, which is 
more highly expressed in T-lineage cells than in B-lineage cells [70]. A simplistic hypothesis 
along the lines that Notch disables the B-lineage program by suppressing E47 activity is 
certainly inadequate. An inhibitory effect of Notch signaling on EBF or Pax5 would make 
sense, but has not yet been reported. 
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2.8 Id2 Titration of E Proteins Shunts Lymphoid-Inclined Progenitors 
Towards the NK Fate 
As effectors of innate immunity, NK cells resemble T cells morphologically, but forego the 
somatic gene rearrangements needed to generate the TCR. In contrast to B and T cells, NK 
cells can emerge from either the bone marrow or the thymus. Accordingly, they are neither 
inhibited by nor dependent upon Notch1 signaling [58*, 59, 71]. It appears that the decisive 
factor in the NK fate choice is an early, sustained inhibition of E protein function mediated 
by high levels of Id protein expression [72, 73**]. 
Both E proteins and Id proteins belong to the class of bHLH transcription factors. The E 
proteins bind E-box sites as dimers. Id proteins lack the basic regions needed for DNA 
binding, but can still dimerize with E proteins. The resulting E–Id heterodimers cannot bind 
DNA. Thus, Id proteins act as “dominant negative” stoichiometric antagonists, titrating the 
activity of the E factors. There is evidence that the Id proteins often act as buffers, 
sequestering E proteins before they are needed to engage developmental programs. 
As we have mentioned, the E47 protein is crucial to the initiation of the B-lineage program. 
E proteins also play a part in T-cell survival at early stages of commitment, including pTα 
activation [74*, 75]. They have additional roles in the downstream gene-rearrangement steps 
of both B- and T-cell development [3]. It appears that E proteins are uniquely dispensable to 
the development of NK cells, at least after the earliest progenitor stage [72], and indeed the 
early-onset activation of an E protein antagonist, Id2, seems to be the causative factor in 
pushing progenitors toward the NK-cell fate. High Id2 expression has been found in thymic 
progenitor subpopulations that express NK markers (MK Anderson, G Hernandez-Hoyos 
and EV Rothenberg, unpublished data; [72, 73**]) as well as in “committed NK progenitors” 
21 
 
in the bone marrow [76]. Id2 knockouts give rise to T cells but not NK cells, whereas forced 
expression of the related Id3 protein pushes thymocytes towards the NK-cell fate [72, 77]. 
2.9 Lymphoid/Dendritic Cell Relationships: A Legacy of PU.1 
Dependence? 
The role we propose for PU.1 in the generation of lymphoid precursors could explain the 
close relationship between these cells and dendritic cells (DCs). DCs, similar to 
macrophages, express PU.1 and depend upon PU.1 for their development in vivo [78, 79], 
and overexpression either of PU.1 or of its close relative, Spi-B, can cause preferential DC 
development [80*, 81]. Lymphoid precursors remain capable of differentiating into DCs, or 
in some cases into macrophages, until after the T- and B-lymphoid specification pathways 
have diverged [82–87]. In T-cell differentiation, PU.1 downregulation, shortly followed by 
Spi-B downregulation, coincides with the end of the period in which DC or macrophage 
differentiation can occur [28, 52, 86, 87, 88**]. In B cells, PU.1 and Spi-B continue to be 
expressed throughout maturation. This might underlie the susceptibility of some B-lineage 
cell types to conversion into macrophage-like cells, even after immunoglobulin gene 
rearrangement [82–84]. 
The other conditions that divide up the developmental potential space of lymphoid 
precursors are all permissive for at least some classes of DCs. Notch signaling is not required 
for DC development, but equally, it is not inhibitory [71, 89]. In fact, Notch signaling can 
induce preferential DC-like differentiation from monocytes while blocking their 
differentiation into macrophages. A variety of Id:E protein ratios are also permissive for 
DCs in the broadest sense, although particular subsets are sensitive to high or low ratios [90]. 
This broad tolerance for Notch/bHLH conditions suggests that DC (and sometimes 
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macrophage) development can result from an increase in the activity of PU.1 (or possibly 
Spi-B) across the whole plane of lymphoid-permissive conditions shown in figure 2.2. 
2.10 Conclusions 
In this discussion, we have reviewed evidence suggesting that the crucial conditions for 
initiating lymphoid development and specifying distinct lymphoid types are the balances 
established among different transcription factors, including PU.1, GATA-1, Notch-ICN–
CSL, and E proteins versus Id proteins. In our model, the transcriptional subnet state PU.1lo 
GATA-1– “encodes” the lymphoid choice in a hematopoietic stem cell or an early, 
multipotent progenitor. The Id2hi state shunts these progenitors towards the NK-lineage 
pathway, whereas CSL-mediated Notch signaling in response to an instructive Delta signal 
forces thymically localized cells towards the T-lineage pathway. The remainder of the 
lymphoid-tagged cells activate the B-cell program. 
This model prompts us to classify the B-cell fate as the default pathway for lymphoid 
development, in as much as it pinpoints two agents, Notch and Id2, whose intervention 
appears to be required to promote the alternative T- and NK-lineage fates. Given our 
ignorance of the antecedents that establish the all-important E:Id protein expression profiles 
of lymphoid precursors, we should probably resist such a leap of logic. An evolutionary 
argument can be made for the NK cell as the founder member of the lymphoid class, and 
there is at least a suggestion of this in the way that E proteins play key roles both in B- and 
T-lineage fate commitment and in the downstream engagement of adaptive immunity-
specific differentiation genes. 
Even if we believe that we have identified the key factors driving the lineage decisions in this 
system, we find ourselves on shakier ground when we turn to the question of how these 
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factors engage the selected developmental programs. The best-understood case, that of B 
cells, prominently features two additional transcription factors activated only within the B-
cell pathway: EBF and Pax5. It is not known what factors might play corresponding roles in 
the T- or NK-lineage pathways. The most problematic part of the story is the means by 
which Notch signaling promotes the T-lineage fate at the expense of the B-lineage fate. We 
know that E proteins are critical in the early development of both lineages, but it remains 
obscure how the E protein-triggered cascade that leads to Pax5 expression and B-lineage 
commitment is disabled in Notch-activated thymic progenitors. 
The biggest open question remaining, however, is the most interesting, and the most general 
in its implications: where does the diversity in the lineage-choice-directing factors come 
from? In lymphopoiesis, we have a partial answer for T cells, as we know that the T-lineage 
fate choice is directed by at least one instructive signal from the microenvironment, even if 
some of the details are uncertain. We can only speculate on the basis of the variety in 
expression levels of what we might term the “internal” signals used here: the PU.1, GATA-1 
and Id2 levels that subdivide developmental space. The problem reduces to one of finding 
stable modes in a stochastically agitated gene regulatory network. New expression assays, 
such as gene chips and single-cell PCR, hold much promise for addressing the fundamental 
question of how natural heterogeneity in gene expression is converted into the ordered 
diversity of functionally specialized cell types. 
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Chapte r  3 
SINGLE-CELL GENE-EXPRESSION ANALYSIS 
3.1 Gene-Expression Assays 
The “central dogma” of developmental biology holds that development is underwritten by 
regulated changes in gene expression.  In order to study this process, we need techniques for 
measuring how gene activity patterns vary within the developing organism. Since most genes 
encode messenger RNAs which are translated into proteins, expression can be assessed at 
either the RNA or the protein level.  In principle, protein quantitation is more informative, 
because only a gene’s peptide end product directly affects cell function. As translation and 
protein degradation can be loci for gene-specific regulation, RNA assays cannot capture all 
the expression changes which attend development.  This is mitigated by the fact that post-
transcriptional control is often effected by transcriptional modulation of regulatory genes. 
Moreover, it has been discovered recently that eukaryotic genomes harbor large, previously 
unrecognized classes of untranslated genes, such as microRNAs and shRNAs [1-3]. These 
genes encode short RNAs which modulate translation, mRNA degradation, epigenetic 
silencing, and perhaps still other processes; many seem to be involved in developmental 
processes.  It seems likely, then, that most of the gene-expression changes involved in 
development are associated with measurable changes in the level of cellular RNAs.   
3.1.1 In Vivo Assays 
Ideally, we would like to monitor genetic activity in vivo, to follow exactly how genes are 
regulated in time and space. Over the past few years, transgenic reporter methods have made 
this feasible.  In the reporter-gene approach, a synthetic gene coding either a fluorescent 
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protein (e.g., Green Fluorescent Protein, or GFP), or an enzyme which catalyzes the 
production of a visualizable product (e.g., β-galactosidase or luciferase), is introduced into a 
living organism. The transgene may be expressed under the control of a promoter sequence 
derived from a gene of interest, so that its spatiotemporal expression recapitulates that of the 
natural gene. Alternatively, the endogenous gene is replaced with one encoding a fusion 
protein which incorporates a reporter peptide sequence into the natural product. Reporter 
genes can provide unprecedented insight into developmental processes, and have also been 
used to study the basic mechanisms of gene regulation.  Advanced microscopy techniques 
allow reporter expression to be evaluated at the single-cell level—in some cases, even at the 
single-molecule level.  Reporter-based experiments have been used to investigate the sources 
of noise in gene expression [4, 5]; to characterize a stochastic genetic switch [6, 7]; to 
evaluate the “gene regulation function” of a gene [4, 8]; to analyze the behavior of natural 
and artificial transcriptional circuits [7, 9, 10]; to demonstrate the bursty nature of translation 
[11]; and, to quantitate the kinetics of transcription factor induction, binding, and facilitated 
(1D/3D) diffusion [12]. Of course, the experimental procedures involved in reporter-based 
studies are difficult and time consuming.  Another important limitation is that these analyses 
are generally limited to evaluating a single gene, or at most a very few genes, at one time. 
3.1.2 In Situ Assays 
For developmental studies, the next best thing to looking at the dynamic regulation of gene 
expression in vivo is to visualize the spatial patterning of expression in situ, in preserved tissue 
samples. Histological staining has been applied for decades to examine the distribution of 
specific proteins within fixed, permeabilized tissue. Originally, staining was performed using 
small-molecule dyes which had been shown by trial and error to bind particular proteins or 
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other cellular macromolecules with some degree of specificity. The generality and selectivity 
of the histological staining approach has been greatly enhanced by the development of 
immunological methods, and it is now possible to make dye-conjugated antibodies to label 
almost any protein of interest.  In situ staining of RNA targets can be achieved with 
oligonucleotide hybridization probes. In traditional in situ hybridization (ISH) protocols, a 
radioactive probe is used to label the RNA of interest.  This approach is being supplanted by 
fluorescence in situ hybridization (FISH), which employs dye-conjugated probes.  
Techniques like confocal microscopy have made it possible to look at the subcellular 
localization of protein or RNA targets with fluorophore-tagged antibodies or oligo probes.  
Advanced FISH protocols have been used to take snapshots of transcriptionally active 
genes, and to count RNA transcripts in the nuclei and cytoplasm of individual mammalian 
cells; these studies have revealed the bursty character of transcription, and suggest that gene 
expression in eukaryotes involves the stochastic decondensation of large chromatin domains 
[13-15]. Fluorescence-based assays can be multiplexed through the use of multiple dye colors 
in the same assay.  Generally, spectral overlap between dyes severely limits the number of 
targets that can be assayed in the same in situ experiment; however, simultaneous evaluation 
of ten different genes has been demonstrated using a bar-coding strategy in which different 
fluorophore combinations are assigned to each RNA target [13]. 
3.1.3 In Vitro Assays 
As valuable as in vivo and in situ techniques are, their applicability is restricted to highly 
focused studies targeting one or, at most, a handful of genes.  These methods do not permit 
the profiling of a large panel of genes, nor are they suited to high-throughput surveys 
involving many individual samples.  Although there are exceptions, the expression data 
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yielded by in vivo and in situ methods tend to be non-quantitative, and generally do not lend 
themselves to statistical analysis, collation in public databases, or systematic data mining.  In 
vitro protein and RNA assays were originally developed to facilitate detection of rare 
molecular species in homogenized samples using specialized chemistries.  Improvements in 
the sensitivity of these molecular assays, and in the technology for reading out the results, 
have yielded methods which can rapidly and inexpensively generate masses of quantitative 
gene-expression data. In consequence, the term gene profiling is now almost synonymous with 
the use of in vitro techniques such as quantitative RT-PCR (qRT-PCR) and “gene chip” 
arrays. 
3.1.3.1 Protein Assays 
Antibody-based protein assays such as western blot, chromatin immunoprecipitation (ChIP), 
and Enzyme-Linked Immunosorbent Assay (ELISA) are widely used to isolate, detect and 
quantitate specific proteins within homogenized samples. However, the production of an 
antibody against a novel protein target is a lengthy and expensive process.  Moreover, the 
specificity of protein-antibody binding in any given experimental context is unpredictable, so 
immunological assays frequently require considerable optimization.  These techniques are 
incompatible with high-order multiplexing and, since proteins cannot be amplified, relatively 
large amounts of analyte are required to perform even a single assay.  
3.1.3.1.1 Immuno-PCR 
In the last few years, the sensitivity of in vitro protein quantification has been improved by 
combining antibody labeling with PCR amplification and detection [16, 17].  In “immuno-
PCR,” the antibody probes used to label a target are linked to oligonucleotides; the binding 
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of two antibodies to the same molecule brings these “tails” into proximity, establishing a 
substrate for ligation and qPCR-based quantification.  Immuno-PCR is at least a hundred 
times as sensitive as ELISA, the traditional “gold standard” for in vitro protein detection.  In 
principle, the method can detect a single protein molecule. This level of sensitivity is rarely 
approached in practice owing to the relatively poor specificity of antibody-target binding.   
3.1.3.1.2 Protein Microarrays 
Highly multiplexed protein microarray assays have recently become available [18].  In a 
protein microarray, antibody probes for thousands of different targets are arrayed on a solid 
substrate.  A sample of protein extract is incubated on the array, and the probes capture and 
segregate their specific targets.  The array is imaged after the incubation to obtain the 
abundance profile of the probed species.  The antigens bound to the antibody array can be 
detected using a variety of different labeling techniques—for example, covalent coupling of 
fluorophores to the sample proteins prior to the incubation step.  Typically, the intensities of 
equivalent spots in assays run on distinct biological samples are compared to read out fold 
differences in the expression of the associated species; absolute quantitation and interspecies 
abundance comparisons are generally not supported.   
3.1.3.1.3 FACS 
One well-established protein assay which lends itself to a survey approach is fluorescence-
activated cell sorting (FACS).  This technique allows the expression of plasma membrane 
proteins to be quantitated in living cells ex vivo; it therefore straddles the divide between in 
vivo and in vitro methods. In FACS, a suspension of cells is stained with dye-conjugated 
antibodies against cell-surface proteins, and the sample is aspirated into a cell sorter for 
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analysis.  Within the instrument, cells are pressure-fed through a narrow channel in single 
file.  Each cell is individually illuminated by a laser and photodetectors measure the light 
output, thus affording a quantitative readout of protein expression. The more sophisticated 
instruments incorporate a programmable electrostatic cell-deflection mechanism which 
permits the selective recovery of cells based on surface phenotype. FACS is therefore a 
powerful tool for sorting and purifying cells, as well as for protein expression analysis. 
The latest generation of cell sorters can analyze thousands of cells per second. Advances in 
optics and dye chemistry are constantly increasing the number of different cell-surface 
markers which can be evaluated simultaneously [19-21].  Four- or five-way multiplexing is 
now common practice.  High-end systems can support the quantification of ten or more 
proteins at once, although exploiting their full potential remains challenging given the 
unpredictable specificity of antibody labeling.  While FACS is normally used to analyze 
surface-protein expression, intracellular protein levels can be evaluated in situ in fixed, 
permeabilized cells. This is still relatively uncommon, owing to the limited availability of 
antibodies against intracellular proteins and the complexity of the sample preparation 
protocol. Intracellular fluorescent reporters such as GFP can be assayed without the need 
for permeabilization and staining [22, 23]. 
Bacteria and hematopoietic cells make ideal targets for FACS analysis. Certain solid-tissue 
cell types can be evaluated after disaggregation, the difficulty involved varying with the size 
and morphology of the cells of interest. Our understanding of the cellular differentiation 
process in mammals is to a large extent based on studies of hematopoiesis enabled by FACS.  
The analytical power of flow cytometry is tied to the fact that it measures gene expression at 
the single-cell level. Most in vitro gene profiling techniques provide ensemble-average 
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expression measurements on samples derived from thousands or even millions of individual 
cells. For developmental studies, the significance of the data they produce is limited by the 
phenotypic purity of the cells contributing to the analyte. In contrast, FACS can be used to 
explore the population structure of a biological sample. By revealing how morphologically 
similar cells cluster into subpopulations when viewed in gene-expression space, FACS has 
spurred the stepwise refinement of cell taxonomies. As the classification of developmental 
progenitors gets more fine grained, it becomes more practical to pinpoint the regulatory 
events which move differentiation forward. From this standpoint, the main limitation of 
FACS is that it does not let us follow these events directly, since the key actors involved are 
predominantly transcription factors which operate within the cell nucleus.  
3.1.3.2 RNA Assays 
Generally, available in vitro RNA assays outperform protein assays with respect to ease of 
use, sensitivity, quantitative accuracy, and potential for multiplexing.  This can be attributed 
to the relative simplicity of nucleic-acid chemistry; the specific and predictable character of 
strand hybridization can be exploited for RNA amplification and detection, but peptides 
offer no such convenient “handle” for analysis. Of the many RNA assays now available, the 
most prevalent are serial analysis of gene expression (SAGE), microarray analysis, and 
quantitative reverse-transcription PCR (qRT-PCR).  A sequencing-based method, SAGE can 
be used to profile an entire mRNA transcriptome based on a single RNA sample, without 
requiring any prior knowledge of the transcripts to be assayed.  Microarray experiments can 
evaluate tens of thousands of preselected mRNA targets at a time, at a considerably lower 
cost than SAGE.  qRT-PCR offers much higher sensitivity than the other two methods, and 
can be applied to tiny amounts of starting material—even the RNA isolated from a single 
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cell.  It can also provide more accurate quantification of specific transcripts, and is the most 
flexible and cost-effective assay for focused studies targeting from one to a few dozen genes. 
3.1.3.2.1 SAGE 
In SAGE, the messenger RNA fraction of an RNA isolate is reverse transcribed into cDNA 
using oligo(dT) primers that bind the transcripts’ poly(A) tails. Special restriction enzymes 
are used to clip short (10–14 bp) fragments from the transcripts; these “tags” are amplified 
by PCR and the products are ligated together to form long “concatamers” which are cloned 
and sequenced. The resulting sequence data is parsed to determine the relative frequencies of 
recovered tags in the cDNA pool. These “expressed sequence tags” (ESTs) can be matched 
against cDNA and genomic sequence databases to profile the abundance of known mRNAs, 
individual exons, and previously unknown transcripts in the original sample.   As with all 
techniques which rely on global reverse transcription of mRNA, SAGE incurs the risk of 
underrepresenting hard-to-transcribe sequences.  In addition, while the tag-sampling 
approach may give fairly accurate profiling of particular exons, it cannot accurately measure 
the abundance of specific mRNA splice forms.   
Other sequencing-based profiling strategies can provide the coverage of SAGE while 
offering more robust quantitation—for example, the “brute-force” sequencing of a library of 
full-length cDNA clones.  As a typical mammalian cell contains 105–106 mRNA transcripts, 
with most species expressed at below 10 copies [24-26], on the order of a million sequencing 
reactions might be required to comprehensively profile even a single cell type.  This is not 
yet a practical proposition, but the availability of low-cost, high-throughput sequencing 
technologies may change this situation within the next decade. 
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3.1.3.2.2 Microarray Analysis 
In microarray analysis, polyadenylated RNA is globally reverse transcribed into cDNA using 
oligo(dT) primers, fluorescently labeled, and hybridized to immobilized oligonucleotide or 
cDNA probes arrayed on a glass slide or a “gene chip.”  In some protocols, the cDNA pool 
is used to template runoff RNA transcription reactions, in which case complementary RNA 
(cRNA) rather than cDNA is hybridized to the array.  Dye labels are incorporated into the 
transcripts using fluorophore-tagged primers or by means of covalent-coupling chemistries.  
Following hybridization of the analyte, the microarray is imaged to obtain a readout of the 
mRNA expression profile in the original sample.  Typically, microarray analyses are run in 
parallel on at least two biologically distinct samples; after normalization to allow for global 
variations in signal level, relative spot intensities are used to estimate fold expression changes 
in differentially regulated genes.  
3.1.3.2.3 Quantitative RT-PCR 
Quantitative RT-PCR is currently the “gold standard” for mRNA analysis, offering the best 
sensitivity, dynamic range, and reproducibility of any standard technique [27].  In qRT-PCR, 
mRNA transcripts are first reverse transcribed into cDNA using oligo(dT), random 
oligomer, or gene-specific primers; the cDNAs of interest are then exponentially amplified 
by PCR using gene-specific primers. The concentration of amplicon in the reaction is 
monitored with fluorophore-conjugated hybridization probes or DNA-intercalating dyes. 
Template quantitation is based on the number of PCR cycles required for fluorescence to 
reach an arbitrary threshold. Low-order multiplexing (2–5 targets) is feasible using multiple 
primer pairs and different-colored probes, but tends to be problematic due to formation of 
“primer dimer” side products and competition between assay targets [28, 29].  Moreover, 
51 
 
since very small amounts of template are required, evaluation of multiple targets can usually 
be achieved more easily by aliquoting sample to parallel simplex qPCR reactions.  
3.2 Single-Cell Analysis 
With the exception of FACS, in vitro protein assays are generally insufficiently sensitive to 
carry out expression analysis on individual cells.  RNA assays are more readily adapted to 
this task, but single-cell mRNA profiling is still uncommon.  The first studies were reported 
about twenty years ago, and several dozen more have since appeared in the literature.  The 
main obstacle that must be overcome is the tiny quantity of RNA recoverable from an 
individual cell. Most mammalian cells contain about 10–40 pg of RNA, of which about 0.1–
1 pg is mRNA, corresponding to 105–106 messages [30-32].  The mRNA population of these 
cells includes ~104 transcript species, mostly present at below ten copies.  Housekeeping and 
effector genes tend to be expressed at medium-to-high levels (102–104 copies).  Transcription 
factors, which are among the most interesting targets for developmental studies, are usually 
expressed at low abundance (<100 copies) even when the genes are fully active. 
3.2.1 Technical Approaches 
Standard SAGE and microarray protocols call for microgram quantities of input material, 
corresponding to on the order of 106 cells’ worth of RNA.  The sample requirement can be 
reduced by two orders of magnitude in advanced versions of these assays [33, 34].  Global 
mRNA amplification methods have been developed which can generate sufficient analyte 
from much smaller amounts of RNA; the most popular approaches are runoff transcription 
from cDNA templates, and PCR amplification of cDNA using generic primers. Both 
techniques have been applied to facilitate broad-spectrum single-cell transcript profiling with 
microarrays or (as in early studies) “slot-blotted” cDNA arrays. There has been little interest 
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in applying SAGE to single cell analysis, presumably because of the labor and expense that 
would be entailed in the processing of each individual sample.   
In principle, qRT-PCR can detect a single molecule of messenger RNA.  With efficient 
reverse transcription, detection of one mRNA copy using standard qPCR dye chemistries 
requires about forty cycles of PCR; a typical housekeeping transcript in a single cell might be 
detected after around thirty cycles of amplification.  However, the RNA input for gene 
profiling experiments is routinely scaled to support detection after around 15–25 PCR cycles, 
as this is considered the most trustworthy regime for quantitation.  qRT-PCR-based 
expression profiling is therefore usually performed on homogenized samples derived from 
hundreds or thousands of cells.  While conventional protocols have occasionally been 
applied to quantitate mRNA transcripts in single-cell lysates, such assays have been limited 
to the evaluation of a few, relatively highly expressed genes. 
The difficulty of achieving reliable qRT-PCR quantitation from a single cell is compounded 
when multiple genes or rare transcripts are targeted in the analysis.  Global mRNA 
amplification has been used in conjunction with PCR to allow profiling of multiple targets in 
a single cell.  Increasingly, though, qRT-PCR studies have turned to sequence-specific 
preamplification for the profiling of panels of genes.  In this strategy, a short round of 
multiplex PCR is used to make enough analyte for independent, simplex qPCR analyses on 
all genes of interest.  For studies based on limiting amounts of RNA, this “preamp” 
approach establishes a middle ground between conventional, simplex or low-order 
multiplexed qRT-PCR assays and broad-spectrum microarray analysis based on global 
mRNA amplification.   
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3.2.2 Sample Preparation 
Most of the single-cell gene profiling work reported to date involves the use of intrinsically 
low-throughput techniques for harvesting cell samples, such as patch-clamp aspiration of the 
cytosol [30, 35], or the picking of individual cells in a micropipette, sometimes with the aid 
of a micromanipulator stage [36-48]. Laser Capture Microdissection (LCM) supports a more 
automated approach to single-cell recovery. In this technique, an acetate film is placed on 
top of a tissue slice and fused to operator-designated targets with a laser; cells of interest are 
recovered by peeling away the film [31, 32]. Flow sorting can be used to isolate single 
immunophenotyped cells at high throughput, but so far only a few studies have employed 
this method [49-51].  Single-cell lysis, mRNA isolation, and cDNA synthesis have been 
combined on a microfluidic chip [52]. It may soon be possible to integrate cell culture, 
phenotypic characterization, and nucleic acid analysis in a lab-on-a-chip approach [53-63]. 
Traditional RNA isolation protocols involve multiple materials transfer steps, which is 
laborious when many samples have to be processed in parallel, and may risk sample loss and 
inconsistent recovery when applied to tiny amounts of RNA.  These methods typically entail 
the use of chaotropic salts or proteases to inactivate RNases released by cell lysis; as these 
reagents are incompatible with enzymatic reactions, an RNA purification step is almost 
always required. An optimized chaotropic-salt strategy designed for single-cell applications 
has been described [64].  However, in most single-cell studies the need for RNA purification 
has been obviated through the use of freeze-thaw, heat, detergent or hypotonic cell lysis in 
the presence of a peptide RNase inhibitor [36-38, 41-46, 50, 65-68].  More elaborate 
protocols allow nuclear and cytoplasmic material to be fractionated through the application 
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of mild detergents which disrupt the plasma but not the nuclear membrane, followed by 
centrifugal separation of the cell nuclei [69].  
Most of the single-cell RT-PCR studies published to date have employed a traditional, two-
step approach to RT-PCR, in which mRNA is first reverse transcribed into cDNA, and then 
all or part of the reaction product is transferred into a separate PCR reaction.  A more 
streamlined single-cell protocol has been described in which the RT and PCR steps are 
performed in the same reaction buffer using a blend of reverse transcriptase and Taq 
polymerase, a simplification which reportedly also improves the sensitivity of the assay [70]. 
3.2.3 Global mRNA Amplification 
Much effort has gone into the development of global mRNA amplification methods to 
reduce the sample requirement for broad-spectrum gene profiling assays.  The two most 
widely-used methods are linear amplification based on in vitro transcription (IVT), and 
exponential amplification by Sequence-Independent RT-PCR (SIP RT-PCR): 
1. The most common IVT strategy is the “antisense RNA” (aRNA) method described 
by Eberwine et al in 1990.  In this approach, mRNA is globally reverse transcribed 
using a “heeled” oligo(dT) primer which incorporates a promoter sequence for T7 
phage RNA polymerase on its 5’ end.  After second-strand synthesis, T7 polymerase 
is used to make runoff RNA transcripts from the double-stranded cDNA.  Typically, 
runoff transcription permits a thousandfold amplification of the original template.  
Million-fold amplification can be achieved by adding a second round of cDNA 
synthesis and runoff transcription. Expression profiling on the RNA amplification 
product can be performed using any of a number of standard assays, including RT-
PCR, Northern Blot, slot-blot cDNA arrays, and microarray analysis [30, 71, 72].   
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2. SIP RT-PCR involves PCR amplification of cDNA based on generic primers.  The 
most widely-used version approach was originally presented in 1993 by Brady and 
Iscove [73]: oligo(dT)-primed first-strand cDNAs are homomerically tailed with 
adenosine (dA) using terminal transferase, and the resulting products are amplified 
by PCR using oligo(dT) primers.  Because PCR efficiency is sensitive to amplicon 
length, the duration of the RT step or the reverse transcriptase concentration is 
typically limited to keep all the transcripts short.  In the related Three-Prime End 
Amplification (TPEA) approach, the tailing reaction is eschewed in favor of the use 
of a generic upstream primer designed to anneal to a random sequence that occurs 
every few hundred bases of mRNA sequence [34, 35, 37, 74]. 
Many commercial IVT kits are now available for preamplifying small mRNA samples for 
microarray analysis [34].  However, as the aRNA protocol is laborious and lengthy, two-
round amplification is rarely applied, and single-cell microarray analysis using IVT is not a 
routine procedure [34, 44]. The amplification factor attainable with SIP RT-PCR is much 
higher than for IVT—up to 1011-fold amplification has been claimed with high-fidelity 
representation [75]—and the protocol is much simpler and quicker. Modified versions of the 
Brady-Iscove technique have largely superseded aRNA as the method of choice for broad-
spectrum profiling of single cells [31, 34, 37, 40, 41, 43-46, 48, 68, 74-76].  
Global amplification is not without drawbacks.  Most of the available methods exhibit so-
called 3’ bias because the RT step is based on oligo(dT) priming, and therefore only mRNA 
sequences near the poly(A) tail are recovered [31].  While this may be viewed as an 
acceptable limitation when collecting data on thousands of different targets, in more focused 
studies it is desirable to have the option of looking at any preferred region of a target, e.g., 
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because only certain splice variants are of interest, or because sensitivity is limited for targets 
whose 3’ sequence is inefficiently reverse transcribed or amplified [68].  The uniformity of 
both linear and exponential amplification across different transcripts is also subject to some 
uncertainty, especially when amplifying very small samples [34, 68].   
3.2.4 RT-PCR Techniques 
Microarrays evaluate thousands of genes in a single assay, but the data they produce may not 
always be reliable with respect to particular mRNAs, owing to the diversity of species 
involved in the hybridization process.  High-quality expression data on a small set of genes 
are often preferred, and qRT-PCR therefore remains popular as a gene-profiling tool.  For 
single-cell work, microarray analysis has the additional drawback that analysis of each RNA 
sample involves a relatively lengthy and costly experiment.  Typically, single-cell analysis is 
used to survey cell-to-cell heterogeneity or population structure. Currently, qRT-PCR is the 
highest-throughput method for evaluating single-cell gene expression at the RNA level.  
3.2.4.1 Transcript Quantification 
While PCR has long set the standard for sensitivity in nucleic acid detection, the technique 
has only recently become highly quantitative, due to the development and commercialization 
of qPCR (or “real-time PCR”).  In the PCR-based single-cell studies published in the 
nineties, amplified cDNA was evaluated on a gel at the PCR end point using ethidium 
bromide staining or autoradiography.  PCR end-point analysis usually gives only a 
“positive/negative” call or, at best, a semiquantitative readout of template abundance.  Now 
that real-time PCR instruments are widely available, qPCR is increasingly being applied to 
quantitative profiling of gene expression in individual cells [36, 47, 52, 66, 68, 77].   
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While qPCR “threshold cycle” (Ct) readouts can be used to profile single-cell transcript 
levels cross-sectionally within a given study, they do not facilitate the comparison of data 
from independent researchers. The traditional approach to this problem is to normalize 
gene-expression measurements to an internal standard, such as the readout for a 
housekeeping gene.  This approach has significant weaknesses even when applied to 
population-level measurements [78-84].  Relative expression data becomes almost 
meaningless at the single-cell level, because the copy numbers of all transcripts vary widely 
and to a large extent independently from cell to cell [14, 36, 48, 51, 68].  However, the move 
to single-cell analysis raises the possibility of putting gene profiling data on an absolute basis, 
i.e., transcript copies per cell. One early single-cell study demonstrated the possibility of 
transcript counting in individual cells by applying Poisson analysis to PCR reactions 
conducted on limiting dilutions of cDNA prep [69]. As will be described in the next chapter, 
single-cell transcript counting can be automated through the use of “digital PCR” [51, 85].   
Some single-cell studies have used DNA or RNA quantitation standards to permit absolute 
transcript quantitation.  In this strategy, the copy number of an endogenous transcript is 
estimated based on the gel band intensity or qPCR threshold-cycle readout relative to 
standards-based reactions [52, 66, 68].  The reference templates can be spiked into lysate 
reactions, if they are distinguishable from the natural targets, in a technique called 
“competitive PCR.” Alternatively, diluted PCR products or runoff-transcribed copies of the 
natural RNA template can be analyzed in separate reactions run alongside cell-based 
samples.  Since the efficiency of cDNA synthesis can vary significantly based on the specific 
RT enzyme, priming strategy, and other reaction conditions [86, 87], the use of RNA 
standards is the most robust approach to absolute quantification of mRNA copy number. 
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3.2.4.2 Multiplexing Strategies 
RT-PCR analysis of multiple genes in single cells is hindered by the very limited amount of 
RNA in each sample.  Four main options are available to tackle this problem: 
1. Subdivision of the analyte. In this approach, the single-cell RNA isolate or cDNA prep is 
aliquoted to independent, gene-specific RT-PCR or PCR assays for amplification and 
analysis.  This strategy has been used to evaluate a few genes per cell in several 
published studies [36, 40, 42, 66, 69].  As the quantitation of even a single mRNA in 
a cell lysate pushes the limits of conventional qPCR, the subdivision method is not 
scalable to the profiling of panels involving dozens of genes.  Further, the reduction 
in dynamic range and the sampling noise associated with aliquoting inevitably 
compromise quantitation of low-abundance transcripts. 
2. Single-tube multiplexing.  The entire RNA or cDNA sample is amplified in a single-tube 
multiplexed RT-PCR or PCR, and the different amplicons are size-separated and 
visualized on a gel, or analyzed in situ with color-coded probes in a multichannel 
qPCR machine.  While this avoids the loss of sensitivity incurred by subdividing the 
analyte, the design and validation of multiplex PCR assays is complicated by 
increased potential for primer-dimer side reactions, and the possibility of competitive 
inhibition of rare targets by abundant targets [28, 29].  These problems increase with 
the level of multiplexing and the number of PCR cycles needed to detect product.  
Four- and five-channel qPCR instruments are now relatively affordable, but their full 
potential is rarely exploited even in conventional gene profiling work, and single-tube 
multiplexed analysis has not found favor for single-cell studies.   
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3. Global mRNA amplification.  SIP RT-PCR or IVT is applied to the cDNA prep to 
amplify polyadenylated transcripts, and the product is aliquoted to gene-specific PCR 
or RT-PCR reactions for analysis.  This method offers great flexibility in the choice 
of analyzed genes, and has found application in a number of single-cell studies [40, 
48, 68, 76].  The main disadvantages to global mRNA amplification have already 
been mentioned in the context of microarray studies: (1) the restriction that the gene-
specific assays must target the 3’ end of transcripts, and (2) the concern that the 
amplification may distort transcript representation. These weigh more heavily in the 
RT-PCR context as alternative strategies are available; when the genes of interest are 
known beforehand, more reliable quantification can be achieved by using sequence-
specific reverse transcription and amplification.  Global amplification also adds 
complexity to the assay protocol, particularly in the case of the IVT approach.   
4. Sequence-specific preamplification.  Multiple cDNA targets are initially amplified together 
in a single-tube multiplexed reaction, using a limited number of PCR cycles so that 
the uniformity of amplification is uncompromised by reagent depletion effects; the 
product is then aliquoted to gene-specific PCRs for analysis.  Some early single-cell 
studies employed low-order single-tube multiplexing and aliquoted the product to 
simplex PCRs, often using nested primers to increase specificity and avoid 
amplification of primer-dimer products carried over from the multiplexed reaction; 
second-round products were subjected to gel analysis [38, 50, 88].  The potential of 
the staged PCR approach has been further explored in the last few years, both in the 
context of single-cell studies and more generally for applications involving limiting 
amounts of RNA [77, 89, 90].  Refined protocols have been developed which permit 
multiplexing of dozens of assays, in some cases using primer sets originally designed 
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for simplex PCR; the analysis phase has also been rendered fully quantitative through 
the use of SYBR Green or TaqMan qPCR.  Recently, the approach has been applied 
to profiling microRNA expression in single cells, using special looped primers for 
the RT step, allowing 220 targets to be quantitated within the same sample [47, 67].  
Currently, sequence-specific preamplification (also referred to as “multiplexed tandem 
PCR,” or “preamp”) looks like the most promising strategy for increasing the breadth of 
single-cell qRT-PCR analysis.  The technique leverages the experience already gained in the 
design of highly specific qRT-PCR assays.  Validated primers and probes are available off the 
shelf for thousands of different human and rodent mRNA targets, including splice variants, 
and it should be feasible to apply these as is to highly multiplexed single-cell studies using 
standard assay chemistries.  The main obstacle to the full exploitation of “preamp” to single-
cell studies is the number of individual qPCR analyses that will have to be performed on 
each cell lysate.  However, lab-on-a-chip solutions that automate the subdivision and parallel 
analysis of preamplified reactions have recently become available, and this difficulty should 
be considerably alleviated in the near future.  
3.2.5 Applications 
An early motivation for the development of single-cell gene profiling was to evaluate cell 
types which are found in highly heterogeneous tissues—particularly specialized classes of 
neuron [30, 39, 42, 66, 72, 88].  Gene expression in such cells cannot be evaluated by analysis 
of homogenized tissue samples, nor is it generally practical to recover and pool many 
phenotypically similar cells by microdissection.  Cell types which are by their very nature 
rare, such oocytes, stem cells, and certain neoplastic cells, also represent obvious targets for 
single-cell analysis [31, 76, 91].  
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Owing to the difficulty of current protocols, the scale of the single-cell gene profiling studies 
performed to date has been small, encompassing dozens or at most hundreds of cells per 
survey.  However, this has already been sufficient to offer some insights into the population 
structure of morphologically similar cells, such as early hematopoietic progenitors [40, 50, 
51], cells of the developing and mature pancreas [36, 43], embryonic stem cells [47], stem 
cells and downstream progenitors of the skin [45] and muscle [38], and activated T cells [77].  
Quantitative profiling of mRNA expression in single cells has revealed that, even among 
phenotypically similar cells, the heterogeneity of transcript levels is substantial [14, 36, 51].   
These studies have shown that cellular transcript abundance typically exhibits a longtailed 
distribution, with a small fraction of the cell population expressing much higher-than-
average level of transcript.  Recently, the possibility that gene-expression “noise” or 
regulatory instability increases with age has been raised by quantitation of cell-to-cell 
variability in cardiomyocytes harvested from young and old animals [48].   
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Chapte r  4 
THESIS METHODS 
4.1 Overview 
Research conducted during the nineties demonstrated the technical feasibility of single-cell 
transcript profiling, opening up the possibility of analyzing gene-regulatory states cross-
sectionally in differentiating cell populations. Early single-cell studies were limited with 
respect to their ability to quantitate transcript abundance, evaluate multiple genes per cell, 
detect rare messages, and survey many individual cells.  The high-throughput, 
multiparametric single-cell profiling FACS enables at the surface-protein level remains 
beyond the capabilities of RNA methods.  In spite of the restrictions of the technique, FACS 
has transformed the study of cellular differentiation.  It seems likely that cross-sectional 
studies of intracellular gene expression will eventually offer a similar boost to developmental 
studies, especially once the assays become sensitive enough to characterize the networks 
controlling fate commitment and phenotypic specification.  The experimental work 
described here was undertaken with the aim of bringing this goal within reach. 
The thesis work encompassed single-cell assay development and two research studies, 
described in detail in the following chapters. The first study focused on the early steps of 
hematopoietic cell differentiation. From a technical standpoint, the main objective was to 
demonstrate that transcription factors, which are typically expressed at mRNA levels of 
ا100 copies per cell, can be profiled quantitatively in single cells.  The second study sought 
to evaluate the recently advanced hypothesis that gene regulation is destabilized in aging 
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animals; the analysis involved absolute quantitation of six different transcripts within 
hundreds of individual hematopoietic cells.  
A common strategy was applied in both research projects for mRNA recovery and reverse 
transcription. High-throughput sample preparation was enabled by flow-cytometric sorting 
of individual, immunophenotyped cells directly into RT-PCR buffer. Using this approach, 
hundreds of single-cell lysates can be prepared in 96-well plates in the course of a single 
FACS session. The recovered cells undergo hypotonic lysis after being dispensed to reaction 
buffer, eliminating the need for an RNA isolation step; ribonuclease inhibitors were used to 
protect transcripts from degradation by RNases released on cell lysis.  To maximize the 
efficiency and specificity of cDNA synthesis, samples were reverse transcribed using a 
thermostable RT enzyme and gene-specific primers. To simplify sample processing and 
increase RNA recovery, DNase digestion of genomic DNA was eschewed in favor of the 
use of exon-straddling primers, where possible, and No-RT controls were used to check the 
genomic-background signal. Use of an RT-Taq enzyme blend obviated any need for dilution 
or aliquoting between the RT and PCR steps of the analysis. 
Different technical strategies were employed for cDNA quantitation in the two research 
studies. Since the hematopoiesis work focused on transcription factor expression, an assay 
method which was quantitative down to a few cDNA copies per cell was essential. To meet 
this requirement, single-cell cDNA preps were analyzed by “digital PCR” in a microfluidic 
chip. In digital PCR, a sample is subdivided into many compartments before amplification, 
and a count of positive reactions at the PCR end point provides a direct readout of template 
copy number. Within the chip, a duplex TaqMan assay was used to measure the levels of a 
transcription factor (PU.1) and a housekeeping gene (GAPDH) in each single-cell prep. The 
64 
 
aging study presented less of a challenge from a sensitivity standpoint, as rare transcripts 
were not evaluated. On the other hand, there was a greater premium on achieving a high 
level of multiplexing and surveying many cells. For this work, the analysis of cDNA began 
with a round of multiplexed PCR, which was coupled with the RT step in a single-tube 
protocol; the “preamplified” products were then analyzed in a conventional real-time PCR 
machine using SYBR Green qPCR assays.  Absolute quantification of transcript copy 
number was facilitated by running parallel reactions on runoff-transcribed RNA standards. 
4.2 Sample Preparation 
4.2.1 Cell Isolation 
In most published single-cell protocols, samples are collected by manual recovery of cells 
from a suspension using a micropipette.  This is labor intensive, but not excessively 
burdensome in the context of studies which, at this point, still require extensive assay 
development and validation, and involve multistep protocols for the analysis of each sample.  
However, faster, more automated cell-isolation strategies will be required if single-cell 
profiling studies are ever to be scaled up to evaluate thousands of cells.   The only available 
single-cell isolation technique which can support high-throughput recovery is cell sorting by 
flow cytometry, so this was clearly the method of choice for the thesis work. 
Cell sorting can be applied to cultured cell lines or primary cells recovered from laboratory 
animals.  In general, primary cells cannot be maintained in culture for long periods, so the 
exploratory work on single-cell analysis was facilitated by the use of a cell line, SCID.adh.  
These immortalized cells, derived from a murine T-cell lymphoma, are phenotypically similar 
to thymocytes. SCID.adh suspension cultures are easily maintained in a 37 °C incubator; 
they grow vigorously, requiring replating to fresh medium daily.  The cell concentration in 
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the SCID.adh cultures was typically >105 cells/mL, so an ample supply of cells was always 
on hand for early experiments. 
FACS sessions generally have to be scheduled well in advance, so the early cell-based 
experiments were done using homogenized lysates made up from cells recovered directly 
from culture plates. For this purpose, the cell concentration of the SCID.adh culture was 
first estimated using a hemocytometer.  An aliquot of cells was then collected and 
centrifuged, and the pelleted cells were brought up in lysis buffer.  The lysates were diluted 
as necessary and analyzed by qRT-PCR to evaluate different mRNA recovery methods.  
Experiments on FACS-sorted cells began once the general outlines of a lysate-analysis 
protocol had been defined.  These trials focused on refinement of the cell-lysis method, 
strategies to contain RNA degradation, and standardization of post-sample collection 
handling and storage. For these experiments, all the reagents required for cell lysis and one-
step qRT-PCR were combined in a master mix, including primers, probes and enzyme. 
20 μL aliquots of this solution were dispensed to the wells of a 96-well PCR plate.  Cultured 
SCID.adh cells were pelleted, washed, and brought up at a concentration of ~105 cells/mL 
in Phosphate-Buffered Saline (PBS) supplemented with 2% FCS and 2 mM EDTA to 
maintain viability.  Since these experiments involved an homogeneous cell population, 
antibody staining against surface markers was not required for the FACS sort; live cells were 
gated based on Forward Scatter/Side Scatter and 7-Amino-Actinomycin D (7-AAD) 
staining.   
The process of FACS-sorting individual cells to the wells of a 96-well plate (“clone sorting”) 
is highly automated.  A motorized X-Y stage repositions the plate to permit dispensing to 
each well.  For the FACS operator, setting up a sort involves the definition of sort gates to 
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isolate the populations of interest, some testing and adjustment to maximize the accuracy of 
cell dispensing, and entry of the plate layout for the sort in a spreadsheet.  The plate layout 
specifies the number of cells to dispense and the gating to apply at each well position.  For 
the early trials, these layouts were very simple, the machine being set to dispense a single 
live-gated cell to most of the wells in the plate—the remaining wells were left blank, to serve 
as No Template Controls (NTCs) during the subsequent qRT-PCR analysis. 
In early trials, as soon as the sorter had completed dispensing cells to a 96-well plate, the 
plate was chilled on ice and transferred to a qPCR machine for mRNA analysis.  For the 
purposes of optimizing the assay protocol, all these trials were done using an off-the-shelf 
TaqMan assay for GAPDH, a housekeeping gene expressed at 102–103 copies in mammalian 
cells.  The output of each experimental run comprised a set of Ct readouts which could be 
used to evaluate the efficiency and reproducibility of the single-cell assay, and the effects of 
differing lysis conditions, cell concentrations, additives, etc., on these parameters.   
The prototyping experiments confirmed that the FACS-based isolation approach is rapid, 
convenient, and effective.  Once appropriate sort criteria have been defined, a cell sorter can 
set up a 96-well plate of single-cell lysates in a matter of minutes; 1000–2000 samples can be 
prepared in the course of a single FACS session with minimal operator intervention.   
The cell-isolation strategy formulated during the assay-development phase was elaborated 
and modified in several respects for the later research studies: 
1. The cells recovered in the hematopoiesis and aging studies were primary cells, 
necessitating a more complex sample prep. Hematopoietic stem cells (HSCs) and 
early lineage progenitors were recovered from the bone marrow of dissected mice; 
lymphocytes and granulocytes were obtained by tail bleeding live mice. Red blood 
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cells were removed from all isolates using ACK lysis buffer. Progenitor cells were 
purified from bone marrow-derived cell suspensions using beads coated with 
antibodies against c-kit (a membrane receptor expressed in these populations). The 
beads were recovered by magnetic-column separation. Enriched cell isolates were 
incubated with fluorescently-labeled antibodies against a variety of cell-type-specific 
surface markers to permit immunophenotyping during the FACS sort. 
2. Complex, hierarchical sort gates had to be defined to support the recovery of 
different cell types from the heterogeneous primary-cell isolates.   A portion of each 
isolate was analyzed by FACS to calibrate the gating.  Single-cell isolation can be 
performed in one pass, or the isolate can be fractionated into phenotypically purified 
populations which are then clone sorted separately.  In the “single-sort” approach, 
used in the hematopoiesis study, the heterogeneous isolate is clone sorted directly to 
96-well plates, and the FACS operator revises the plate layout to specify the 
appropriate gating for each collection plate.  In the double-sort strategy, used in the 
aging study, the isolate is first sorted by cell type into a series of collection tubes, and 
these samples are then resorted to single-cell collection plates.  The single-sort 
method is quicker and reduces the time cells have to be maintained ex vivo on ice, 
while double sorting increases the phenotypic purity of the collected cells. 
3. In the research work, multiple collection plates were prepared during each FACS 
session; the plates were transferred to a -20 °C freezer immediately after cell recovery 
and analyzed over a period of days or weeks.  Tests showed that the qRT-PCR 
readout level and consistency were at least as good from plates subject to a single 
freeze-thaw cycle as from directly-analyzed plates.  (A trial with -80 °C storage 
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indicated that this may compromise assay performance, perhaps because the RT, 
Taq, or RNase inhibitors in the lysate preps are not fully refractory to freezing; 
however, the data were very limited, and this option was not further investigated.) 
4. For the research studies, primers and enzymes were left out of the collection-plate 
master mix, and added to the samples only at the start of the reverse transcription 
reaction.  This approach adds a step to the protocol, but brings two benefits: (1) it 
decouples the selection of assay targets from sample preparation, and (2) it reduces 
the potential for RT-mediated primer-dimer product formation, which is especially a 
concern for multiplexed assays. 
5. While assay development was carried out using a FACSVantage cell sorter (BD 
Biosciences, San Jose, CA), cell sorting for the research studies was done using the 
more advanced, 13-color FACSAria system. Clone sorts were done into 12, 20, or 
50 µL buffer volumes in early trials; based on the qRT-PCR readouts from the 
lysates, the FACSVantage had no problem reliably sorting cells into any of these 
volumes.  A 10 µL volume was used in the research work. The single-cell recovery 
efficiency was high in the hematopoiesis study, confirming that it is feasible to 
reliably dispense cells to this sample volume.  The FACSAria system used in the 
aging study had a persistent problem reliably hitting the wells, which was not 
resolved. The missed wells (~40%, on average) were randomly distributed in each 
plate, which suggests an issue with the stability of the sort stream on this particular 
machine. 
A potential added benefit of the FACS isolation strategy is that surface-protein expression 
measurements are made on each cell that passes through the sorter.  Thus, in principle, the 
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data collected on recovered cells could include both transcript and protein levels, increasing 
the dimensionality of the analysis.  The “index sort” function required to retrieve 
fluorescence data for clone-sorted cells had not been implemented in the FACSAria software 
at the time the research was carried out, so there was no opportunity to exploit this 
possibility. 
4.2.2 Cell Lysis 
The plasma membrane of mammalian cells can be lysed using a variety of relatively gentle 
methods, including the application of detergents, freeze-thaw cycles, heating, and osmotic 
stress.  Initial trials focused on detergent lysis, taking a cue from an early study which used 
flow cytometry to recover mRNA from lymphocytes sorted into a buffer containing 0.05% 
NP-40 [49].  First, qRT-PCR experiments were done with NP-40 spiked into the reaction 
mix, to see if assay performance would be compromised using a single-tube lysis/RT-PCR 
buffer.  (A similar non-ionic detergent, Triton X-100, has been identified as a potential PCR 
inhibitor [92].) These trials indicated that PCR efficiency was unaffected by NP-40, although 
at high concentrations (≥1%), perturbations in the fluorescence signal were noted.  The 
effect of different detergent concentrations was then evaluated in cell-based reactions, using 
FACS to sort single cells into the reaction buffer.  Table 4.1 summarizes the GAPDH data 
from one of these experiments.  This and subsequent trials showed that there was no benefit 
to adding detergent to the lysis buffer.  Other workers have observed that efficient lysis of 
mammalian cells can be achieved by directly transferring cells to RT-PCR buffer [36].  Most 
likely, the cells swell and rupture due to the hypotonicity of the reaction buffer.   
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Table 4.1. Effect of NP-40 concentration on single-cell GAPDH readouts 
Samples [NP-40] Average Ct Ct s.d. Min Ct Max Ct
21 0% 28.5 0.5 27.3 29.7
21 0.005% 28.6 0.5 27.5 29.5
21 0.05% 28.5 0.4 27.8 29.4
21 0.5% 28.5 1.8 23.8 30.7
NP-40 was omitted from the buffer for the research work, but another non-ionic detergent, 
Tween 20, was used at a final concentration of 0.15% in the digital PCR project, to facilitate 
loading reverse-transcribed lysates into the microfluidic chip.  The practice of adding Tween 
20 was carried over to the aging study, even though the qPCR analysis was performed in a 
conventional instrument.  Judging from the results of the NP-40 trials, the inclusion of 
detergent in the lysis buffer is probably redundant, at least for hematopoietic cells.   
4.2.3 RNA Recovery 
The main obstacle to the efficient recovery of mRNA from a cell lysate is that ruptured cells 
release potent ribonuclease activity into the lysis buffer. Inside an intact cell, the half-life of 
messenger transcripts is typically on the order of hours or days, despite the presence of 
endogenous ribonucleases [93-95]. The intracellular rate of mRNA degradation is slowed by 
several factors: (1) many cellular RNases are sequestered in lysosomes, (2) natural RNase-
inhibitor (RI) proteins titrate the activity of some RNase species by binding the enzymes’ 
functional sites, and (3) the folding of ribonucleases requires formation of internal disulfide 
bridges, which is disfavored in the reducing environment of the cytosol. These protections 
are lost once the cell membrane is disrupted. Unchecked, the RNase liberated on cell lysis 
can degrade much of the released mRNA before it can be reverse transcribed into cDNA. 
A number of strategies are available for countering RNase activity during mRNA recovery: 
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1. High temperatures can be used to temporarily denature RNase. 
2. Chaotropic salts can be used to non-specifically denature protein. 
3. Proteases can be used to non-specifically degrade protein. 
4. High lysate volumes can be used to slow degradation kinetics. 
5. Natural or synthetic RIs can be used to block RNase activity. 
Heat-inactivation of RNase is hindered by the rugged character of these proteins, whose 
tertiary structure is stabilized by disulfide cross-links.  The exploratory phase of assay 
development included a few experiments with the Cells-to-cDNA II kit (Ambion, Austin, 
TX), which uses a 10 minute, 75 °C heat treatment to inactivate RNases.  The GAPDH Ct 
readouts from analyses of SCID.adh lysates processed with the kit were several cycles higher 
than expected, which suggested that the RNA recovery efficiency was low.  RNA is heat-
labile, so isolation techniques which involve heat treatment may incur sample loss due to 
spontaneous hydrolysis.  The poor results of the initial trials, the proprietary, “black-box” 
nature of the Cells-to-cDNA buffer, and the concern that RNA hydrolysis might reduce 
assay sensitivity discouraged further evaluation of this technical approach.  
More traditional RNA isolation kits use chaotropic salts or enzymatic proteases to inactivate 
RNases.  Since these reagents also inactivate reverse transcriptase, an RNA purification step 
is typically included in the protocols, making them ill suited to high-throughput applications. 
Proteolytic digestion of RNases can be followed up with thermal-inactivation to irreversibly 
denature the protease, obviating RNA purification.  However, this method again introduces 
the possibility of inefficient recovery owing to RNA hydrolysis during the heat treatment. 
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At the outset of assay development, simple dilution looked like a promising strategy for 
RNase containment.  The volume of a typical hematopoietic cell is on the order of 1 pL, so 
endogenous RNases should be diluted 107-fold when one cell is lysed in 10 µL of buffer.  It 
therefore seemed possible that the need for chemical ribonuclease inhibitors would be 
obviated in single-cell analysis.  This was attractive because the preferred RT-PCR strategy 
involved performing cDNA synthesis at temperatures (50–70 °C) outside the recommended 
operating range of most RI products.    
Many early trials focused on establishing a safe cell concentration range for mRNA recovery 
in the absence of ribonuclease inhibitors.  Experiments using homogenized SCID.adh lysates 
gave an early indication that dilution would not be the hoped-for cure-all.  Serial dilutions of 
lysate were allowed to stand for a several minutes and then analyzed by qRT-PCR.  Ideally, 
the resulting Ct values would be expected to go down by one cycle with each doubling of the 
lysate concentration, in a classic qPCR standard-curve relationship.  In practice, while this 
relationship was observed for the most dilute samples, the Ct values fell more slowly than 
expected going to higher concentrations, and then started increasing.  Analysis of the data 
from these trials indicated that, in the absence of RIs, lysate concentrations of >0.1 cells/µL 
might entail a significant loss of mRNA before cDNA synthesis, with a steep falloff in 
recovery going to higher concentrations.  Thus, while efficient recovery of mRNA from one 
cell dispensed into 10 µL of buffer might be borderline feasible, there would be no leeway 
for analyzing lysates made from higher number of cells in the same volume.   
FACS-based trials provided insight into the relation between cell concentration and mRNA 
recovery under more realistic assay conditions.  For these experiments, the cell sorter was set 
to dispense a ramped number of cells to wells containing a fixed volume of RT-PCR buffer.  
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After qRT-PCR analysis of the lysates, the Ct values were plotted against cell count.  Similar 
trends emerged to those seen in the trials with homogenized lysates, with the qPCR signal 
falling off at high cell concentrations (figure 4.1).   
 
 
 
Figure 4.1. Cell-concentration ramp analysis. FACS was used to sort a binary ramp of 1–64 SCID.adh cells into 
20 µL of qRT-PCR buffer. The GAPDH Ct values for single-cell samples were around 30, which is reasonable 
for this target. The Cts for two-cell samples were slightly lower, but at higher cell concentrations the Ct actually 
increases, indicating significant degradation of mRNA before the RT step. 
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The data from the “cell ramp” experiments were fit to a mathematical model to estimate the 
safe cell-concentration range for mRNA recovery.  The model assumes that (1) endogenous 
RNase activity is the main factor in the cell-concentration-dependent RNA losses, and (2) 
RNases quickly and freely diffuse away from the cell on lysis.  On this model, mRNA levels 
should undergo exponential decay with a half-life inversely proportional to the RNase 
concentration (and therefore the cell concentration) in the lysate.  If N cells are dispensed to 
V µL of buffer, the fraction, F, of mRNAs recovered into the RT step is given as follows: 
F ൌ eି୩N/V. 
Here, k is a proportionality constant whose value depends on a number of factors which 
should be (approximately) invariant within a given set of experimental conditions, including 
the number of RNases per cell, the kinetic rate constant governing the degradation reaction, 
and the time interval between lysis and cDNA synthesis.  Once the model is fitted to the 
data, k can be estimated and the efficiency of mRNA recovery can be calculated relative to 
the ideal case where no RNases are present (F = 1).   
To fit the model to the data, we need to convert between Ct readouts and relative amounts 
of cDNA.  We start by computing a “delta Ct” value for each sample relative to the average 
single-cell readout, Ctsc: 
∆Ct ൌ  Ct െ Ctୱୡ. 
The ratio of the concentration of cDNA in a sample to that in an average single-cell sample 
can be calculated from the ΔCt value given the efficiency of PCR amplification, Epcr:   
ሾୡDNAሿ
ሾୡDNA౩ౙሿ
ൌ ൫1 ൅ E౦ౙ౨൯
ି୼େ୲
. 
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With a good set of primers, Epcr should be close to 100%, i.e., the amplicon doubles every 
cycle, so we will introduce the following simplification: 
ሾୡDNAሿ
ሾୡDNA౩ౙሿ
ൌ 2ି୼େ୲. 
From the recovery model, we expect this ratio to depend on the number of cells in the lysate 
and the attendant loss factor due to RNase activity: 
ሾୡDNAሿ
ሾୡDNA౩ౙሿ
ൌ N·ୣ
షౡN V⁄
ୣషౡ/V
ൌ N · eି୩ሺNିଵሻ/V ൌ 2ି୼େ୲. 
Therefore: 
ln൫N · eି୩ሺNିଵሻ V⁄ ൯ ൌ lnሺNሻ െ k · ሺN െ 1ሻ V⁄ ൌ െΔCt · lnሺ2ሻ. 
Rearranging: 
lnሺN · 2୼େ୲ሻ ൌ k · ሺN െ 1ሻ V⁄  ׵   k ൌ  ୪୬ሺN·ଶ
౴ి౪ሻ
ሺNିଵሻ/V
. 
The value of k can therefore be estimated from a least-squares linear fit of the appropriately-
transformed data (figure 4.2).  For the 20 μL ramp data, we get an estimate of k = 6.4 μL. 
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Figure 4.2. Least-squares fit to mRNA-loss model. From the slope of the line, we get an estimate of k = 6.4 µL. 
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The Ct data from the cell-ramp trials gave a good fit to the model, and the values obtained 
for k from trials using 20 μL and 50 μL lysate volumes were within 10% of each other.  For 
the single-cell case, we have: Fୱୡ ൌ  eି୩/V.  We can substitute the estimate of k into this 
formula to compute the mRNA recovery efficiencies for single-cell samples prepared in 
different lysate volumes (table 4.2). 
 
Table 4.2. Projected single-cell mRNA recovery (k = 6.4 µL) 
Lysate Volume (μL) mRNA Recovery
10 53%
20 73%
50 88%
100 94%
 
The data from the SCID.adh ramp trials indicated that a high lysate volume (≥50 μL) would 
be needed to recover ≥90% of the mRNA from a single cell without the use of ribonuclease 
inhibitors.  This was particularly problematic for the digital PCR study, as the sample volume 
in the microfluidic chip was only 7.5 μL.  In addition, it seemed likely that the actual “safe” 
dilution would be sensitive to cell type and cell-to-cell heterogeneity. 
It may seem surprising that the RNase burden of one cell could have such potent activity 
after ~107-fold dilution.  A simple order-of-magnitude calculation gives an idea of how this 
is possible.  The rate constants for diffusion-limited reactions involving small molecules are 
usually on the order of 108 L·mol-1·sec-1, but rates of 1010–1011 L·mol-1·sec-1 have been 
reported for protein-nucleic acid interactions, even in the absence of facilitated diffusion 
[96].  Assume that the cellular RNase burden is ~106 molecules (equivalent to ~0.1% of the 
10-10 g of protein in a cell), and take a rate constant for the RNase-mediated degradation 
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reaction of 1010 L·mol-1·sec-1.  Within a 10 μL volume, the reaction rate per mRNA molecule 
is then:  
1010 L·mol-1·sec-1 · (106 / NA) mol / 10-5 L = 0.002 sec-1. 
In this scenario, the half-life of mRNA in lysis buffer is on the order of minutes.  It is not 
clear when most of the RNase-mediated losses occur—whether during the preparation of 
the lysate, or during the RT step itself—but RNases probably do have a window of several 
minutes to attack their targets in between cell lysis and reverse transcription. 
After it became clear that RIs would have to be included in the reaction buffer, experiments 
focused on evaluating different products and measuring the range of cell concentrations over 
which they restored normal standard-curve relationships. SUPERase-In (Ambion) emerged 
as a promising RI for the single-cell application.  According to the manufacturer’s datasheet, 
SUPERase-In is active in the range of 37–65 °C, making it compatible with high-
temperature reverse transcription.  FACS trials showed that the addition of this RI to the 
RT-PCR buffer effectively inhibited RNase activity in the cell-concentration range of interest 
(figure 4.3).   
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Figure 4.3. Effect of SUPERase-In on mRNA recovery. The charts show the GAPDH Cts obtained from 
12 µL qRT-PCR reactions based on FACS-dispensed binary ramps of 1–16 SCID.adh cells per reaction.  
Addition of SUPERase-In to the buffer restores normal PCR standard-curve relationships, at least up to the 8-
cell case.  
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In cell-ramp trials conducted using a 12 μL volume, the standard-curve relationships looked 
good for 1–5 cells per reaction, but the recovery efficiency and consistency dropped off at 
cell concentrations of ≥0.5 cells/μL.  Since this cannot be taken as a general result, 
applicable to all cell types, cell-ramp controls were used during the research work to check 
that the single-cell samples were in the “safe zone” for RNase activity (figure 4.4). 
 
 
 
Figure 4.4. Cell-concentration ramp control from the aging study. Analysis of 8-tube strips containing from 1 
to 128 cells FACS-dispensed to 10 µL of buffer showed that normal standard-curve relationships were 
preserved even at cell concentrations well above those used to evaluate single cells, indicating that RNase-
mediated RNA loss was contained under the assay conditions applied.  
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The fit between the cell-ramp data and the exponential-decay model and the observation 
that RI rescued standard-curve relationships supported the theory that the falloff in qRT-
PCR signal at high cell concentrations was due to freely diffusing endogenous RNases.  Still, 
it remained possible that other RNA losses were incurred in the hypotonic-lysis protocol; for 
example, transcripts might be degraded before the plasma membrane ruptures or become 
entrapped in cellular debris and made unavailable for reverse transcription. To check that 
hypotonic lysis was efficient at recovering mRNA into the RT step, experiments were 
performed to compare this strategy to traditional RNA isolation methods.  RNeasy (Qiagen, 
Valencia, CA), a popular, GITC-based RNA isolation kit, was used to lyse 10,000 viable cells 
sorted into CB buffer by FACS, and a qRT-PCR standard curve was run on serial dilutions 
of RNA purified from the cell prep.  The results were compared to a standard-curve analysis 
on an isolation-free cell-ramp trial (figure 4.5).  The comparison showed that the efficiency 
and consistency of recovery with the isolation-free protocol was, if anything, superior to that 
achieved with the conventional, multistep chaotropic prep.  Later experiments compared 
hypotonic lysis to RNA isolation using PicoPure (Molecular Devices, Sunnyvale, CA), a 
GITC-based kit optimized for processing very small samples.  In these experiments, low 
numbers of cells were sorted directly into the PicoPure extraction buffer.  Again, the results 
gave an edge to the isolation-free protocol. 
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Figure 4.5. Hypotonic lysis versus chaotropic mRNA isolation.  The charts show GAPDH Cts from 12 µL 
qRT-PCRs conducted on cellular mRNA prepared using the isolation-free, hypotonic-lysis method or Qiagen’s 
RNeasy RNA isolation kit.  The results indicate that the isolation-free protocol recovers at least as much 
mRNA as the chaotropic lysis prep. 
83 
 
4.2.4 Genomic Background 
Most RNA isolation protocols incorporate an optional DNase treatment step to digest 
contaminating genomic DNA (gDNA).  Since DNase activity is incompatible with cDNA 
synthesis, inclusion of this step generally mandates either RNA purification or thermal 
inactivation of the DNase enzyme.  Digestion of gDNA therefore complicates sample 
processing, and may compromise assay sensitivity due to losses incurred during RNA 
purification or heat-induced RNA hydrolysis [64].  These considerations argued against the 
inclusion of a DNase step in the single-cell assay protocol, but the issue of genomic 
background had to be addressed nonetheless. 
At first sight, gDNA carryover might not appear to be a major concern for mRNA 
quantitation, as the cellular copy number of all but the rarest transcripts well exceeds the two 
copies of the encoding gene present in a diploid genome.  To some extent, the inclusion of a 
DNase step in standard RNA isolation protocols may reflect low mRNA-to-cDNA 
conversion efficiency in early RT protocols.  However, genomic background can still be a 
problem, even given efficient reverse transcription.  Many genes have multiple homologues 
within the genome, including both related, functional genes and untranscribed pseudogenes; 
this is particularly true of highly conserved genes involved in basic cellular processes [97].  
Non-specific amplification of these homologous gDNA sequences may produce a non-
trivial background signal during qRT-PCR [98].   
To keep the protocol streamlined and maximize RNA recovery, DNase treatment was not 
included in the single-cell analysis protocol, and the problem of genomic background was 
instead addressed at the level of assay design and validation. For most of the targets analyzed 
in the research studies, the qPCR assay design included an exon-straddling primer or probe, 
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increasing specificity for cDNA over gDNA templates.  “No RT” controls using Taq rather 
than an RT/Taq enzyme blend were performed to verify that the genomic background signal 
from lysate preps was well below that typical of RT+ reactions.  In the aging study, which 
employed SYBR Green qPCR, melt-curve analysis was also applied to check if the 
predominant amplification product had a melting temperature (Tm) characteristic of the 
expected cDNA transcript (figure 4.6).  
 
Figure 4.6. Melt-curve analysis of qRT-PCR products. In the aging study, melt curves were performed at the 
end of SYBR Green qPCRs to check for primer-dimer or non-specific product formation. These are plots of 
dI/dT from one qPCR run; the peaks indicate the Tm of the amplification products.  The red curves 
correspond to cell-lysate reactions, and the green curves to parallel reactions on runoff-transcribed RNA 
standards.  In these analyses, Rpl5 and Rpl19 sometimes gave significant secondary peaks around 70 °C, a few 
degrees below the Tm of the standards.  These peaks probably came from non-specific amplification of 
homologous transcripts or genomic DNA; the ribosomal-subunit genes are evolutionarily ancient and have 
many homologues.  The non-specific product peaks were only significant in granulocytes, which had low levels 
of Rpl5/Rpl19 expression.   
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4.3 Transcript Quantitation 
4.3.1 RT Priming Strategy 
Reverse transcription can be primed using gene-specific primers (GSPs), so that only 
particular mRNA targets are transcribed into cDNA; alternatively, non-specific oligo(dT) or 
random-hexamer primers can be used to synthesize a cDNA pool representing the entire 
population of messages in the RNA sample.  Non-specific priming is mandatory for broad-
spectrum evaluation of cDNA by microarray or SAGE, and affords total flexibility in the 
choice of assay targets in the qPCR context. However, the two common non-specific 
priming methods both have significant drawbacks: 
1. Since reverse transcriptase is inefficient at producing full-length transcripts, cDNA 
made using oligo(dT) primers usually only gives good representation of the 3’ ends 
of messages; qPCR assays designed for use on these preps must be targeted 
accordingly.  The 3’ bias effect can make it difficult to design an efficient or selective 
qRT-PCR assay for some targets. 
2. If random-primed RT is applied directly to total RNA, the resulting cDNA prep will 
contain a superabundance of ribosomal RNA sequence, which can compromise the 
performance of downstream quantitation assays.  Preisolation of poly(A) mRNA 
using oligo(dT)-coated columns or beads can be used to address this problem, but 
complicates sample processing and may impact mRNA recovery efficiency. 
For qRT-PCR studies targeting a few, preselected genes, there is evidence that assay 
sensitivity and accuracy can be improved through the use of gene-specific RT primers [86, 
92].  This might also be expected on theoretical grounds: 
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1. The sensitivity of qRT-PCR assays is strongly dependent on the efficiency of reverse 
transcription. It is fairly easy to achieve almost 100% transcription efficiency from 
DNA templates using Taq polymerase, but robust, efficient reverse transcription 
from RNA templates remains problematic [86].  The reasons for this are not fully 
understood, but there is a consensus that RT enzymes have difficulty transcribing 
through regions of RNA secondary structure [92, 99, 100].   
2. Random priming has to be performed at low temperatures (~25 °C) because of the 
low affinity of short oligomers for their templates.  The RT incubation temperature 
can be ramped up once nascent transcripts are formed, to disrupt RNA secondary 
structure and allow more complete transcript extension.  Even so, any regions of 
template which were highly folded at the initial priming temperature may be 
underrepresented at the end of cDNA synthesis.   
3. While oligo(dT) priming can be performed at temperatures similar to those used for 
gene-specific priming (~50 °C), mRNAs which are GC-rich and high in secondary 
structure at the 3’ end may not be efficiently converted to cDNA.  In contrast, gene-
specific RT primers can be designed to target template regions with low predicted 
secondary structure, increasing the likelihood of efficient reverse transcription.   
4. Global reverse transcription may reduce the specificity and therefore the accuracy of 
transcript quantitation because a large, heterogeneous population of cDNA 
transcripts is carried forward into the qPCR analysis, increasing the probability that 
non-specific priming of homologous sequences will affect the Ct readout.   
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Since sensitivity, specificity and quantitative accuracy were priorities for the single-cell 
analysis work, gene-specific priming was preferred from the outset, and no attempt was 
made to evaluate global reverse-transcription strategies during assay development. 
4.3.2 RT Chemistry 
In traditional “two-step” qRT-PCR protocols, reverse transcription and qPCR analysis are 
performed in separate buffers optimized for the different enzymatic reactions involved.  In 
the last few years, more convenient “one-step” qRT-PCR kits have become increasingly 
popular.  In one-step qRT-PCR, reverse transcriptase and Taq polymerase are included in the 
same reaction buffer; after RT incubation, the cDNA product is immediately analyzed by 
qPCR without opening the reaction vessel.  Two-step RT-PCR protocols are compatible 
with GSP, oligo(dT), and random priming strategies.  In a single-tube reaction, carryover of 
undiluted random hexamers or oligo(dT) primers and primer extension products into PCR 
may result in competitive inhibition of the target reaction.  For this reason, gene-specific RT 
priming is almost always preferred for single-tube RT-PCR; typically, the reverse PCR primer 
serves as the GSP for the reverse-transcription reaction. 
One-step RT-PCR kits are still fairly new on the market, and most of the single-cell studies 
reported in the literature have applied conventional, two-step RT-PCR protocols. Benefits of 
the single-tube approach include streamlined sample processing and reduced opportunities 
for sample loss and contamination [70].  Traditional two-step protocols call for a substantial 
dilution of the RT reaction product going into the PCR step, which can be problematic for 
single-cell work. For example, the manual for the SuperScript III First-Strand cDNA 
Synthesis kit (Invitrogen, Carlsbad, CA) suggests that a maximum of 10 μL of a 20 μL RT 
reaction be taken forward into a 50 μL qPCR; however, the use of only 2 μL of product is 
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preferred.  The recommended volume for qPCR reactions in a standard thermocycler is 10–
100 μL, while the sample-panel volume in the digital PCR chip used for the hematopoiesis 
study was only 7.5 μL.  Given that the practical volume for recovering single cells by FACS 
is about 10 μL, a 10ൈ-to-250ൈ dilution of RT product would hard to reconcile with qPCR 
analysis of the entire mRNA content of a cell.  Dilution going into the qPCR step can be 
obviated by purifying the cDNA away from the reaction buffer [101], but this approach 
significantly complicates sample processing.   
From the outset, then, one-step RT-PCR chemistries looked promising for high-throughput 
single-cell analysis.  Two-step RT-PCR is often cited as the more sensitive approach, but the 
reasons why this should be so are rarely explored.  Two issues are probably involved: 
1. Usually, the limiting factor in the sensitivity of qPCR assays is competitive inhibition 
due to the amplification of primer-dimer (PD) products.  Today, most commercial 
Taq enzymes incorporate “hot start” protection mechanisms which virtually 
eliminate formation of PD products during reaction setup.  In general, though, RT 
enzymes are not hot-start protected.  These enzymes are active at low temperatures, 
and have DNA-dependent as well as RNA-dependent polymerase activity.  
Consequently, significant amounts of PD product may be present in cDNA preps 
[102].  Two-step GSP-based reactions may be less affected because the forward PCR 
primers are excluded from the RT buffer [103].  PD-related inhibition is probably 
not a significant issue in two-step qRT-PCR protocols based on oligo(dT) or 
random-hexamer priming, because (1) the RT primers are highly diluted in the 
qPCR, and (2) primer-extension products carried over from the RT step cannot be 
efficiently amplified by the gene-specific primers used in the PCR. 
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2. Although the mechanism is not understood, reverse transcriptases can inhibit PCR at 
the concentrations used in traditional RT protocols [101, 102, 104-107].   This effect 
can lead to poor qPCR assay performance in single-tube reactions, unless the RT-to-
Taq ratio and other aspects of the buffer chemistry are carefully optimized.  
Evaluation of a variety of single-tube kits, attempts to “home brew” a single-tube 
chemistry using a preferred combination of RT and Taq products, and discussions 
with vendors’ technical staff all indicate that this is a non-trivial and, to some extent, 
unresolved problem.   
Given the compelling advantages of single-tube RT-PCR chemistries for the single-cell 
application, the sensitivity question was addressed by systematic validation of assays using 
standard-curve trials.  About half a dozen different one-step reaction kits were evaluated 
during assay development, including products based on AMV, MMLV and proprietary RT 
enzymes and two-enzyme blends.  Invitrogen’s CellsDirect SuperScript III/Taq gave the 
most consistent sensitivity and reproducibility of all the products evaluated (figure 4.7). 
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Figure 4.7. Six-plex qRT-PCR standard curve with SSIII/Taq. Aggregated results from 5-point standard-curve 
analyses on six different targets by simplex TaqMan qRT-PCR using CellsDirect SuperScript III/Taq enzyme 
blend. The templates were runoff-transcribed RNA; the x-axis gives the RNA copy number per 20 µL reaction. 
The PCR efficiency and single-copy Ct intercept is based on the data for all six assay targets. 
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4.3.3 Assay Design 
4.3.3.1 Template Analysis 
The first step in designing a qRT-PCR assay involves retrieving the sequence of the target 
transcript from public databases.  Two databases were referenced for the single-cell studies: 
1. NCBI Entrez Nucleotide (www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) 
2. Ensembl Mus musculus (www.ensembl.org/Mus_musculus) 
Differences were often found in the sequences recovered from Entrez and Ensembl, 
especially near the beginning and end of the transcripts.  For this reason, all the finalized 
assay designs were checked for compatibility with sequences from both databases.   
RNA-folding prediction software was used to identify secondary structure-free stretches of 
the mRNA template long enough to accommodate a qPCR assay (figure 4.8).  While no 
systematic attempt was made to evaluate the impact of secondary structure on RT efficiency, 
some evidence for its significance emerged during assay development.  Substandard Ct 
readouts were noted in standard-curve trials with a PU.1 assay whose amplicon overlapped 
predicted RNA secondary structure.  A new assay was designed which completely avoided 
secondary structure.  The revised assay gave a 2.5-fold improvement in RT efficiency relative 
to the original design, as assessed by digital PCR. 
  
92 
 
 
Figure 4.8. Secondary structure prediction. Part of the output obtained using the “Template Structure Search” 
feature of Premier Biosoft’s Beacon Designer, showing the predicted folding of the first ~160 bases of the 
ActB transcript.  The program uses the Quickfold server to predict the self-hybridization of PCR templates.  
The primer and probe sequences of the ActB assay designed for the aging study are highlighted.  To maximize 
RT efficiency, the primers were designed to fall within a region that is completely free of secondary structure.  
To minimize amplification from genomic templates, assays were designed to be cDNA-
specific whenever possible.  Specificity was achieved by including exon-straddling primers or 
probes in the assays.  The Ensembl database gives the exon structure of mRNA transcripts. 
Figure 4.9 shows the first few hundred bases of the ActB mRNA sequence retrieved from 
Ensembl, with the exon structure indicated by alternating black and blue text; the primer and 
probe sequences for the ActB assay used in the aging study are underlined.  Here, the 
TaqMan hybridization probe straddles a splice junction.  In each of the other five assays 
used in the study, at least one of the selected primers straddles an exon boundary.*   
                                                 
* SYBR Green qPCR chemistry was ultimately preferred for the aging study, so the cDNA-
specificity afforded by the probe in the ActB assay design was unavailed.  Even so, the fact 
that the primers bracket an intron gives this assay some specificity toward cDNA. 
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Assay designs were also checked for specificity by running BLAST searches using the entire 
predicted amplicon sequence against genomic and cDNA databases.  High-scoring matches 
were reviewed to see if the primer sets were likely to coamplify homologous transcripts or 
genes along with the primary mRNA target. 
 
Figure 4.9. Design of a cDNA-specific assay. Part of the ActB mRNA sequence retrieved from the Ensembl 
database is shown, with the exon structure indicated by alternating black and blue text. Underlining indicates 
the positions of the ActB assay primers and probe. The probe sequence straddles an exon boundary and is 
therefore highly specific for the cDNA template. In addition, the primers target different exons, which are 
separated by a 959 bp intron in the ActB gene; 1031 bp amplicons derived from the genomic template will 
amplify less efficiently than the 72 bp cDNA-templated amplicons, adding to the specificity of the assay. 
4.3.3.2 Primer/Probe Selection 
Most of the assay design for the hematopoiesis study was done using a commercial software 
package, Beacon Designer Version 4 (Premier Biosoft, Palo Alto, CA).  At the time of 
purchase, this product was unusual and possibly unique in supporting the automated design 
of multiplexed TaqMan assays.  However, the program also had important limitations: it was 
not “exon aware,” and the algorithm for qualifying multiplex primer combinations seemed 
excessively conservative, treating all high-affinity PD interactions, and not just 3’ end 
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interactions, as equally problematic.  As the single-cell work progressed, this fully automated 
solution was set aside in favor a semiautomated, iterative design approach.   
All the assay design for the aging study was performed using Primer3 (frodo.wi.mit.edu), a 
free, web-based program (figure 4.10).  First, regions of transcript long enough to 
accommodate a TaqMan assay (≥75 bases) were qualified based on the absence of RNA 
secondary structure and presence of exon-splice junctions.  Each candidate region was 
evaluated separately as a template for Primer3 assay design.  The program was set to pick 
forward and reverse primers with Tms around 60 °C (the program default), and a 
hybridization probe with a Tm of 70 °C; the desired product size was set to 75–150 bases.  
Default settings were used for all other parameters.  Primer3 was usually able to find 
multiple, high-scoring assay designs for each candidate region.  Designs lacking an exon-
straddling primer or probe were eliminated from further consideration.    
 
 
Figure 4.10. Primer design using Primer3. Part of the listing produced by Primer3 for the ActB assay, showing 
the predicted Tm for the primers and probe (approximately 60 °C and 70 °C, respectively) and the size of the 
PCR amplicon (72 bases). The program also highlights the positions of the primers and probe in the template.
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Candidate primers were checked against assays previously qualified for use in multiplexed 
reactions using FastPCR (www.biocenter.helsinki.fi/bi/Programs/fastpcr.htm), a freeware 
application (figure 4.11). Primer picks which showed significant potential for 3’ PD 
interactions were disqualified.   
 
 
Figure 4.11. FastPCR analysis of primer-dimer interactions. (a) The six primer pairs used in the aging study 
were entered into the FastPCR program. (b) The program identified two significant base-pairing interactions 
for the input primer set. (The first two entries in the listing refer to the same interaction.)  Neither of these 
interactions involves 3’-end complementarity, so it is unlikely that the identified primer dimers will template the 
production of efficiently-amplified secondary products.  The primer set therefore passes in silico screening. 
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For some targets, the multiplicity of design criteria made it difficult to find a suitable assay in 
a single pass, and multiple rounds of Primer3 design and FastPCR analysis were required 
before a satisfactory solution was identified. In such cases, a larger pool of candidate assays 
could be generated by relaxing Primer3’s design parameters, e.g., widening the acceptable 
range of primer Tm values, or reducing the minimum permitted probe Tm.  Most of the 
primers designed using Primer3 and FastPCR performed well in empirical qualification trials, 
and it rarely proved necessary to redesign assays. 
4.3.4 Assay Validation 
4.3.4.1 PCR Efficiency 
Programs like Primer3 apply well-established design rules to identify primer sequences that 
should give highly efficient PCR amplification.  However, the in silico screening of primers is 
still imperfect, and some automated primer picks give low PCR efficiency in practice.  In 
principle, high PCR efficiency is not a prerequisite for accurate cDNA quantitation: 
1.  Within the digital PCR chip used for the hematopoiesis study, a perfect assay might 
give a “callable,” above-background TaqMan signal after about 25 cycles of 
amplification.  An assay with 70% amplification efficiency would give the same 
fluorescence readout after around 33 cycles (25 ൈ log(2.0)ൊlog(1.7) = 32.7).  In 
theory, then, both assays should give the same digital readout if the end-point 
analysis is conducted after 40 cycles of PCR.  
2. In the real-time PCR assays used in the aging study, transcript copy number was 
computed based on the ΔCt between a cell-lysate sample and reference reactions 
bearing 1000 copies of runoff-transcribed RNA.  The ΔCt calculation is as follows: 
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N୫RNA  ൌ  1000 ·  ൫1 ൅ E୮ୡ୰൯
ሺେ୲౩౪ౚ – େ୲ሻ. 
So long as the value of Epcr is known for a given assay, this formula can be used to 
calculate transcript abundance regardless of PCR amplification efficiency. 
Nevertheless, low-efficiency assays are more vulnerable to competitive inhibition by non-
specific side reactions. Suppose a short primer-dimer extension product amplifies with 100% 
efficiency. After 30 PCR cycles, its abundance relative to the target amplicon will be over a 
hundred times higher in a 70% efficient assay than in a 100% efficient assay 
(2.030 ൊ 1.730 = 131).  Since it is relatively easy to find primers which give near-optimal PCR 
efficiency, all candidate assays were evaluated in simplex qPCR standard-curve trials to 
ensure that they gave efficient amplification. In standard-curve analysis, qPCR is performed 
on a dilution series of templates, and the efficiency of amplification is calculated from a plot 
of Ct versus the log of template concentration. The Ct readouts for samples with 1 unit of 
template and N units of template are related as follows: 
N ൌ  ൫1 ൅ E୮ୡ୰൯
ሺେ୲భିେ୲ሻ. 
Taking the log of both sides: 
logሺNሻ ൌ  ሺCtଵ െ Ctሻ · log൫1 ൅ E୮ୡ୰൯. 
Rearranging, we derive an expression with the form y = mx + c: 
Ct ൌ  െ ଵ
୪୭୥൫ଵାE౦ౙ౨൯
· log ሺNሻ  ൅ Ctଵ. 
Therefore, given a plot of Ct versus log(N), the PCR efficiency of an assay is computed from 
the slope of the best-fit line as follows: 
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E୮ୡ୰ ൌ  10ିଵ/ୱ୪୭୮ୣ െ  1. 
The intercept of the plot on the y-axis gives the value of Ct1; if the template is quantitated in 
copies per reaction, this is the projected single-copy Ct for the assay. 
The Epcr estimates derived from standard-curve analysis are approximate; typically, adjusting 
the fluorescence threshold or baseline normalization used in calling Ct values can easily alter 
the calculated value by several percentage points.  There is no absolute cutoff for what 
constitutes an acceptable assay, but primers which have ≥90% PCR efficiency may be 
considered near optimal, while an Epcr value below 80% indicates a substandard assay.   
Sometimes, a low-efficiency assay can be rescued by increasing the primer concentration of 
one or both primers in the pair, raising their effective Tm in the reaction.  This kind of 
optimization was explored early on in assay development, but the use of high primer 
concentrations was eventually rejected because it promotes primer-dimer formation.  All 
primers were empirically qualified at a relatively low, fixed reaction concentration (100 nM); 
assays which failed to give satisfactory PCR efficiency under these conditions were 
eliminated or redesigned. 
In addition to providing an estimate of priming efficiency, qPCR standard-curve trials can 
provide clues to other problems.  A standard curve which gives a near-optimal Epcr value but 
an unexpectedly high Ct1 intercept may signal poor TaqMan probe performance or, in RNA-
based reactions, low RT efficiency.  Non-linearity in the standard curve at the low end of the 
template-concentration range, with increasing ΔCt between successive template dilutions, 
may indicate that the primers have significant PD-forming potential even in the context of 
simplex PCR.  Primer-dimer formation can be investigated by using SYBR Green assays to 
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visualize the accumulation of low-Tm products in no-template reactions; increased primer 
concentrations can be used to exaggerate the problem in debug assays.   
4.3.4.2 Multiplex Compatibility 
Transient base-pairing between primers with 3’-end complementarity can produce substrates 
for polymerization by reverse transcriptase and Taq (figure 4.12).   Often, the resulting short 
primer-dimer extension products amplify very efficiently during PCR; they can give rise to 
spurious signals in SYBR Green reactions, and compete with target amplicons for reagents 
irrespective of dye chemistry.  Competitive inhibition of the primary amplification reaction is 
most likely when the true PCR template is at low abundance.  Under these conditions, the 
ratio of template to secondary product starts out low, and any advantage in amplification 
efficiency enjoyed by the latter is magnified by the many cycles of exponential amplification 
required to reach the detection threshold.  The primer-dimer problem is exacerbated in 
multiplexed PCR, owing to the high overall primer concentration and diversity of primer 
sequences in the reaction.  In silico evaluation of multiplex primer sets is not always effective 
at identifying problematic interactions; in any case, as the level of multiplexing increases, 
compromises usually have to be made to meet other design criteria.  
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Figure 4.12. Primer-dimer extension. When primers have significant complementarity, they can hybridize to 
form short-lived dimers, especially at low temperatures. In the presence of abundant polymerase, primer dimers 
can template the synthesis of primer-extension products. If the base pairing occurs at the 3’ ends of the 
primers, the extension products will have Tms close to the annealing temperatures used in the PCR reaction.  
Efficient amplification of these short secondary products may exhaust PCR reagents or saturate polymerase 
activity before legitimate assay targets can be amplified to detectable levels. 
 
Multiplexed PCR was used throughout the single-cell work, so the primer-dimer-forming 
potential of combined assays was a major concern.  The specialized PCR methods employed 
provided some margin of safety: (1) in the chip assay used for the hematopoiesis study, the 
sequestration of individual cDNA molecules into 6 nL subreactions raises the concentration 
of template relative to PD products; (2) the multiplexed preamplification PCR used in the 
aging study was limited to 15 cycles to minimize the effect of reagent depletion on PCR 
efficiency.  Nonetheless, multiplexed assay sets were qualified empirically to ensure that PD-
mediated PCR inhibition was contained.  For the digital PCR work, combined assays were 
evaluated by running standard curves in a 4-channel qPCR system, the Chromo4 (Bio-Rad, 
Hercules, CA); the same TaqMan probes used in the multiplexed chip assay were employed 
in these desktop trials.  In the aging study, 6-plex primer sets were tested for compatibility by 
running low-concentration standard curves using the full two-stage “preamp” protocol. 
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4.3.4.3 Reverse-Transcription Efficiency 
Reverse-transcription efficiency is not as easily assessed as PCR efficiency, and values are still 
hard to come by in the literature.  The most thorough study on this question yet published 
reports numbers ranging from 2% to 90%, depending on the assay target, RT enzyme, and 
priming strategy [86].  In the current state of the art, then, it is hard to set an expectation 
level for the RT efficiency attainable in qRT-PCR.  For this reason, no formal qualification 
procedure was used to screen candidate assays for RT efficiency.  During assay development 
for the hematopoiesis study, efficiency estimates were made based on digital PCR analysis of 
cDNA preps derived from quantitated RNA runoff transcript (figure 4.13).  The estimates 
routinely varied over a ~3-fold range depending on the assay target.  One early assay design 
which gave particularly low efficiency was successfully redesigned based on this analysis. 
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Figure 4.13. On-chip standard-curve assays. (a) Combined results from a series of three on-chip standard-curve 
trials performed on purified DNA template (Ambion GAPDH DECAprobe cDNA) using Bio-Rad iQ Taq 
polymerase supermix.  Four template concentrations were analyzed: 12.5, 25, 50 and 100 copies/µL. Each 
concentration was evaluated in triplicate in every chip.  The standard-curve fit was near-optimal (R2 ≥ 0.99) in 
the individual chips, and the interreplicate variation was within the expected Poisson sampling error. The 
slightly higher variability in the combined results probably reflects differences in final loaded sample volume 
between chips. (b) Combined results from three on-chip standard curve trials based on pooled GAPDH and 
PU.1 runoff RNA. Reaction mixes were made up with SSIII/Taq. The RT step was performed off chip in a 
conventional thermocycler.  On-chip cDNA analysis was done using a duplex TaqMan assay. The RNA-based 
analyses displayed higher technical variability than seen in the trials based on purified DNA: the CV for the RT 
efficiency estimates derived from each panel was 20% for PU.1 and 29% for GAPDH.  
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No attempt was made to assess mRNA-to-cDNA conversion efficiency in the aging study.  
Since the transcript copy number quantitation was based on RNA references, RT efficiency 
was only a concern from a sensitivity standpoint in this case.  The assays all gave reasonably 
high single-cell readouts on the six medium-to-high abundance transcripts evaluated in the 
study, so the efficiency of the RT step did not emerge as a major concern.  The Ct values for 
1000-copy RNA standards reactions were surprisingly tightly clustered across all six targets 
(figure 4.14), typically giving a standard deviation of less than one cycle after ~35 cycles of 
PCR amplification (15 cycles of “preamp” plus ~20 cycles of qPCR).  At least some of the 
spread in Cts must have come from variations in PCR amplification efficiency between the 
different assays.  This observation suggests that the RT efficiency was at least roughly similar 
for all six targets, with none of the individual assays performing substantially “below par.” 
 
Figure 4.14. Clustering of RNA standards Cts. Quadruplicate RT/preamplification reactions were templated 
with a mixture of six different runoff-transcribed RNA standards. Each template was present at 1000 copies 
per reaction. Preamplification products were analyzed in 24 (4 ൈ 6) SYBR Green qPCRs. The graph shows the 
amplification curves from the qPCR analysis; each assay target is represented by a different color. The six 
targets gave tightly clustered readouts, indicating that the RT and qPCR efficiencies were similar for all assays. 
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4.3.4.4 Experimental Templates 
Much of the early assay validation work was done using mouse thymus cDNA and Poly(A) 
RNA preps purchased from Ambion.  As a rule of thumb, 1 pg of either of these products is 
approximately equivalent to the transcript content of a single cell.  However, the abundance 
of individual transcript species in the preps is unknown.  This was not an issue for PCR 
efficiency calculations, but single-copy Cts could not be computed from standard curves 
based on these templates, nor could they be used for RT efficiency measurements.   
Use of DECAprobe GAPDH cDNA template (Ambion) and homemade DNA standards 
made from UV-absorbance quantified, purified PCR products enabled a more quantitative 
approach to qPCR assay characterization.  As the work progressed, though, the need for 
RNA standards became more pressing.  This was addressed by using an in vitro transcription 
kit to make runoff RNA transcripts corresponding to all assay targets.  The steps involved in 
producing these RNA standards were as follows: 
1. PCR primers were designed against each target transcript, bracketing the amplicon 
regions of the qRT-PCR assays.  A T7 phage promoter sequence was prepended to 
the upstream primers. 
2. The primers were used to make templates for the in vitro transcription reactions, with 
Ambion’s thymus cDNA prep serving as the PCR template.  PCR products were 
cleaned up with the QIAquick kit (Qiagen) and checked for size and purity on a gel. 
3. The MEGAscript T7 kit (Ambion) was used to make runoff transcripts from the 
PCR templates.  Template DNA was removed from the preps in a DNase digestion 
step, and the RNA was column purified with Ambion’s MEGAclear kit. 
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4. The purity and size of the runoff-transcribed RNA was evaluated using Novex gels 
(Invitrogen) or the Experion gel electrophoresis system (Bio-Rad). 
5. RNA was quantitated by UV absorbance.  The RNA concentration was converted to 
copies per μL after using Mongo Oligo (library.med.utah.edu/masspec/mongo.htm) 
to calculate the molecular weight of the transcripts. 
6. A high-concentration stock comprising equimolar amounts of all target transcripts 
was prepared in TE pH 7.0; serial 10-fold dilutions were made from the stock.  RNA 
reference dilutions were kept at -20 °C, and the master stock was archived at -80 °C.  
4.3.5 Digital PCR 
4.3.5.1 Background 
Before the invention of real-time PCR, PCR was considered primarily a non-quantitative 
assay—visualization of reaction products on a gel at the PCR end point signaled if the target 
was present or absent, but usually little more than that. End-point PCR analysis can be made 
quantitative by performing reactions on serial dilutions of template; the dilution factor which 
causes PCR failure gives a rough estimate of DNA concentration. The limiting-dilution 
approach can also be used for highly accurate DNA quantitation, if the analyte is subdivided 
into many parallel PCRs so that each has a fractional probability of receiving a molecule of 
template. Then, the number of positive reactions provides a count of the input of template 
molecules [69]. This methodology was systematized and formally presented as “digital PCR” 
in a 1999 paper by Vogelstein and Kinzler [85]. Here, the technique was applied to 
determine the frequencies of wild-type and mutant alleles for a gene of interest. Genomic 
DNA harvested from normal and cancerous tissue was aliquoted to 7 μL PCR reactions 
arrayed in a 96-well plate. The DNA was quantitated and diluted before the analysis to 
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ensure that each well had a 50% chance of receiving template. After PCR, most of the 
positive reactions contained only wild-type or mutant amplicons; molecular beacons 
targeting these variants were added to the reactions to call the frequencies of each allele. 
Digital PCR is a laborious technique when performed in multiwell plates, and the dynamic 
range of the readout is limited.  Subdivision of analyte can be automated by dispersing 
samples into lipid micro-droplets (“emulsion PCR”) [108, 109], or by using microfluidic 
valves to partition a sample in a “lab-on-a-chip” reactor.  In the early 2000s, researchers at 
Fluidigm Corporation (South San Francisco, CA) demonstrated TaqMan-based digital PCR 
in a chip fabricated in PDMS (polydimethylsiloxane) silicone rubber using multilayer soft 
lithography [61, 110, 111].  A 2 μL sample was compartmentalized into 21,000 separate PCR 
reactions within the chip.  Pneumatic pressure was applied to force the analyte into an array 
of parallel channels connected to the sample port by a crossbar channel. A comb-shaped 
valve with teeth perpendicular to these channels was incorporated into an adjacent layer of 
PDMS; hydraulic actuation of the valve pinched off the sample channels, forming a grid of 
90 pL compartments (figure 4.15).  Hydraulic pressure was maintained during thermocycling, 
both to keep the reaction compartments isolated, and to ensure that they remained hydrated 
despite thermally induced outgassing through the PDMS. 
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Figure 4.15. Analyte subdivision in an elastomeric chip. Sample is loaded into an array of channels connected to 
the input port via a crossbar (blue). A comb-shaped valve in an adjacent layer of the chip (red) is hydraulically 
actuated to pinch off the sample channels, partitioning the reaction within a grid of sealed compartments.  
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The early work for the thesis project focused on designing and building PDMS chips based 
on Fluidigm’s original prototype.  A few months into this effort, Fluidigm decided to pursue 
production of a commercial digital PCR chip.  Efforts to manufacture a chip in-house were 
discontinued, and preproduction prototypes of what became known as the “Digital Array” 
chip served as the enabling technology for the hematopoiesis study. 
The prototype Digital Array has a 25 mm square active area which contains an array of 
14,400 6.25 nL PCR reaction chambers or “wells.”  The array is organized into twelve 
isolated sample panels, each with its own dedicated input port.  There are 1200 wells in each 
panel, giving a loaded sample volume of 7.5 μL.*  The number of reaction chambers 
determines the dynamic range of the digital PCR assay.  If the template copy number is well 
below 1200, almost all chambers capture 0 or 1 molecules, and the number of positive 
reactions corresponds closely to the number of template molecules in the panel.  At higher 
DNA concentrations, a significant fraction of chambers capture more than one molecule.  
Using the appropriate statistical correction, it should be possible to accurately estimate 
template abundance with as many as 2000 copies per panel (see appendix). 
The reaction chambers in the original, experimental Fluidigm PCR chip were simply short 
stretches of sample channel pinched off by the teeth of the comb valve. In the Digital Array, 
each sample channel passes through fifty “high-hat” chambers molded into the PDMS; the 
                                                 
* For the production version of the Digital Array, the spacing between sample channels has 
been increased to improve chip yields; in this chip, there are 765 chambers per panel, and the 
loaded sample volume is approximately 5 μL. 
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comb valve is aligned so that its teeth pass between the chambers. This design increases the 
volume of analyte that can be loaded into a given amount of chip “real estate.”  The well 
dimensions in the prototype chips were approximately 150 ൈ 150 ൈ 250 microns.  The 
loaded volume per chamber is slightly higher than the dry volume since (1) the chambers 
swell under pressure and (2) the PDMS is somewhat water permeable.   
Prototype chips were available mounted on silicon wafers or 75 ൈ 50 mm glass slides. Silicon 
wafers provide better thermal contact to the thermocycler block during PCR.  However, 
only slide-mounted chips were compatible with end-point fluorescence imaging using the 
ArrayWoRx scanner at our disposal. Fluidigm supplied an optimized thermocycling profile 
which incorporated “overshoot” in the temperature ramps to make up for the inferior 
conductivity of the slide base.   
To set up an experiment, samples were drawn into gel tips and spiked directly into the input 
ports of the chip. Plastic adaptors were used to connect the gel tips to a house air supply for 
sample loading. It took about 30 minutes to force the air in the sample channels out through 
the gas-permeable PDMS.  This manually controlled loading method was cumbersome and 
trouble-prone. Also, based on PCR analyses conducted using the same analyte in different 
chips, the actual loaded sample volume routinely varied by ~10% between experiments.*  
                                                 
* The production version of the Digital Array is mounted in a plastic carrier the size of a 
microtiter plate; reactions are pipetted into wells molded into the carriers during the PCR 
setup, and then pressure loaded into the chips in an automated priming station.  
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4.3.5.2 Reaction Kinetics 
In a digital PCR using the Fluidigm chip, each template molecule is confined within a 
reaction volume of 6.25 nL.  This is 1/3200 the volume of the 20 μL reactions used for 
desktop standard-curve qPCRs.  The single-copy Ct intercepts for TaqMan-based qPCR 
standard curves clustered around 40 cycles, with some variation depending on assay 
efficiency and the use of RNA or DNA template.  To a first approximation, the 3200-fold 
increase in template concentration in the chip should reduce the number of cycles needed 
for single-copy detection by about 12 cycles (log(3200) ൊ log(2) = 11.6).  On this basis, we 
might expect to detect positive reactions in the chip after around 25–30 cycles of PCR. 
We can derive similar estimates from a consideration of PCR kinetics.  The signal to noise 
(SNR) of TaqMan probes is on the order of 10, i.e., a cleaved, unquenched probe produces 
around ten times the fluorescence of a quenched probe [112].  Therefore, after 10% of the 
probes have been hydrolyzed, the fluorescence should be roughly double the background 
signal produced before PCR (0.9 ൅ 0.1 ൈ 10 = 1.9).  Whether a 2ൈ increase in fluorescence 
is sufficient or more than sufficient to call a positive PCR reaction will depend on the SNR 
of the entire detection system.  However, given that the above-background signal will double 
with every PCR cycle, the number of cycles required to cleave 10% of the probes should be 
close to that needed to reach the threshold of detection. 
Given efficient probe binding and cleavage, the number of unquenched probes in a TaqMan 
PCR will be almost the same as the number of double-stranded amplicons.  Starting from a 
single molecule of first-strand cDNA, the abundance of dsDNA amplicons will grow with 
the PCR cycle number as follows: 
NୢୱDNA ൌ ሺ1 ൅ E୮ୡ୰ሻሺୡ୷ୡ୪ୣିଵሻ. 
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If the TaqMan concentration in the PCR reaction is 50 nM, each chamber of the chip starts 
out with about 2ൈ108 probe molecules (50ൈ10-9 mol·L-1 • 6.25ൈ10-9 L • NA).  The number of 
PCR cycles required to hydrolyze 10% of the probes can be calculated as follows: 
ሺ1 ൅ E୮ୡ୰ሻሺୡ୷ୡ୪ୣିଵሻ ൌ 2 ൈ 10଻  ׵ cycle ൌ
୪୭୥൫ଶൈଵ଴ళ൯
୪୭୥൫ଵାE౦ౙ౨൯
൅  1. 
This gives us estimates for the single-copy Ct in the digital PCR assay: 
   Ct = 29.6 (assumes Epcr = 80%); 
   Ct = 25.2 (assumes Epcr = 100%). 
A clear distinction between the fluorescence in background and PCR-positive reaction 
chambers was seen in several experiments in which chips were imaged after 30–32 cycles.  
The finalized digital PCR protocol included a full 40 cycles of amplification, to provide a 
margin of safety in case any primer sets gave lower-than-expected efficiency on chip. 
4.3.5.3 Primer Dimer Containment 
Early multiplexed digital-PCR trials based on Ambion’s thymus cDNA preps produced 
encouraging results.  A triplex analysis targeting one high-abundance transcript (GAPDH) 
and two low-abundance transcripts (PU.1 and GATA-3) gave well-separated positive and 
negative reaction fluorescence, good interreplicate consistency, and plausible copy-number 
readouts for all three targets (figure 4.16).  However, initial tests based on RNA templates 
produced much less satisfactory results.  In these trials, Ambion Poly(A) RNA or quantitated 
runoff transcript was reverse transcribed off chip using Invitrogen’s one-step SSIII/Taq 
chemistry, and the completed RT reactions were loaded into the Digital Array for cDNA 
quantitation.  The chip assays displayed a variety of problems: (1) weak or highly variable 
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fluorescence in PCR-positive reaction chambers, (2) high interpanel and chip-to-chip 
variation, and (3) very low cDNA copy-number readouts from some reactions.   
 
Figure 4.16. Triplex digital PCR on purified cDNA. Ambion Mouse Thymus cDNA was analyzed in the Digital 
Array using Bio-Rad’s iTaq polymerase and TaqMan assays targeting a housekeeping gene (GAPDH) and two 
transcription factors (GATA-3 and PU.1). Ten panels received 3 pg each of cDNA (~3 cells equivalent); two 
corner panels received no template. The chip was imaged after 30 cycles of PCR. (a) False-color image showing 
all three assay channels. (b) Cy5/GAPDH channel. (c) Cy3/GATA-3 channel. (d) FAM/PU.1 channel. 
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Investigation into the poor performance of the RNA-based assays highlighted several issues: 
1. SuperScript III is a fast-acting polymerase.  The Ct values from qRT-PCRs done 
using a 1 minute RT step were very similar to those obtained using the 15 minute 
incubation recommended by the manufacturer.  
2. SuperScript III has high activity at temperatures well below its recommended 
operating range (42–60 °C).  In trials using the Chromo4, only a slight falloff in 
specific product formation was seen when the RT reactions were done at room 
temperature.  Less than a tenfold reduction in product was seen when the RT 
temperature was lowered to 4 °C.  Thus, either the enzyme retained much of its 
activity at 4 °C, or it was able to make substantial amounts of product during the 
brief temperature ramp between the RT step and the PCR hot start. 
3. SuperScript III can make substantial quantities of PD product during reaction setup 
(figure 4.17).  This might be expected in light of the enzyme’s strong activity at low 
temperature; the amount of PD available for extension should also be much greater 
at the temperatures experienced during reaction setup than during the RT itself. 
4. SuperScript III is much more thermostable than traditional MMLV RTs, with a half-
life of 2.5 minutes at 60 °C [113]. A relatively harsh heat treatment is required to fully 
inactivate the enzyme.  In one-step reactions performed in a conventional qPCR 
system, this is not a problem: (1) the enzyme is killed by the 95 °C hot start used to 
activate the Taq between the RT and PCR steps, and (2) the temperature never falls 
below the primer-annealing temperature during the subsequent qPCR analysis. 
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5. Heat inactivation of SuperScript III at the end of the RT is essential in the chip 
protocol because the completed reactions undergo ~30 minutes exposure to low 
temperatures during the sample-load step.  The Platinum Taq polymerase included in 
Invitrogen’s enzyme blend uses antibody-based hot-start protection.  Although the 
standard qRT-PCR protocol calls for a 95 °C, 2 minute hot start, the manufacturers’ 
literature indicates that the antibody can be released at lower temperatures (≥58 °C), 
albeit more slowly [114]. It was therefore difficult to define an SSIII heat-inactivation 
step which avoided the risk of liberating Taq activity before the chip load. 
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Figure 4.17. Primer-dimer product formation by reverse transcriptase. PD-product accumulation was evaluated 
by SYBR Green qPCR on no-template SSIII/Taq reactions.  The thermal profile used included an RT heat 
inactivation followed by a 30 minute chilldown to 4 °C before qPCR to simulate the chip load step.  Triplex 
primers were added to the samples at several different points: during the reaction setup; on the preheated 
thermocycler block at the start of the RT; immediately after RT heat-inactivation (the beginning of the 
simulated chip load); or just before the qPCR hot start.  The Cts seen when primers were added during setup 
were several cycles lower than those seen when primers were added in later steps, indicating that most of the 
PD product was being formed by the reverse transcriptase during reaction assembly. 
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A variety of options were explored to contain the problem of PD-product formation during 
reaction setup and chip load: 
1. One-tube chemistries were tested based on less thermostable MMLV RTs, including 
SuperScript II (Invitrogen) and Stratascript (Stratagene, San Diego, CA), with the 
idea that this would facilitate RT heat-inactivation without Taq activation. In qRT-
PCR trials conducted in the Chromo4, the reverse-transcription efficiency of these 
enzymes appeared to be significantly below that of SuperScript III.   
2. QuantiTect (Qiagen), a one-step system incorporating a chemically modified Taq 
with a long hot-start requirement (10 minutes at 95 °C), was investigated as another 
approach to the heat-inactivation problem.  Again, Chromo4 trials gave SSIII/Taq a 
performance edge—although, in this case, the difference was slight.   
3. Attempts to synthesize a one-tube chemistry combining the standalone version of 
SuperScript III with a chemically protected Taq initially gave very poor results, 
apparently due to RT inhibition of Taq [101, 102, 104-107]; even after optimization, 
the performance of this blend was never as consistent as that achieved with 
Invitrogen’s one-step chemistry.  
4. AccuRT (Applied Biosystems, Sunnyvale, CA), a single-enzyme RT-PCR solution 
with an aptamer-based, reversible hot-start mechanism, gave promising results, but 
was not qualified by the manufacturer for TaqMan-based qPCR.   Tests were done to 
evaluate the possibility of using AccuRT with LUX primers (Invitrogen), but the 
initial results were unsatisfactory, and the superior specificity offered by TaqMan 
chemistry was in any case preferred.  
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The technical approach ultimately adopted for the hematopoiesis work involved the use of 
several PD-containment strategies: 
1. The reaction concentration of all primers was reduced from 400 nM in early trials to 
100 nM in working assays.  Standard-curve analysis was used to check that high PCR 
amplification efficiency was maintained at the lowered primer concentration.   
2. The assays which contributed most strongly to PD formation were identified by 
desktop qPCR analysis and disqualified, and the original goal of performing triplex 
PCR in the chip was scaled back to duplex PCR. 
3. In the RT step, samples were loaded into a thermocycler after preheating the block 
to the RT incubation temperature (55 °C), and the SSIII/Taq blend was added after 
allowing the samples 1–2 minutes to warm up. 
4. A relatively mild, 70 °C, 5 minute heat-inactivation step was used at the end of the 
RT reaction to denature SSIII without fully activating the Taq.    
5. The chip load step was performed in a cold room at 4 °C. 
Although these measures eliminated the gross problems seen in the early RNA-based chip 
assays, the variation in the cDNA copy number readouts from replicate RT reactions was 
generally significantly higher than that observed in reactions based on purified DNA (figure 
4.13).   In the current state of the art, the reverse-transcription step of qRT-PCR appears to 
be the major source of technical noise in the assay [86]. 
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4.3.5.4 Image Processing 
The commercial Digital Array is designed for use with an integrated thermocycler-imaging 
system.  The Fluidigm system incorporates a full-field CCD camera which permits real-time 
imaging of the chip during the PCR run.  This system was not available at the time of the 
hematopoiesis study; instead, after thermocycling on a standard flat-block thermocycler, 
chips were imaged using an ArrayWoRx microarray scanner (Applied Precision, Issaquah, 
WA).  The scanner was modified to accept a metal carrier designed for slide-mounted 
microfluidic chips.  Valve pressure was maintained during imaging to ensure that the 
reactions remained compartmentalized.  The imaging process took around ten minutes per 
channel at the preferred 13-micron resolution.  The confocal optics of the scanner provide 
relatively even illumination across the entire image field, obviating the need for a reference 
dye such as ROX in the PCR reactions.  All three fluorescence channels of the ArrayWoRx 
(FAM/Cy3/Cy5) were therefore available for TaqMan signal analysis. 
A Microsoft Visual C++ application was written to process the ArrayWoRx scan files.  After 
the user has “tie pointed” the four corners of the active area of the chip (figure 4.18), the 
pixel data is resampled to build normalized images of the twelve sample panels.  The 
software isolates the reaction wells in each panel image and computes a fluorescence-
intensity value for each one.  The user can sweep out rectangles to designate regions that 
should be excluded from the analysis due to chip defects, debris, glare, etc.  The wells in 
each panel are rank ordered by intensity. Wells whose brightness exceeds that of a “baseline” 
percentage of the lowest-ranked wells by a user-specified threshold are called as positive.  
The baseline and threshold settings can be adjusted for each fluorescence channel 
independently.  The DNA concentration in each panel is computed based on the count of 
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Figure 4.19. Digital PCR assay report. The report shows the normalized panel images, with positive well calls 
highlighted. User-excluded regions are indicated in blue. The calculated DNA concentration is shown for each 
sample, along with a statistical summary and a histogram giving the distribution of well intensities in the panel.
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4.3.6 Preamplification PCR 
4.3.6.1 Background 
In a number of the single-cell studies published in the nineties, a round of multiplexed, 
sequence-specific PCR was applied to facilitate the evaluation of multiple genes in parallel, 
simplex PCRs.  In the last few years, this strategy has been further developed and extensively 
characterized by at least three groups of researchers: 
1. Peixoto et al published a study in Genome Research in 2004 [89] demonstrating 20-plex 
qRT-PCR analysis of single cells using multiplexed preamplification PCR.  In the 
Peixoto work, cell lysates were first reverse transcribed using multiplexed, gene-
specific RT primers.  The cDNA was amplified ~30,000-fold in a 15-cycle multiplex 
PCR, and the amplification products were quantitated in parallel, independent SYBR 
Green qPCRs.   The amplified templates were diluted 100-fold going into the qPCR 
round.  A seminested priming strategy was employed, with only one of the primers in 
each simplex qPCR assay being shared with the preamplification PCR.  
2. In a paper published in Nucleic Acids Research in 2005 [90], Stanley and Szewczuck 
described a similar methodology, which they entitled “Multiplexed Tandem PCR” 
(MT-PCR).  In their protocol, a GSP-based RT reaction was coupled with 10–20 
rounds of 72-plex PCR in the same tube; a short, 1 minute RT incubation and a low 
reverse-transcriptase concentration was used to minimize PD formation.  SYBR 
Green qPCR analyses were done on 100-fold diluted preamplified cDNA.   
Seminested primers were used in the qPCR round, as in the Peixoto study.  The MT-
PCR protocol has since been commercialized by Corbett Research (Sydney, 
Australia). 
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3. Within the last year, Applied Biosystems (ABI) has introduced a commercial kit for 
preamplification PCR, the TaqMan PreAmp Master Mix Kit.  ABI’s protocol calls 
for 10–14 cycles of multiplexed “pre-PCR,” followed by standard simplex TaqMan 
qPCR analysis of the product.  A 20-fold dilution of the preamp product going into 
the qPCR is recommended with a 10-cycle pre-PCR, or an 80-fold dilution when 
using 14 cycles of pre-PCR.  The kit is designed for use with the company’s off-the-
shelf TaqMan Gene Expression Assays, which combine primers and probes in the 
same mix.  Up to a hundred assays may be pooled in the pre-PCR.  The assays are 
used at their standard concentration (900 nM primers, 250 nM probes) for qPCR, 
but each individual assay is used at only 1/20 this concentration in the pre-PCR, to 
minimize primer-dimer formation.  A 4 minute anneal-extend step is specified in the 
pre-PCR thermocycling profile, to give the primers time to bind their targets.* The 
ABI kit covers cDNA analysis only; an RT step is not included in the protocol.   
4.3.6.2 Principle of the Method 
The aim of preamplification is to take a limiting amount of cDNA and turn it into enough 
material to support the analysis of multiple target genes.  For the method to be quantitative, 
                                                 
* The average time primers take to bind their templates is inversely proportional to their 
concentration in the reaction.  At the primer concentrations normally used in PCR (around 
0.1–1.0 μM), this time is on the order of seconds.  The rate of primer-dimer formation scales 
with the product of the concentrations of the primers involved.  Therefore, a 20ൈ reduction 
in primer concentration should reduce PD product formation 400-fold, while increasing the 
required primer annealing time only 20-fold. 
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the PCR amplification efficiency of all targets must be maintained during both the pre-PCR 
and the qPCR steps of the protocol.  In a multiplex PCR, amplification of high-abundance 
targets can lead to early depletion of reagents such as dNTPs or saturation of polymerase 
activity, compromising the amplification of less abundant targets and introducing bias into 
the quantitation.  In both simplex and multiplex PCR reactions, highly efficient amplification 
of short PD products can competitively inhibit amplification of legitimate, low-abundance 
targets. Multiplexed reactions are especially prone to this effect because the diverse primer 
sequences used increase the possibility of primer-dimer formation.  In preamplification 
protocols, these problems are contained by (1) limiting the number of cycles of multiplex 
PCR, and (2) by diluting the first-round products going into the qPCR. 
In the context of single-cell analyses, few if any cDNA targets will exceed 104 copies. In a 
standard PCR, around 30 cycles of exponential amplification are required for a 104-copy 
template to significantly deplete a reaction. Thus, resource-competition between target 
amplicons should be trivial in 10–20 cycles of multiplexed PCR performed on single-cell 
preps. The amount of PD product produced during reaction setup and the pre-PCR itself 
will depend on the number and concentration of primers in the mix, their specific sequences 
and therefore PD-forming potential, and other reaction conditions (such as whether or not 
reverse transcriptase is present). Ultimately, the number of multiplex pre-PCR cycles which 
can be performed without incurring PD-mediated inhibition and amplification bias must be 
established empirically. 
The dilution of the first-round reaction going into the qPCR step serves two purposes.  A 
preliminary dilution, performed directly after the pre-PCR, quenches the reaction: the rapid 
dilution of Taq, dNTPs, magnesium ions, and primers prevents any significant PD-product 
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formation during the cooldown of the reaction.  The pre-PCR product is further diluted in 
the assembly of the qPCR reactions.  The net result is that the inherited multiplex primers 
will be at too low a concentration to find their targets efficiently in the qPCR.  The dilution 
does not directly advantage the template relative to first-round PD products, since the 
concentration of both is reduced by the same factor.  However, the only PD products which 
will be amplified efficiently during the qPCR step will be those derived from the specific 
assay primers during the pre-PCR (figure 4.20). 
 
 
 
Figure 4.20. Pre-PCR secondary-product amplification in qPCR. Here, it is assumed that the primers used for 
the qPCR analysis are also used in the multiplexed pre-PCR, as in the ABI and aging-study protocols. Primer-
extension products made from the simplex primer pair in the pre-PCR may be exponentially amplified on 
carryover to the qPCR round. If a qPCR primer and a primer from a different assay dimerize in the pre-PCR, 
the extension product from the non-qPCR primer may be transcribed efficiently in the qPCR phase; however, 
as the resulting transcripts will not themselves be efficiently primed, only linear amplification will result.  PD 
products formed from two non-qPCR primers should not be efficiently transcribed during the qPCR phase.
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Importantly, PD extension products derived from the qPCR primer pair during the pre-PCR 
round may amplify exponentially during the qPCR round, impacting assay performance.  In 
fact, as more PCR cycles will be required overall to reach the threshold of detection (to make 
up for the dilution step) these PD products will have more opportunity to out-race the 
legitimate assay target than they would in a standard qPCR.  The two-stage PCR approach 
only helps here if the assay primers are switched in the second round, as in the nested or 
seminested priming method preferred by Peixoto and Stanley.   
4.3.6.3 Priming Strategy 
The seminested priming approach adopted by Peixoto and Stanley adds a useful extra level 
of protection against primer-dimer effects in the qPCR round of analysis.  However, nested 
priming was rejected for the aging study, for two reasons: 
1. A requirement to use nested primers would have made it much harder to design 
assays which avoided RNA secondary structure. 
2. Wide adoption of preamplification PCR will be encouraged if protocols can be 
defined which allow use of standard assay-design practices or off-the-shelf assays. 
Traditionally, the design of multiplexed PCR assays involves qualification of compatible 
primer sets using software that identifies problematic 3’ primer-dimer interactions.  Peixoto 
et al used this approach for their 20-plex assay.  The problem of in silico qualification 
becomes intractable as the desired level of multiplexing increases, because the number of 
possible pair-wise interactions between primers goes up with the square of the number of 
assays.  The MT-PCR and ABI PreAmp protocols do not call for in silico primer 
qualification, relying instead on the built-in protections afforded by the method to limit the 
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impact of PD on assay performance.  In silico qualification was applied in the aging study 
since (1) the work required the multiplexing of only six assays, and (2) the use of single-tube 
chemistry for RT/pre-PCR was expected to increase PD formation during the pre-PCR. 
4.3.6.4 Preamp Parameters 
A 10-cycle pre-PCR was used during initial assay prototyping, along with 100-fold template 
dilution going into the PCR step (40-fold during reaction quenching, and a further 2.5-fold 
during the qPCR setup).  These conservative parameters gave good results in runoff RNA-
based standard curve trials.  A 10-cycle pre-PCR should provide ~1000-fold amplification of 
the cDNA template; after a 100-fold dilution, the template concentration in the qPCR step 
should therefore be ten times higher than in the original cell-lysate preps.   A higher 
preamplification factor was preferred so that low-abundance targets would be detected well 
before the end of the 40-cycle qPCRs.  Experiments showed no falloff in assay performance 
when the number of pre-PCR cycles was increased to 15, and this number was used for the 
working assays.  Using these protocol parameters, the targets evaluated in the single-cell 
study generally gave Cts well below 30 during the qPCR analysis.   
4.3.6.5 Real-Time PCR Chemistry 
Since the aging study was designed to evaluate cell-to-cell heterogeneity, low intrinsic assay 
variability was particularly important.  All the assays for the study were originally designed to 
incorporate TaqMan probes. Tests were done to compare the technique-related noise using 
TaqMan or SYBR Green chemistry in the qPCR step.  Overall, SYBR Green gave slightly 
superior intrareplicate consistency (figure 4.21).  This is probably because the early-cycle 
fluorescence in TaqMan reactions tends to fluctuate, impacting the baseline-subtraction 
process.  Based on this analysis, SYBR Green chemistry was selected for the working assays. 
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Figure 4.21. Technical noise in SYBR Green and TaqMan preamp assays. The plots show the results of qRT-
PCR standard-curve trials based on a 6-plex RNA standards mix. The templates are at from 10 to 105 copies 
per reaction. RT/pre-PCR reactions were performed in duplicate for each point in the titration series.  The 
qPCR standard curves here include the data for all six assay targets. SYBR Green chemistry gave more tightly 
clustered Cts, better calculated PCR efficiency, and lower single-copy Ct intercepts.  
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4.3.6.6 RNA Standards 
Based on the digital PCR study, the cell-to-cell variation in transcript copy-number was 
expected to be fairly large, with a coefficient of variation (CV) of around 60%–100% (similar 
numbers emerged from aging study).  Since the research was designed to evaluate whether 
this variation is different in young and old animals, it was important that the technique-
related variation in mRNA quantitation be substantially less than the intrinsic biological 
variation.  Trials conducted using runoff-transcribed RNA showed that the variation in the 
Ct readout between technical replicates analyzed in the same qPCR experiment was quite 
small—typically, under a half a cycle even at low template concentrations. However, the Ct 
values obtained for technical replicates evaluated in different qPCR runs routinely varied 
over a 2–3 cycle range.  Thus, pooling raw Ct values from different experiments would have 
introduced unacceptable measurement noise into the aggregated data.  This problem was 
addressed by converting the Ct readouts from cell lysates into absolute copy-number values, 
based on the readouts from RNA-standards reactions analyzed in the same experiment.    
Four reactions containing 1000 runoff-transcribed copies of each of the six assay targets 
were processed alongside every strip of eight cell-lysate samples.  The 1000-copy number 
was chosen to be close enough to the expected cell-based readouts to minimize the effects 
of variations in PCR efficiency on delta Ct calculations, but high enough that any Poisson 
sampling noise introduced during aliquoting of the RNA master mix would be insignificant.   
A nominal 1000-copy Ct was first interpolated for each assay target based on the four Ct 
readouts from the standards reactions, as follows: 
Ctଵ଴଴଴ ൌ l og ቈ
ସ
∑ ൫ଵାE౦ౙ౨൯
షి౪೔೔సర
೔సభ
቉ /logሺ1 ൅ E୮ୡ୰ሻ. 
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A nominal Epcr value of 1.95 was used for all calculations.  The absolute RNA copy number 
in the cell lysates was calculated by the ΔCt method: 
NmRNA ൌ 1000 · ൫1 ൅ Epcr൯
ሺCt1000െCtሻ. 
The interpolated standards Ct was also used to compute the estimated number of RNA 
copies in each technical replicate, again using the ΔCt method.  The CV of the four estimates 
gives the well-to-well technical variability of the assay in terms of target copy number, rather 
than PCR cycles.  This variation was ~25% for all six assays. 
4.4 Conclusions 
The following points emerge from the experimental work: 
1. The qRT-PCR measurement error at low template copy number was similar using 
both digital PCR and preamplification PCR (20%–30%), and probably reflects tube-
to-tube variability in the reverse transcription reaction.  Given that the mechanism of 
transcription seems to introduce high levels of stochastic noise in cellular mRNA 
levels (CV > 60%), this accuracy should be adequate for most single-cell studies.   
2. Although transcription-factor expression was only evaluated using the digital PCR 
method, it should also be possible to quantitate low-abundance transcripts with 
preamp PCR.  In standard-curve trials using preamp, no falloff in assay linearity was 
discerned at 10–100 copies of RNA per reaction.  With good primers, there is no 
reason in principle why qPCR should not be quantitative down to this level.   
3. The limited sensitivity reported in some early single-cell qRT-PCR studies (10–20 
mRNA copies limit of detection) may reflect aliquoting of cDNA following first-
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strand synthesis or low RT efficiency using some of the older reverse transcription 
protocols. The RNA copy-number limit of detection for the protocols applied in the 
two single-cell studies is determined by the RT effiency of the individual assays and, 
in the case of the digital PCR method, the fraction of the total cDNA sample loaded 
into the active area of the chip (50%).  Assuming 30%–50% RNA-to-cDNA 
conversion efficiency, this limit is ~2–3 copies using the preamp technique, and ~4–
6 copies using the prototype chip assay. 
4.  The digital PCR work showed that primer dimer can be a significant issue in the 
chip assay, at least when using single-tube RT-PCR chemistries.  A robust solution 
needs to be found before the potential of the chip for multiplexed single-cell analysis 
can be fully exploited.  Use of a hot-start-protected reverse transcriptase is probably 
the best way to “end run” this problem.  The options in this regard are still very 
limited, but vendors have indicated that this situation should improve in the near 
future.  
5. High assay sensitivity and consistency were achieved with the multiplexing strategy 
developed for the aging study, despite the use of a coupled RT/pre-PCR step.   It 
remains to be seen if this level of performance can be maintained if dozens of assays 
are combined in the pre-PCR.  If this turns out to be problematic, changes could be 
made to the protocol to alleviate PD formation, e.g., adding forward PCR primers 
only after the reverse transcriptase has been inactivated, or incorporating a generic 
pre-PCR primer sequence into the RT primers.  Use of a hot-start-protected reverse 
transcriptase might obviate any amendments to the protocol.  AccuRT, evaluated in 
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the digital PCR work, may be worth revisiting for the pre-PCR application, since the 
enzyme’s low 5’-exonuclease activity is only an issue for TaqMan qPCR. 
6. The concept of normalizing expression measurements to an endogenous reference 
gene breaks down at the single-cell level.  Use of RNA standards enables absolute 
transcript quantitation with the preamp protocol.  Standards are not hard to make 
using in vitro transcription reactions, although this is still not a widespread practice.  
Digital PCR provides absolute copy-number readouts directly.  Some of this 
advantage is lost due to the need to calibrate RNA-to-cDNA conversion efficiency 
for each assay target.  This could change if future RT enzymes ever match the 
consistent, near-optimal transcription efficiency obtained with Taq polymerase. 
7. Using flow cytometry and isolation-free mRNA recovery, a thousand single-cell 
mRNA samples can easily be prepared in the course of one FACS session.  Even 
pipelining the RT/pre-PCR steps and performing five or six experiments a day, it 
would take weeks to process this number of cell lysates using the analysis protocols 
described here.  In the near future, then, sample preparation should not be a 
bottleneck in single-cell studies targeted at hematopoietic cells. 
8. Preamplification PCR is more scalable with respect to multiplexing than the chip 
assay, since the latter is limited by the number of TaqMan probe colors which can be 
discriminated in one reaction.  With that being noted, the throughput of the methods 
is best compared in terms of expression measurements rather than cells analyzed.  
Fully pipelined, both protocols require about 2 hours per experiment.  With preamp, 
up to 96 measurements can be taken in each experiment using a standard qPCR 
instrument.  The number of data points yielded by each chip experiment depends on 
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the level of multiplexing.  Using a duplex assay, 24 measurements can be made per 
PCR (12 samples ൈ 2 channels).  If primer dimer can be contained, it should be 
straightforward to do 5-plex analysis in the chip, to increase this to 60 data points.   
9. The cost of the preamp assay is driven by qPCR reagent costs; a full 96-well plate of 
reactions runs less than $100.  Reagent use is minimal in the digital PCR assay, but 
the microfluidic chips are still priced in the hundreds of dollars.  Chip prices should 
decline substantially as the technology matures and production volumes increase. 
Currently, the preamplification method looks more promising than digital PCR for single-
cell gene profiling work, based on its low cost and scalability to high-order multiplexing.  
Efforts are underway to adapt the preamp protocol developed during the thesis work for use 
with a new Fluidigm chip, the “Dynamic Array.”  Using microfluidics to automate the 
qPCR-analysis phase of the protocol, a 100-fold improvement in throughput should be 
attainable with this approach.  Preamplified cDNA and TaqMan assays are combined in the 
Dynamic Array to create a matrix of sample-assay combinations, which are then evaluated by 
real-time PCR using an integrated thermocycler-imaging system.  In the production version 
of the chip, 48 samples can be combined with 48 assays, allowing 2304 qPCR measurements 
in the course of a single experiment.  A 96 ൈ 96 version of the chip is forthcoming.  With 
the aid of this technology, it should soon become feasible to conduct gene-profiling studies 
encompassing thousands of individual cells and dozens of different assay targets.   
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Chapte r  5 
TRANSCRIPTION FACTOR PROFILING IN INDIVIDUAL 
HEMAPOIETIC PROGENITORS BY DIGITAL RT-PCR* 
Luigi Warren, David Bryder, Irving L. Weissman, and Stephen R. Quake 
5.1 Summary 
We report here a systematic, quantitative population analysis of transcription factor 
expression within developmental progenitors, made possible by a microfluidic chip-based 
“digital RT-PCR” assay that can count template molecules in cDNA samples prepared from 
single cells. In a survey encompassing five classes of early hematopoietic precursor, we 
found markedly heterogeneous expression of the transcription factor PU.1 in hematopoietic 
stem cells and divergent patterns of PU.1 expression within flk2- and flk2+ common myeloid 
progenitors. The survey also revealed significant differences in the level of the housekeeping 
transcript GAPDH across the surveyed populations, which demonstrates caveats of 
normalizing expression data to endogenous controls and underscores the need to put gene 
measurement on an absolute, copy per-cell basis. 
  
                                                 
* This chapter was originally published in Proceedings of the National Academy of Sciences, 
103(47), 2006.  The references for this chapter appear in the bibliography. 
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5.2 Introduction 
Stem cells give rise to terminally differentiated cells of diverse types through a stepwise 
process involving the production of intermediates of progressively restricted lineage 
potential. This unfolding program is controlled by a transcriptional regulatory network: a 
chemical state machine with sequencing logic implemented by cross-regulating transcription 
factors, the states of the network realized in the abundance profile of these regulatory 
molecules. Transitions between preferred states are brought on by intrinsic metastability, 
stochastic fluctuation, and external signals [10, 115, 116]. Understanding the behavior of 
these networks is the key to understanding development itself. A prerequisite is the ability to 
characterize network states quantitatively, but the sensitivity of current gene profiling 
methods is not fully adequate to this task. Here we report on a study of hematopoietic stem 
cells (HSCs) and other early blood progenitors using an assay that overcomes the sensitivity 
problem. 
Conventional gene-expression assays typically require thousands of cells’ worth of RNA as 
analyte. Developmentally interesting cells, especially stem cells, are not always easily isolated 
in such quantities. More fundamentally, population-average expression data provide an 
incomplete picture, because functionally significant variations in regulatory-network state 
undoubtedly exist in cell types defined on the basis of a few phenotypic criteria. One 
consequence of this is that population-averaged experiments are subject to systematic errors 
in interpretation: although one can reliably infer qualitative trends from their results, it is 
difficult if not impossible to generate precise, quantitative results. Modern theories of 
systems biology are able to make quantitative predictions, and to test these theories 
quantitative data are required. Flow cytometry has transformed the study of cellular 
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differentiation by revealing diversity in the patterns of surface protein expression within 
populations of superficially similar cells. Similarly, one would like to survey transcriptional 
network states within populations cross-sectionally, which is possible only by measuring 
gene expression in individual cells. 
In principle, RT-PCR has the sensitivity required for single-cell gene-expression analysis. 
However, the quantitation of rare messages, such as those for transcriptional regulators, 
pushes the limits of the art. Published single-cell protocols tend to be elaborate in terms of 
assay validation and practice [74]. To address this problem, we have developed a highly 
sensitive quantitative RT-PCR assay based on standard 5’-nuclease probe (TaqMan) 
chemistry and primer–probe design rules. The method uses a commercially available 
microfluidic chip to partition individual cDNA molecules into discrete reaction chambers 
before PCR amplification (figure 5.1). In effect, the chip performs a massively parallel 
limiting-dilution assay, a form of “digital PCR” [85]. In conventional quantitative PCR, 
quantitation is based on the number of amplification cycles required for dye fluorescence to 
reach a given threshold. Slight variations in amplification efficiency between reactions are 
magnified because of the exponential character of PCR; for this reason, interassay 
comparisons are only valid if gene-of-interest measurements are normalized to 
measurements on endogenous controls or synthetic standards [78]. In digital PCR, 
quantitation relies on binary, positive/negative calls for each subreaction within the 
partitioned analyte, affording an absolute readout of DNA copy number with single-
molecule resolution. Applying the chip assay to cDNA generated from synthetic RNA 
standards, we have demonstrated that the sensitivity and linearity of quantitation is sufficient 
to address transcript measurements on single cells (see Materials and Methods). 
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Figure 5.1. The Digital Array chip. (a) A PCR end-point scan of a chip. In this false-color image, the FAM 
signal (GAPDH) is shown in green and the Cy5 signal (PU.1) in red.  The 12 samples analyzed here correspond 
to cDNA preparations derived from individual HSCs.  Within a sample panel, 7.5 μl of analyte is partitioned 
into 1200 isolated reaction chambers (“wells”) prior to PCR.  At the cDNA concentrations encountered in the 
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single-cell survey, almost all wells capture either zero or one template molecules; after PCR, the count of high-
intensity wells provides a readout of the number of template molecules in the original, unamplified sample.  (b) 
Histogram of well intensities within a single Digital Array panel after 40 cycles of PCR. The analyte was cDNA 
reverse transcribed from PU.1 runoff transcript. Positive/negative calls are based on an operator-defined 
threshold.  (c) Digital PCR response characteristic.  In the digital assay, positive reactions signal compartments 
capturing one or more template molecules at the start of the PCR. At high template concentrations, a 
significant fraction of compartments start out with multiple template copies and the response curve becomes 
increasingly non-linear.  For a panel with n compartments, the number of input molecules, x, can be computed 
from the readout of positive compartments, y, using the equation ݔ ൌ logሺ1 െ ݕ/݊ሻ/log ሺ1 െ 1/݊ሻ (see 
Materials and Methods).  
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We applied the digital assay to a single-cell gene-expression survey focused on the early steps 
of hematopoiesis. After staining with fluorescent antibodies, flow cytometry can be used to 
fractionate blood progenitors based on membrane-protein expression. The lineage potential 
of many different subsets has been investigated by using clonal assays, resulting in schema 
for the prospective isolation of progenitors based on surface antigen profiles.  
Immunophenotyped cells are readily sorted into individual tubes for single-cell analysis [49]. 
In our experiments, cells were sorted directly into RT-PCR buffer; we subsequently added 
primers for the genes of interest, reverse transcribed the RNA, and quantitated the cDNA in 
the digital PCR chip (figure 5.2). The study encompassed murine blood progenitors 
belonging to the following canonical populations: HSCs, common lymphoid progenitors 
(CLPs), common myeloid progenitors (CMPs), and megakaryocyte–erythroid progenitors 
(MEPs) [117-122]. (Figure 5.3 positions these cell types within the classical model of the 
hematopoietic lineage tree.) Some recent work argues that the CMP subset is heterogeneous, 
functional diversity being correlated with differential expression of the cytokine receptor flk2 
[23, 123]. We therefore decided to look at flk2+ and flk2- CMP subsets, to see whether their 
gene-expression profiles were different. Our survey includes data from 116 individual cells, 
about two dozen from each of the five cell types of interest (HSC, CLP, CMP/flk2+, 
CMP/flk2-, and MEP).  
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Figure 5.2. Experimental procedure used in the single-cell survey.  (a) Cells are harvested from mouse bone 
marrow, then enriched for c-kit+ early progenitors by immunomagnetic separation.  (b) Purified cells are 
stained with a panel of fluorescent antibodies to surface proteins whose expression patterns define progenitor 
types of interest.  (c) FACS is used to dispense individual immunophenotyped cells into RT-PCR buffer, where 
they undergo hypotonic/detergent lysis, releasing their mRNA.  (d) Gene-specific primers and probes, reverse 
transcriptase, and DNA polymerase are added to the lysates, and the samples are reverse transcribed in a 
standard thermocycler. (e) Completed reactions are loaded into the digital PCR chip, which is pneumatically 
partitioned and thermocycled on a flat block.  (f) End-point fluorescence images of the chip are processed to 
read out the levels of the transcripts targeted by the TaqMan assays. 
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Figure 5.3. Early progenitors in the hematopoietic lineage tree, according to the classical model of blood 
differentiation.  Upon activation, self-renewing hematopoietic stem cells (HSCs) give rise to a proliferating 
population of multipotent progenitors (MPPs).  Two more restricted oligopotent precursors are derived from 
the MPP: the common myeloid progenitor (CMP), and the common lymphoid progenitor (CLP).   The CMP 
population forks into still-more restricted oligopotent precursors: the megakaryocyte-erythroid progenitor 
(MEP), and the granulocyte-macrophage progenitor (GMP).  The CLP develops into the unipotent precursors 
of B and T cells directly.  Phenotypically, these early progenitors are all positive for the stem-cell factor 
receptor, c-kit, and negative for the lineage-specific markers which characterize more mature cells.  The surface 
marker phenotypes which distinguish the different progenitor types within the Lineage- c-kit+ compartment are 
indicated in the figure.  
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We measured the levels of two transcripts within every cell: a transcription factor, PU.1, and 
a housekeeping gene, GAPDH. PU.1 is known to be a major regulator of hematopoiesis. Its 
best understood role is the promotion of granulocyte–macrophage fate: expressed at high 
levels, PU.1 activates granulocyte–macrophage differentiation gene batteries, and PU.1 
upregulation seems to be instrumental in funneling CMPs toward the granulocyte–
macrophage progenitor (GMP) lineage [124, 125]. PU.1 is also thought to play other, 
context-dependent roles in blood differentiation at intermediate levels of expression [126, 
127]. GAPDH encodes a glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase. 
This gene commonly serves as an endogenous control in quantitative RT-PCR assays. In this 
practice, the readout for every gene of interest is normalized to the GAPDH signal, on the 
idealized assumption that GAPDH expression is uniform across cell types. Our assay reports 
absolute transcript levels, in copies per cell, so we did not need a reference for PU.1 
quantification. However, we were interested in finding out to what extent GAPDH 
expression is truly independent of cell type. In addition, we expected levels of PU.1 to be so 
low that Poisson noise might obscure any clues our analysis would give to the general 
character of expression distributions. GAPDH is a high-abundance transcript, so we 
anticipated that its expression would be more informative in this regard. 
5.3 Results and Discussion 
We carried out on-chip assays using RNA runoff template to measure the efficiency and 
reproducibility of the digital RT-PCR assay. The estimated RNA-to-cDNA conversion 
efficiency was 0.50 ± 0.10 for PU.1 (CV = 20%) and 0.29 ± 0.09 for GAPDH (CV = 29%). 
We found an interassay CV of ~10% in similar trials using DNA standards, so some of the 
variability in the efficiency estimates came from the chip itself. Variation in the loaded 
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sample volume probably accounts for most of the chip-related technical noise. The limiting 
factor in the precision of the digital RT-PCR method is likely to remain the technical 
variability of reverse transcription [86]. 
The results of the single-cell survey are summarized in figure 5.4. All cell types gave mean 
readouts for GAPDH and PU.1 substantially exceeding the background of false positive 
signals detected in No Template and No RT control panels (table 5.1). PU.1 expression is 
highly elevated in the CMP/flk2+ subset, and strongly downregulated in the MEPs (table 
5.2). The other three subsets show intermediate levels of expression, but the CMP/flk2- 
resembles the MEP, with a less pronounced downshift. We used the Kolmogorov–Smirnov 
(K-S) test to measure the resemblance between the PU.1 data sets (table 5.3). The HSC 
distribution bears a strong resemblance to the distributions in the CLP and CMP/flk2- cell 
types. The CMP/flk2+ stands alone: the P value for similarity was <0.01 in every comparison 
involving this set. 
 
 
Table 5.1. False positives 
 NTC (n=6) No RT (n=3) 
GAPDH 2 1 1 4 3 1 3 2 2 
PU.1 0 0 0 0 0 0 1 0 0 
Counts of false-positive wells within NTC and single-cell No RT control panels. The equivalent copies-per-cell 
readouts would be double these values, as the loaded sample volume is half the RT reaction volume. 
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Table 5.2. Descriptive statistics (PU.1) 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
Number of Samples 21 23 25 24 23 
Median cDNAs/cell 6.0 4.1 14.1 3.0 2.0 
Mean cDNAs/cell 8.5 5.5 21.7 6.5 3.7 
Coefficient of Variation 95% 82% 120% 149% 180% 
Geometric Mean cDNAs/cell 6.0 n/a 14.8 n/a n/a 
Geometric Standard Deviation 2.3 n/a 2.4 n/a n/a 
 
Descriptive statistics for the PU.1 expression single-cell data.   The geometric mean and geometric standard 
deviation correspond to the back-transformed mean and standard deviation of the log-transformed data.  
These two statistics are more informative than the mean and standard deviation for lognormally distributed 
data.  (Their values are mathematically undefined for data sets which include zero values, as was the case with 
the CLP, CMP/flk2- and MEP data sets here.) 
 
Table 5.3. Subset comparisons (PU.1) 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
HSC 1.00 0.89 0.00 0.37 0.03 
CLP 0.89 1.00 0.00 0.89 0.20 
CMP/flk2+ 0.00 0.00 1.00 0.00 0.00 
CMP/flk2- 0.37 0.89 0.00 1.00 0.67 
MEP 0.03 0.20 0.00 0.67 1.00 
 
Results of pairwise Kolmogorov-Smirnov comparison tests between PU.1 expression data sets.  The tabulated 
values are the significance levels assigned by the test to the null hypothesis that the data from the two 
compared sets come from the same underlying distribution.  A low P value (<0.05) is evidence that the 
distributions differ significantly.  
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Figure 5.4. Gene expression in cDNA copies per cell, by cell type.  The histograms show the number of 
individual cells in each subset that expressed PU.1 and GAPDH within the indicated bin ranges.  PU.1 
expression is heterogeneous in the stem cells, upregulated in the CMP/flk2+ cells, downregulated in CMP/flk2- 
cells, and sharply downregulated in the MEPs.  The similarity between PU.1 expression in CMP/flk2- and MEP 
cells is consistent with the possibility that flk2- CMPs are already biased towards the MEP lineage choice.  
GAPDH expression was significantly elevated in the CMP/flk2+ cells, adding weight to the inference that the 
flk2- and flk2+ CMP subpopulations are functionally distinct.  
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A previous, nonquantitative single-cell study of blood progenitors found that HSCs display 
variegated expression of transcripts normally associated with downstream lineages, including 
PU.1 [50]. This could represent nonproductive, “leaky” transcription, if the loci for 
downstream lineages are kept in a default, open chromatin state until fate commitment [128]. 
Alternatively, “noisy” transcription might be a mechanism for symmetry breaking, priming 
daughter cells toward diverse fates when the stem cell starts to proliferate and differentiate 
[129]. The distinction between leaky or noisy transcription and regulated transcription may 
be hard to draw; our data suggest that wide variations in message abundance between 
individual cells are the rule rather than the exception. However, the K-S comparison results 
and the relatively broad profile of the PU.1 distribution in the HSC subset argue that PU.1 
expression is either loosely regulated or heterogeneously regulated within the stem-cell 
compartment. 
A keystone of the classical model of hematopoietic differentiation is the division of 
progenitors into two major populations downstream of the multipotent progenitor (MPP): 
the lymphoid-restricted CLP, which gives rise to pro-B and pro-T cells, and the 
myeloerythroid-restricted CMP, which gives rise to granulocyte–macrophage progenitors 
and MEPs [130]. It has recently been claimed that the canonical CMP population is 
internally heterogeneous with respect to lineage potential [23]. According to this research, 
the expression level of the cytokine receptor flk2 is a marker for functional divergence: the 
flk2+ CMP compartment is PU.1hi, has lost MEP potential, and retains lymphoid as well as 
myeloid potential; flk2- CMPs comprise mostly PU.1lo cells with predominantly MEP 
potential. Our measurements reveal a sharp divergence in PU.1 expression within the flk2- 
and flk2+ CMP subsets. The GAPDH results for these subsets, discussed below, add further 
evidence that they are nontrivially distinct, as the 2D gene-expression plot in figure 5.5 
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makes clear. The similarity between PU.1 expression in the CMP/flk2- cells and the MEPs 
meshes with the observation that the bulk of the flk2- CMP compartment is already 
megakaryocyte-erythroid-lineage restricted. 
 
Figure 5.5.  Resolution of flk2- and flk2+ CMP populations based on gene expression.  (a) The sort gates used 
to fractionate CMP cells into flk2+ and flk2- subsets (biexponential plot).  These gates were applied after first 
selecting Lineage- c-kit+ Sca1lo IL7R- CD34+ FcGrlo cells.  (b) The distribution of GAPDH and PU.1 
expression in the flk2+ and flk2- CMP subsets, as determined by single-cell analysis.  The shaded ellipsoids 
capture >85% of the observations within each set.  
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The expression of GAPDH was not constant across the six cell types examined, with the 
subset mean expression levels varying over a 2-fold range (table 5.4). K-S tests show that the 
differences are statistically significant (table 5.5). In 4 of 10 pairwise comparisons between 
subsets, the hypothesis that the data came from the same underlying distribution had a P 
value below 0.05. The CMP/flk2+ subset had the highest GAPDH expression, and it was 
also the best resolved from the other subsets by the K-S measure. The variation in GAPDH 
level within these closely related subsets highlights a problem with the use of endogenous 
controls in RT-PCR quantitation. Normalization to the GAPDH signal reduces the apparent 
magnitude of PU.1 upregulation in the CMP/flk2+ cell type, and equalizes the differences in 
mean expression between the HSC, CLP and CMP/flk2- types (table 5.6). It is impossible to 
say, at this level of analysis, whether such equalization is justified. Although normalized 
measurements are not necessarily less informative than absolute measurements, no two 
housekeeping genes can reasonably be expected to show the same dependence on cell type. 
No consensus exists as to the best choice of endogenous control and, indeed, no one gene is 
likely to be a good reference for every application [131]. Weighted normalization schemes 
based on multiple housekeeping genes have been proposed [83]. Still, it can be argued that 
this only makes the problem of standardization worse. The uncertainty which the practice of 
normalization introduces into gene measurement comparisons can only be resolved by a 
move to absolute quantitation, either through the use of quantitated synthetic controls (e.g., 
purified PCR product or RNA runoff transcript), or by the adoption of techniques which 
yield absolute measurements directly, such as the one described here. 
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Table 5.4. Descriptive statistics (GAPDH) 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
Number of Samples 21 23 25 24 23 
Median cDNAs/cell 45 26 65 43 45 
Mean cDNAs/cell 58 37 72 47 61 
Coefficient of Variation 86% 102% 58% 63% 78% 
Geometric Mean cDNAs/cell 43 22 57 39 46 
Geometric Standard Deviation 2.5 3.1 2.3 1.8 2.2 
Descriptive statistics for the GAPDH single-cell expression data.   The geometric mean and geometric standard 
deviation correspond to the back-transformed mean and standard deviation of the log-transformed data.  
These two statistics are more informative than the mean and standard deviation for lognormally distributed 
data.  
 
Table 5.5. Subset comparisons (GAPDH) 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
HSC 1.00 0.01 0.04 0.93 0.67 
CLP 0.01 1.00 0.00 0.07 0.20 
CMP/flk2+ 0.04 0.00 1.00 0.03 0.06 
CMP/flk2- 0.93 0.07 0.03 1.00 0.33 
MEP 0.67 0.20 0.06 0.33 1.00 
Results of pairwise Kolmogorov-Smirnov comparison tests between GAPDH expression data sets.  The 
tabulated values are the significance levels assigned by the test to the null hypothesis that the data from the two 
compared sets come from the same underlying distribution.  A low P value (<0.05) is evidence that the 
distributions differ significantly. 
  
149 
 
Table 5.6.  Gene expression by subset 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
Number of Samples 21 23 25 24 23 
Mean PU.1 cDNAs/cell 8.5 5.5 21.7 6.5 3.7 
Mean GAPDH cDNAs/cell 58 37 72 47 61 
PU.1/GAPDH Ratio 0.15 0.15 0.30 0.14 0.06 
 
It has recently been reported that the abundance of gene transcripts is lognormally 
distributed at the single-cell level [36]. We used several standard normality tests to ask 
whether the expression of GAPDH within each population was compatible with a normal or 
lognormal distribution (table 5.7). In all but the CMP/flk2+ population, the lognormal model 
was clearly preferred. Lognormal distributions can arise when normally distributed variations 
compound multiplicatively, as might occur during the sequential steps of biochemical 
synthesis [132]. Intermittent, exponentially distributed bursts of biosynthesis can also give 
rise to similar, nonnormal, positively skewed distributions [11] which are also consistent with 
our observations. The geometric standard deviations for the GAPDH data sets are in the 
range of 1.8–3.1 (table 5.4), which indicates that transcript levels can routinely fluctuate over 
a full one-log range. It might seem surprising that robust behavior can be achieved by a 
system in which signal levels vary so widely. It must be remembered, however, that a 
snapshot of mRNA transcript level is not necessarily a true measure of the abundance of the 
corresponding protein. Messenger transcripts generally turn over much faster than the 
proteins they encode, which implies that protein expression may be buffered against 
stochastic fluctuations at the mRNA level. Redundancy and distributed control are additional 
strategies by which cells could make up for the inherent sloppiness of biochemical signaling 
[14]. If so, efforts to “reverse engineer” the transcriptional circuits controlling development 
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must ultimately address the synthesis of quantitative observations on multiple transcription 
factors within single cells. The power of flow cytometric population analysis has increased as 
the technology for multiplexing has improved; we expect the same to be true of single-cell 
surveys conducted at the transcriptional network level. In hematopoiesis, cell fate decisions 
depend on the coordinate activity of multiple transcription factors [133]. 
 
 
Table 5.7. Normality tests 
 HSC CLP CMP/flk2+ CMP/flk2- MEP 
Ra
w
 D
at
a Shapiro-Wilk 0.00/0.00 0.00 0.49/0.35 0.00 0.00 
Anderson-Darling 0.00/0.00 0.00 0.42/0.27 0.02 0.01 
Lillefors 0.00/0.00 0.00 0.02/0.01 0.17 0.02 
Jacque-Bera 0.00/0.00 0.00 0.53/0.43 0.00 0.01 
Lo
g 
D
at
a 
Shapiro-Wilk 0.00/0.13 0.35 0.00/0.12 0.80 0.81 
Anderson-Darling 0.00/0.10 0.44 0.01/0.17 0.49 0.66 
Lillefors 0.02/0.08 0.53 0.01/0.23 0.55 0.52 
Jacque-Bera 0.00/0.21 0.58 0.00/0.13 0.91 0.65 
Significance levels assigned by four different normality tests to the GAPDH expression data.  Low P values 
(<0.05) favor rejection of the normality hypothesis.  In the case of the HSC and CMP/flk2+ data sets, tests 
were conducted on the complete data set (first tabulated value), and on the data set with a single, very low 
outlier data point removed (second value).  The tests were applied to both raw and log-transformed expression 
data.  With log-transformed input, the assigned significance levels pertain to the hypothesis of lognormality 
rather than normality.  The normality hypothesis is strongly disfavored for all except the CMP/flk2+ data set.  
The CLP, CMP/flk2- and MEP data sets were highly compatible with a lognormal distribution.  Lognormality 
scores reached significance for the remaining HSC and CMP/flk2+ data sets if their lowest outlier data points 
were excluded from the analysis.  
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When the targets for quantification are present at of the order of ten copies, a subdivision of 
the sample to permit independent single-plex assays introduces substantial measurement 
noise. For several reasons, digital PCR offers improved scope for high-order multiplexing 
relative to conventional quantitative PCR. In a standard multiplex PCR, mismatched 
transcript levels can lead to competitive inhibition of reactions involving less abundant 
targets, which is typically addressed by adjusting primer concentrations so that the 
amplification of abundant targets is primer limited. Such fine-tuning may not be practical in 
single-cell surveys, if transcript levels vary widely on a cell-by-cell basis, and is obviated in 
the digital assay. A second benefit arises from the concentration of template molecules 
because of reaction partitioning, which ameliorates the impact of primer–dimer side 
reactions. On the readout side, the digital assay lends itself to bar-coding schemes, whereby 
distinct probe color combinations are assigned to each target [13]. 
5.4 Conclusion 
If cross-sectional analysis of cell populations at the transcriptional network level were to 
become routine, the impact on developmental studies could be profound. In the near term, 
PCR-based methods cannot be expected to yield single-cell expression data with the speed 
and economy of flow cytometry. This must be set against the consideration that 
transcription factor studies provide data bearing directly on the internal decision-making 
machinery of the cell. In a small-scale survey we could easily resolve two subpopulations 
within a progenitor type, the CMP, which has until recently been considered homogeneous. 
Here we were able to focus the analysis based on recent findings from the hematopoiesis 
literature. In principle, however, the heterogeneity in PU.1 levels within the CMP 
compartment could have been detected in a “blind” single-cell survey. The scale of survey 
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required to detect network state diversity will depend on several factors, including (1) the 
relative frequencies of divergent subsets, (2) the magnitude and sharpness of the expression 
differences, and (3) the extent to which such differences are correlated across transcripts and 
surface markers analyzed in the survey. If the case of PU.1 expression in the CMP is 
representative, indications of heterogeneity should emerge after looking at a few tens of cells, 
and surveys at the 100- to 1,000-cell level may offer significant insight into population 
substructure. 
We have shown that it is possible to extend the sensitivity of quantitative RT-PCR to permit 
profiling of transcription factor expression within individual cells. This opens the door to 
sophisticated regulatory network analysis on even the rarest developmental progenitors. The 
dynamic range of the chip assay is suited to measuring the gamut of expression levels for 
regulatory genes, whether working from single-cell samples or from higher numbers of cells 
prepared at appropriately scaled concentration. By combining flow cytometry and digital RT-
PCR, we can put gene-expression measurements on an absolute, copy-number-per-cell basis. 
The attainment of this “gold standard” should facilitate the spread of public databases 
cataloguing cell-type-specific expression data. Our assay can also support the progressive 
refinement of the taxonomies underlying such resources through the single-cell survey 
approach, helping to uncover diversity at the level of the cell’s most delicate apparatus, the 
transcriptional regulatory network. 
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5.5 Materials and Methods 
5.5.1 Microfluidic Digital PCR Chip 
The single-cell measurements reported here were made using the Digital Array chip 
(Fluidigm, South San Francisco, CA). This single-use device supports the simultaneous 
analysis of 12 samples. Within each sample panel, fluid is distributed into parallel, dead-end 
channels under pneumatic pressure. After the load step, a comb valve with teeth at right 
angles to these channels is actuated, deflecting an elastomeric membrane down to partition 
the panel into 1200 isolated reaction chambers. The chip is then thermocycled, carrying out a 
total of 14,400 PCRs at once. A microarray scanner is used to image the chip at the end 
point of PCR. If a panel holds ا1200 copies of template at the start of the PCR, the copy 
number can be read out accurately just by counting positive reactions. At higher DNA titers, 
a significant fraction of the reaction chambers capture more than one copy of template, and 
there is no longer a simple correspondence between positive reactions and individual 
template molecules. However, unless a panel is at or near saturation, template abundance can 
still be calculated with acceptable precision (see Digital PCR Response Characteristic, 
below). The quantitative dynamic range of the Digital Array is therefore about three logs: 
from a single copy to on the order of a thousand copies. This should be sufficient for single-
cell quantification of all but the most abundant mRNA species [24]. 
5.5.2 Synthetic Standards 
PU.1 and GAPDH RNA runoff transcripts were made for use in evaluating the RT 
efficiency and PCR amplification efficiency of our assays. The transcripts were designed to 
flank the amplicon regions of the TaqMan assays by at least 100 bases on each side, so that 
the secondary structure context seen by the reverse transcriptase would be similar to that in 
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lysate-based reactions. PCR products incorporating a T7 RNA polymerase promoter were 
used as template for the runoff reactions, which were done with the MEGAscript T7 kit 
(Ambion, Austin, TX). The concentration of the purified RNA was measured by UV 
absorbance spectroscopy, and the percentage of full-length template was estimated with a 
capillary electrophoresis system (Experion; Bio-Rad, Hercules, CA). 
The PCRs used to make templates for runoff transcription were based on Mouse GAPDH 
DECAtemplate and Mouse Thymus PCR-Ready cDNA (Ambion). The PCR primers were 
as follows (T7 promoter tails underlined): for PU.1, 5’-
TAATACGACTCACTATAGGGAGACTGACCCACGACCGTCCAGT-3’ (forward) and 
5’-TTGTCCTTGTCCACCCACCA-3’ (reverse); for GAPDH, 5’-
TAATACGACTCACTATAGGGAGCCCATCACCATCTTCC-3’ (forward) and 5’-
CTGTAGCCGTATTCATTGTC-3’ (reverse). 
5.5.3 TaqMan Assay Design 
All RT-PCR data reported here were obtained by using duplex PU.1/GAPDH TaqMan 
assays. Primers and probes were designed with commercial software (Beacon Designer; 
Premier Biosoft, Palo Alto, CA), accepting the default Tm criteria for TaqMan assay design, 
which are based on a standard 60 °C annealing/extension step during the PCR. Primers were 
chosen so that the amplicon range was free of predicted secondary structure, as this is 
thought to impede efficient reverse transcription. To minimize background signal from 
genomic template, the PU.1 assay was designed so that the forward primer straddled an exon 
splice site. Assays were validated empirically using conventional quantitative PCR standard 
curve analysis with runoff transcript as template. Primers were at 100 nM concentration and 
probes at 50 nM concentration in all of the reported experiments. Oligonucleotides were 
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synthesized by Integrated DNA Technologies (Coralville, IA). The oligonucleotides used in 
the TaqMan assays were as follows: for PU.1, 5’-CATAGCGATCACTACTGGGATTTC-3’ 
(forward primer), 5’-GGTTCTCAGGGAAGTTCTCAAA-3’ (reverse/RT primer), and 5’-
CGCACACCATGTCCACAACAACGA-3’ (Cy5-labeled probe); for GAPDH, 5’-
CCAATGTGTCCGTCGTGGATC-3’ (forward primer), 5’-
GCTTCACCACCTTCTTGATGTC-3’ (reverse/RT primer), and 5’-
CGTGCCGCCTGGAGAAACCTGCC-3’ (FAM-labeled probe). 
5.5.4 RT Efficiency Measurements 
For on-chip standard curve assays, equimolar mixtures of PU.1 and GAPDH runoff 
transcript were added to RT-PCR buffer and the same digital RT-PCR protocol used on the 
cell lysates (described below) was executed on the samples. Three identical on-chip standard 
curve experiments were run, with each chip bearing four sets of three samples, at nominal 
template concentrations of 12.5, 25, 50, and 100 copies per microliter. All samples were 
derived from the same master mix; each individual sample was reverse transcribed in a 
separate tube. Data were recovered from 35 of the 36 panels in these chips. 
5.5.5 Cell Isolation and Staining 
A bone marrow cell suspension was prepared from five 8- to 12-week-old C57BL/6 mice. 
The suspension was filtered through a nylon membrane and contaminating red cells were 
lysed with ACK. The isolate was enriched for c-kit-positive early progenitor cells by 
immunomagnetic separation with anti-c-kit MACS beads (Miltenyi Biotec Auburn, CA). The 
cells were next stained for other surface markers by using the following fluorescent 
antibodies: CD34 FITC, flk2 phycoerythrin, Lineage phycoerythrin-Cy5 (a mixture of 
antibodies including CD3, CD4, CD5, CD8, B220, Mac1, Gr1, and Ter119), Sca-1 Cy5.5-
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phycoerythrin, FcGr allophycocyanin, c-kit allophycocyanin-Cy7, and IL7Ra biotin. All 
antibodies were from Ebiosciences (San Diego, CA), except CD34 FITC (Pharmingen, San 
Diego, CA) and IL7Ra biotin (ILW’s laboratory). The cells were then stained with 
streptavidin QD605 (Quantum Dot, Hayward, CA) to tag the IL7Ra antibodies and 
resuspended in PBS plus 2% FCS, with propidium iodide added to mark apoptotic cells. 
5.5.6 Cell Sorting and Lysis 
Cells were sorted to 0.2 mL sample tubes in 12-tube strips by using the FACSAria cell sorter 
(BD Biosciences, San Jose, CA). Doublets and dead or apoptotic cells were excluded based 
on forward scatter/side scatter and propidium iodide staining. All cells were sorted using 
Lineage- and c-kit+ gates; additional sort criteria used to fractionate the cells into specific 
progenitor subsets were as indicated in figure 5.3. Individual cells were dispensed into 10 µL 
aliquots of RT-PCR buffer. The buffer components included a commercial RT-PCR mix 
(Platinum One-Step Reaction Buffer; Invitrogen, Carlsbad, CA), an RNase inhibitor 
(Ambion SUPERase-In), and 0.15% Tween 20 detergent. The latter was included as a 
surfactant to prevent nucleic acids binding the PDMS walls of the Digital Array during the 
PCR assay. No special cell lysis reagents were added. In tests, the efficiency and 
reproducibility of cDNA recovery was at least as good using direct hypotonic/detergent lysis 
in the RT-PCR buffer as obtained using chaotropic lysis with subsequent RNA purification. 
5.5.7 Reverse Transcription 
Reverse transcription reactions were done at 55 °C for 15 minutes, and followed by a 5 
minute, 70 °C step to heat-denature the reverse transcriptase. Completed reactions were 
stored at -20 °C for later PCR analysis. The RT step was carried out in a 96-well block 
thermocycler. Three microliters of 5ൈ primer–probe mix was added to each frozen lysate, 
157 
 
after which the samples were spun down and transferred to the preheated thermocycler 
block. As a precaution to minimize primer–dimer extension by the reverse transcriptase, the 
samples were warmed to 55 °C before adding 2 µL aliquots of enzyme to the reactions. 
MMLV RT/Taq polymerase enzyme blend (CellsDirect SuperScript III/Platinum Taq; 
Invitrogen) was diluted in RT-PCR buffer to stabilize the enzyme; the final reaction 
concentration was as directed by the manufacturer. 
5.5.8 cDNA Quantitation 
Digital Array chips mounted on 75 ൈ 50 mm glass slides were primed for use by filling the 
control layer with osmolyte (35% PEG 3350). For each assay, 12 stored reverse transcription 
reactions were thawed, drawn into gel tips, and loaded into a chip under 15 psi pneumatic 
pressure. The load was performed in a cold room at 4 °C and took ~30 minutes. The sample 
load step was controlled manually with a 12-port manifold fed from a house air supply and 
connected to the gel tips by Tygon tubing with custom-made hose adaptors. After the load, 
the chip was transferred to a flat-block thermocycler; paraffin oil was used to improve 
thermal contact between the block and the glass-slide base. Samples were partitioned by 
applying 27.5 psi pneumatic pressure to the control layer comb valve via a gel tip filled with 
osmolyte solution. The PCR profile included a 3 minute, 95 °C hot start to activate the Taq, 
followed by 40 cycles of a two-step program: 15 seconds at 95 °C (denaturation) and 60 
seconds at 60 °C (annealing and extension). After PCR, chips were imaged with an 
ArrayWoRx microarray scanner (Applied Precision, Issaquah, WA), adapted to accept a chip 
carrier. Scans were done at 13 µm resolution by using FAM and Cy5 filter sets. We wrote our 
own software to process the PCR end-point images and compute the template 
concentrations in each panel. The loaded sample volume in the chip, 7.5 µL (manufacturer’s 
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data), represents half the volume of the reverse-transcribed lysate. All of the single-cell 
cDNA copy number data reported here was derived by multiplying the calculated template 
concentration in copies per microliter by the total lysate reaction volume, 15 µL. 
5.5.9 Data Analysis 
Normality tests were done with XLSTAT (Addinsoft, New York, NY). The test input 
consisted of the reported cDNA copy number for each cell in the set (normal test), or the 
log of the copy number (lognormal test). We wrote software to perform expression data set 
comparisons based on the K-S routines given in Numerical Recipes in C [134]. When used 
to compare two data sets, the algorithm calculates the maximum absolute distance between 
their respective cumulative distributions, and computes from this measure the significance of 
the null hypothesis that both data sets came from the same underlying distribution. The 
analysis does not involve any assumptions about the character of the underlying distributions 
involved. 
5.5.10 Digital PCR Response Characteristic 
If template molecules are randomly distributed within n compartments, the probability of 
any given molecule being trapped in any given compartment is 1/n.  Hence, the probability 
of a given compartment being empty when there are x template molecules in the sample is 
(1 – 1/n)x.  The expected number of non-empty compartments, y, is therefore as follows: 
y = n · [1 – (1 – 1/n)x]. 
Consequently, a readout of y positive compartments gives the following estimate for x: 
x = log(1 – y/n) / log(1 – 1/n). 
159 
 
If the number of positive reactions is small compared to the number of compartments, 
x ≈ y.   The response curve is therefore close to linear at low template concentrations.  The 
statistical uncertainty in the estimated number of input molecules increases as the fraction of 
occupied compartments approaches unity.  For a Digital Array panel with 1200 
compartments, this error remains small even at an input of 4000 molecules (CV ≈ 5%, by 
Monte Carlo simulation).  However, the shallowness of the response curve above 1000 input 
molecules implies increased sensitivity to uncertainty in positive/negative calls. 
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Chapte r  6 
TRANSCRIPTIONAL INSTABILITY IS NOT A UNIVERSAL 
ATTRIBUTE OF AGING* 
Luigi A. Warren, Derrick J. Rossi, Geoffrey R. Schiebinger, 
Stuart K. Kim, Irving L. Weissman, and Stephen R. Quake 
6.1 Summary 
It has been proposed that cumulating somatic mutations contribute to the aging process by 
disrupting the transcriptional networks which regulate cell structure and function. 
Experimental support for this model emerged from a recent study of cardiomyocytes which 
showed a dramatic increase in the transcriptional heterogeneity of these long-lived post-
mitotic cells with age. To determine if regulatory instability is a hallmark of aging in renewing 
tissues, we evaluated gene-expression noise in four hematopoietic cell types: stem cells, 
granulocytes, and naïve B and T cells. We used flow cytometry to purify phenotypically 
equivalent cells from young and old mice, and applied multiplexed qRT-PCR to measure the 
copy number of six different mRNA transcripts in 324 individual cells. There was a trend to 
higher transcript levels in cells isolated from old animals, but no significant increase in 
transcriptional heterogeneity with age was found in the surveyed populations. Flow-
cytometric analysis of membrane-protein expression also indicated that cell-to-cell variability 
                                                 
* This chapter has been accepted for publication in Aging Cell.  LAW and DJR contributed 
equally to this work.  The references for this chapter appear in the bibliography. 
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was unaffected by age. We conclude that large-scale regulatory destabilization is not a 
universal concomitant of aging, and may be of significance as an aging mechanism primarily 
in non-renewing tissues. 
6.2 Introduction 
For years, theoreticians were divided on whether aging results from a regulated 
developmental program, analogous to growth and sexual maturation, or constitutes an 
essentially passive, wear-and-tear process.  Arguments grounded in evolutionary theory have 
now largely settled this debate in favor of the wear-and-tear model.  The idea that natural 
selection favors “planned obsolescence,” to prevent the aged from competing for resources 
with their own offspring, appears untenable on close examination, at least in the general case 
[135, 136].  However, as even robust animals have a limited half-life in the wild state, owing 
to accident, disease and predation, selection pressure for mutations whose benefits accrue in 
old age is weak, and ultimately falls below countervailing, entropic forces such as genetic 
drift.  In addition, mutations which bring early-life benefits along with late-life deficits tend 
to accumulate, the costs being discounted by the attrition curve.  Hopes for the discovery of 
a cellular or endocrine “death clock” have faded with the recognition that aging is not a 
programmed process, and it now seems likely that a multiplicity of factors contributes to the 
gradual loss of fitness we call aging.  If aging has many causes, then the problem for aging 
research is to identify and characterize the most important drivers of decline at the different 
levels of physiology: cellular, tissue, organ, and systemic.  For the most part, this project 
remains a work in progress.  
Within the cell, the fundamental mechanism of homeostasis is the network which regulates 
the coordinated expression of genes underpinning cellular structure and function.  The 
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connectivity of this network is encoded in the sequence and spatial relationship of regulatory 
elements dispersed through the genome; its activity is mediated by diffusive protein and 
RNA factors.  It is reasonable to ask if this complex governor is vulnerable to age-related 
decline, either due to intrinsic instability in the chemical circuits, or as a result of cumulative 
damage to the genome. Relevant to the latter possibility, it has recently been shown that 
mammalian somatic genomes typically incur dozens of multi-megabase rearrangements over 
the course of a lifetime [137-139].  This has motivated the hypothesis that chromosomal 
instability produces major disturbances in gene expression with age, by altering the 
relationships between genes and distal regulatory elements, and perhaps also by disrupting 
the large-scale chromatin architecture [137, 140].  If so, the rearrangement-triggered 
dysregulation events often seen in oncogenesis may represent catastrophic outliers of a more 
general process underlying aging.  Destabilized gene regulation, then, could be the missing 
link between cumulating DNA damage and age-related loss of cellular function.   
While the regulatory instability hypothesis is conceptually attractive, its evaluation presents 
technical challenges.  Standard mRNA assays work with samples equivalent to hundreds or 
thousands of cells, and the aggregate expression data they yield necessarily obscures the 
signature of transcriptional heterogeneity or “noise” predicted by the model.  Transcriptional 
instability can only be evaluated by quantifying gene expression in single cells, to see how the 
variation between cells depends on age.  Support for the hypothesis has emerged from a 
recent study which measured transcript levels in individual cardiomyocytes isolated from the 
hearts of young and old mice [48].  This work revealed an across-the-board increase in the 
cell-to-cell variability of transcript levels with age, affecting both tissue-specific and 
housekeeping genes.  A direct link between increased transcriptional noise and genomic 
instability was not established, but a similar effect was seen in a cell line following exposure 
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to genotoxic stress. These findings are compatible with the possibility that destabilized gene 
expression is a central mechanism of aging.   It remains to be determined if the regulatory 
instability detected in cardiomyocytes is a general attribute of aging and, in particular, 
whether it has a role in the functional decline of renewing tissues such as the blood.  The 
cellular composition of whole tissues changes with age [141-143], hindering appraisal of cell-
intrinsic expression noise unless phenotypically equivalent cells can be isolated from young 
and old animals.  A refined taxonomy of blood cell types has been established based on cell-
surface markers, allowing specific populations to be purified to near-homogeneity by flow 
cytometry.  Here we describe a study conducted on four different hematopoietic cell types 
which provides evidence that regulatory homeostasis is maintained with age in the cells of 
renewing tissues. 
6.3 Results 
We performed single-cell mRNA profiling on four hematopoietic populations isolated from 
young and old mice: hematopoietic stem cells (HSCs) [117, 122, 144] (figure 6.1), 
granulocytes [145] (figure 6.2), naïve B-2 B cells [146, 147] (figure 6.3), and naïve CD8+ 
T cells [148] (figure 6.4). Individual cells were sorted into lysis buffer and analyzed using a 
two-round qRT-PCR strategy [89, 90]. A total of 324 cells were evaluated, comprising 34–47 
cells of each cell type within each age cohort.  Using synthetic RNA standards as a reference, 
we measured the copy number of six medium-to-high abundance transcripts in each cell: 
ActB, B2M, Rpl5, Rpl19, CD45 and H2K (figure 6.5).  
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Figure 6.1.  HSC sort strategy.  Flow cytometric profiles showing gating strategy for purification of HSCs for 
representative young (top panels) and old (lower panels) mice.  Cells were pregated through FSC-A versus SSC, 
and FSC-A versus FSC-W to exclude doublets (not shown).  Primary and secondary sort data are shown, along 
with the protein expression histogram for CD45 from the final gate. 
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Figure 6.2.  Granulocyte sort strategy.  Flow cytometric profiles showing gating strategy for purification of 
granulocytes for representative young (top panels) and old (lower panels) mice. Cells were pregated through 
FSC-A versus SSC, and FSC-A versus FSC-W to exclude doublets (not shown). Primary and secondary sort 
data are shown, along with protein expression histograms for CD45 and H2K from the final gate. 
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Figure 6.3. B-cell sort strategy. Flow cytometric profiles showing gating strategy for purification of naïve B-2 
B cells for representative young (top panels) and old (lower panels) mice. Cells were pregated through FSC-A 
versus SSC, and FSC-A versus FSC-W to exclude doublets (not shown). Primary and secondary sort data are 
shown, along with protein expression histograms for CD45 and H2K from the final gate. 
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Figure 6.4.  T-cell sort strategy.  Flow cytometric profiles showing gating strategy for purification of naïve CD8 
T cells for representative young (top panels) and old (lower panels) mice.  Cells were pregated through FSC-A 
versus SSC, and FSC-A versus FSC-W to exclude doublets (not shown).  Primary and secondary sort data are 
shown, along with protein expression histograms for CD45, H2K and TCRβ from the final gate. 
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Figure 6.5.  Experimental method.  Cells were recovered from peripheral blood and bone marrow and stained 
with dye-conjugated antibodies. HSCs, granulocytes, naïve B cells, and naïve T cells were purified by FACS.  In 
a secondary sort, individual cells from each isolate were dispensed to RT-PCR buffer, where they underwent 
hypotonic/detergent lysis.  For transcript analysis, primers and an RT/Taq enzyme blend were added to the 
lysates, which were then subjected to multiplex, coupled RT-PCR.  The PCR step was limited to 15 cycles in 
this “preamplification” round to prevent inhibition by primer-dimer reactions.  Aliquots of amplified cDNA 
were taken forward to independent SYBR Green qPCRs to quantify the six target transcripts; first-round 
products and primers were diluted 100-fold going into this round.  Quadruplicate RNA standards-based 
reactions were processed in parallel with each eight-tube strip of lysates. Ct values from cell-based reactions 
were translated into mRNA copy numbers by reference to the standards reactions using the ΔCt method.
169 
 
Gene expression measurements were organized into 48 data sets, based on cell type, age 
cohort, and mRNA target (figure 6.6). The qPCR readouts from the cell-based reactions 
were generally well above the background signals detected in No Template and No RT 
control reactions (table 6.1).  Interestingly, we found a trend to higher transcript levels in 
cells from old animals, particularly evident in HSCs and T cells (figure 6.7).  The shift is 
apparent in median as well as average expression and is therefore not driven by high outliers, 
so there is no reason to suppose that it signals an increase in transcriptional noise.   
 
 
 
 
Table 6.1. NTC and No RT controls 
Control ActB B2M Rpl5 Rpl19 CD45 H2K 
NTC 1.4 0.3 3.2 4.7 0.0 0.9 
No RT 0.0 0.0 3.8 3.2 0.0 0.0 
Background readings from NTC and No RT control reactions, expressed in equivalent RNA copies.  NTC 
values are averaged from 8 individual reactions.  No-RT data are from a standard-curve analysis on an 8-point 
cell-concentration ramp, spanning 1 to 128 cells per well. The NTCs were processed identically to lysate-based 
reactions; for the No RT controls, Platinum Taq polymerase (Invitrogen) was substituted for the RT/Taq blend 
in the RT/preamplification round. 
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Figure 6.6.  RNA expression data.  Single-cell transcript copy number by cell type, gene, and age cohort. 
Young-cohort data are shown in red and old-cohort data are shown in grey within each scattergram pair. 
Superimposed boxplots show the median and the second and third quartiles; whiskers delimit non-outlier 
points, where an “outlier” is a value >1.5ൈIQR outside the middle quartiles.     
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Figure 6.7. Gene-expression profiles. Expression profiles for the four cell populations analyzed in the study, 
based on the single-cell averages for each data set.  Error bars delimit the 95% confidence interval on the mean, 
estimated by bootstrap resampling. 
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The coefficient of variation (CV) was computed for the transcript copy number values in 
each data set (figure 6.8).  The median CV was 0.63 for the young-cohort data sets and 0.69 
for the old-cohort data sets.  The lowest cell-to-cell variation measured (CV = 0.43) was still 
well above the intrareplicate variation observed in RNA standards-based reactions 
(figure 6.9). Transcript copy number distributions are typically longtailed and hence violate 
the assumption of normality underlying most standard statistical tests [36], so we used the 
method of bootstrap resampling to put confidence bounds on the CV values [149].  The 
confidence intervals were wide in some cases, reflecting sensitivity to outliers.   Bootstrap 
resampling was also applied to compute the significance level of the increased-noise 
hypothesis for each mRNA species, using three relative measures of dispersion: CV, 
geometric standard deviation (GSD), and the interquartile range (IQR) of median-
normalized expression (figure 6.10).  None of the P values fell below 0.05 for the HSCs and 
granulocytes, and the average P value was ~0.5 in both these populations.  Thus, no age-
dependent increase in transcriptional noise was detected in these cell types.  The P value 
tables for the B and T cells suggest a modest trend to increased transcriptional heterogeneity 
in old-cohort lymphocytes, but P < 0.05 significance was attained in only 3 of 36 cases.   
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Figure 6.8.  Cell-to-cell variability. Coefficients of variation for the RNA copy number measured in single-cell 
replicates, by cell type, gene and age cohort.  Error bars delimit the 95% confidence intervals for the statistics, 
estimated by bootstrap resampling.  
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Figure 6.9. Technical noise in RNA quantitation. Histograms show the readout variability within the 
quadruplicate RNA standards processed alongside lysate-based reactions in the single-cell survey, using data 
from 63 qPCR runs.  The CV metric is based on relative copy number, computed by the ΔCt method.  The 
technical noise in the copy number values for the lysate-based reactions will reflect inherent well-to-well 
variability, as manifested in the standards replicate CVs, plus a smaller, orthogonal error contribution due to the 
statistical uncertainty in the interpolation of a nominal 1000-copy reference Ct from quadruplicate standards.  
For example, if the intrareplicate technical variation is normally distributed with a CV of 0.22, the expected 
copy number error in the data pooled from multiple qPCR runs is √[0.222+(0.22/√4)2] = 0.25. 
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Figure 6.10. Bootstrap resampling analysis. Significance level of the hypothesis that transcriptional noise is 
increased in old animals, estimated by bootstrap resampling using three metrics of variability: coefficient of 
variation (CV), geometric standard deviation (GSD), and interquartile range (IQR).  
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Although the genes for the ribosomal subunit proteins Rpl5 and Rpl19 lie on different 
chromosomes, microarray analysis has shown that they are tightly coregulated [150]; we were 
interested to see if this coupling would be affected by age.  The levels of these transcripts 
were strongly correlated when data for all cell types were aggregated (figure 6.11).  The 
correlations within specific populations were generally weaker, but this was still the most 
consistently correlated pair of genes (figure 6.12). Pearson coefficients for the Rpl5-Rpl19 
correlation were actually higher in the old cohort for the aggregated data (0.85 versus 0.80), 
and for three of the four specific cell types, implying that there was no transcriptional 
decoupling of these genes with age.  
To determine if the observed transcriptional stability with age was reflected at the protein 
level, we used FACS to analyze cell-surface expression of CD45 in all cell types, H2K in 
granulocytes and lymphocytes, and TCRβ in T cells (figure 6.13). The sort criteria used to 
purify the populations of interest did not involve gating on these markers, permitting an 
unbiased assessment of the expression distribution in each cell type. No trend to increased 
variation in protein expression in the aged cohort was apparent, providing further evidence 
for the age-dependent maintenance of both transcriptional and translational networks. 
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Figure 6.11. Rpl5-Rpl19 correlation data. 2D scatterplots of single-cell copy-number data for the coregulated 
ribosomal subunit genes Rpl5 and Rpl19.   
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Figure 6.12. Transcript correlations.  Pearson correlation coefficients for the expression of each pair of genes 
based on the single-cell RNA copy number data from the survey.  
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Figure 6.13. Protein expression analysis. Surface-protein expression histograms based on flow cytometry data 
from the population sorts. Young-cohort data are shown in red and old-cohort data in grey.  H2K expression 
was bimodal in the cell types evaluated, with the histograms showing a secondary peak of H2K- cells; the CV 
metrics for this target are based on the fluorescence intensity distribution in the H2K+ fraction. 
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6.4 Discussion 
Our analyses revealed no marked tendency to destabilized gene expression with age at either 
the mRNA or protein level.  This finding stands in contrast to the strong noise signature 
reported in cardiomyocytes [48].  The number of cells assayed from each population was 
similar to the total sample size in the cardiomyocyte study, so it is unlikely that the difference 
is a matter of statistical power. The lymphocyte populations showed signs of increased 
heterogeneity with age, but it is by no means clear that this reflects transcriptional instability.  
Higher cell-to-cell variability was manifested in Rpl5 and Rpl19 in these subsets, yet the 
abundance of the two transcripts showed no decorrelation with age.  This tends to exclude 
mutations or epigenetic changes involving the loci for these genes as the source for the 
increased variability.  Noise ramifying through the regulatory network could affect both 
genes without leading to decoupling by affecting a common regulator, but the observations 
are also compatible with changes in the internal population structure of the naïve B and T 
cell compartments, unrelated to cell-intrinsic transcriptional noise.  
If genomic instability causes age-related transcriptional destabilization, then the discordance 
between our results and the cardiomyocyte data could reflect disparate mutation rates among 
somatic lineages.  Studies conducted in mice using a knock-in reporter for mutations have 
measured differences in the burden of chromosomal rearrangements in several whole tissues,  
and these data show that heart tissue incurs almost twice as many mutations with age as the 
spleen, which is rich in B lymphocytes [137].   In this regard, it may be significant that the 
white cells of the blood are especially radiosensitive owing to acute apoptotic responses to 
DNA damage, presumably a safeguard against neoplastic changes in these proliferative 
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lineages [151-153].  It could be that hematopoietic cells escape the worst effects of genomic 
instability because damaged cells are rigorously purged from the population.  
A potentially important difference between the cell types we surveyed and cardiomyocytes is 
the post-mitotic lifetime of the cells.  Granulocyte and naïve B and T cell populations in the 
peripheral blood are continuously renewed from the stem-cell pool in the bone marrow.  
The turnover rate of granulocytes is especially rapid—perhaps less than a day [154]. With 
respect to the HSCs, there is an order of magnitude expansion of the stem cell pool in mice 
between maturity and old age [155, 156], implying that the average post-mitotic age of the 
cells we examined may be no more than a few months.  In contrast, the tissues of the heart 
show little turnover [157, 158], which implies that cardiomyocytes probably have post-
mitotic ages similar to the chronological age of the animals from which they are recovered.  
Since at least some DNA damage repair and apoptotic response mechanisms are linked to 
cell cycle progression, cells with long post-mitotic lifetimes may be particularly vulnerable to 
the accrual of genomic damage leading to transcriptional dysregulation.  It is also possible 
that age-related transcriptional noise is a sign of chemical instability in the regulatory circuits, 
rather than a secondary consequence of changes at the DNA level.  Our data suggest that 
the regulatory logic is inherently quite stable over the course of a lifetime, but it is 
conceivable that cell division provides a “reset” which counters the effects of drift and 
stochastic perturbations in the network.  If so, destabilized gene expression may be largely a 
phenomenon of long-term post-mitotic cells.   
Finally, it remains possible that the elevated cell-to-cell variability detected in aged 
cardiomyocytes is symptomatic of tissue heterogeneity rather than cell-intrinsic 
transcriptional noise, in which case the stringent phenotypic matching attainable with FACS 
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could explain the absence of such a signature in our results. A full resolution on the question 
of age-related transcriptional instability will require additional studies integrating data on 
post-mitotic lifetime, accumulated DNA damage and gene expression noise in disparate cell 
types, using methods which ensure, insofar as possible, the phenotypic identity of cells 
isolated from young and old animals. In conclusion, while our findings do not invalidate the 
noise hypothesis, they do place limits on its generality, frame questions about the 
mechanistic basis of the effect reported in cardiomyocytes, and underscore the need for 
further research before transcriptional instability enters the canon of accepted aging 
mechanisms.  
6.5 Experimental Procedures 
6.5.1 Mice 
All the mice used in this study were C57BL/6. Animals were obtained from the National 
Institute of Aging (NIA, Bethesda, MD), and then maintained at the Stanford University 
Laboratory Animal Facility (SULAF).  The ages of the mice in the young and old cohorts 
were 2–3 months and 23–25 months, respectively. 
6.5.2 Cell Purification 
Peripheral blood samples were taken from three mice in each age cohort, and diluted in cold 
PBS supplemented with 10 mM EDTA. Red cells were lysed using ACK lysis buffer 
(150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.2), and the remaining cells were 
stained with fluorescence-conjugated monoclonal antibodies. The antibodies used were 
Ter119•Cy5PE, CD8•Cy7PE, TCRβ•PE, B220•Cy7PE, CD45.2•APCCy5.5, IgM•PECy5.5, 
IgD•FITC, streptavidin•APCCy7 (e-Bioscience, San Diego, CA), H2Kb•biotin (Pharmingen, 
San Diego, CA), and CD62L•APC, Mac1•PE, GR-1•Alexa405, CD62L•Alexa488, 
183 
 
CD44•APC, CD25•Alexa405 (all prepared in the Weissman lab).  To recover HSCs, whole 
bone marrow cells from three mice in each age cohort were enriched by positive selection 
using CD117-conjugated magnetic beads (Miltenyi, Germany). Enriched cells were stained 
with antibodies to Sca1 (Pharmingen), c-kit (clone 2B8, Pharmingen), CD34 (Pharmingen), 
lineage (e-Bioscience), and flk2 (e-Bioscience). Cells were sorted on a FACSAria (Becton 
Dickinson, San Jose, CA). The subsets evaluated were gated as follows: HSCs (Lin-c-
kit+Sca+flk2-CD34-), granulocytes (Ter119-Mac1+GR-1+CD62L+), naïve B-2 B cells (Ter119-
B220+IgD+IgMloCD62L+), and naïve CD8+ T cells (Ter119-CD8+CD62L+CD44loCD25-).  
Cells were kept on ice during the experiments whenever possible. 
6.5.3 Single-Cell Sort 
10 µL aliquots of cell lysis buffer were dispensed to 0.2 mL PCR tubes in 8-tube strips.  The 
solution comprised RT-PCR buffer (CellsDirect 2X Reaction Mix, Invitrogen, Carlsbad, 
CA), RNase inhibitor (SUPERase-In, Ambion, Austin, TX), and nuclease-free water (RT-
PCR Grade Water, Ambion). Tween 20 detergent (Sigma Chemical, St. Louis, MO) was 
added at a final concentration of 0.1% to ensure rapid cell lysis.  Lysis buffer strips were 
arrayed in 96-well plate holders and kept at -20 °C until needed.  Plates were warmed to 4 °C 
prior to the FACS session, and then frozen down to -20 °C as soon as cells had been sorted 
into lysis buffer. 
6.5.4 Reverse Transcription and Preamplification 
In the RT/preamplification phase of the transcript analysis, two 8-tube strips of cell lysates 
and one 8-tube strip of RNA standards were processed at a time.  A 5 µL aliquot of 
multiplex primer mix was added to each frozen sample, and the tubes were briefly spun 
down in a centrifuge.  The strips were then transferred to a preheated thermocycler block; 
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after giving the samples time to warm up, 5 µL aliquots of diluted RT/Taq blend 
(CellsDirect Superscript III/Platinum Taq, Invitrogen) were pipetted into each reaction.  The 
RT/Taq blend was diluted in RT-PCR buffer to prevent denaturation; the final enzyme 
concentration was as directed by the manufacturer.  The RT-PCR thermal profile comprised 
a 15 minute, 55 °C RT incubation followed by a 3 minute, 95 °C hot start and 15 cycles of 
PCR amplification (15 second, 95 °C denaturation step; 60 second, 60 °C 
annealing/extension step).  Reactions were moved to a cold block immediately the PCR 
completed, and 5 µL aliquots of each reaction were diluted in 200 µL TE (pH 8.0).   
Dilutions were prepared in two 12-tube strips, each corresponding to one strip of cell-based 
reactions plus four standards-based reactions.  Strips were stored at -20 °C until analysis. 
6.5.5 Quantitative PCR 
Each 12-tube strip from the RT/preamplification round was analyzed in a single run using a 
Chromo4 qPCR machine (Bio-Rad, Hercules, CA).  Simplex reactions were set up in six 
rows of a 96-well block.  Each 20 µL reaction comprised 10 µL of qPCR reaction mix 
(SYBR GreenER qPCR Supermix, Invitrogen), 2 µL of primers, and 8 µL of diluted first-
round product.  The PCR profile comprised a 15 minute, 95 °C hot start followed by 40 
cycles of amplification (15 second, 95 °C denaturation step; 60 second, 60 °C 
annealing/extension step).  A melt-curve analysis was included to detect secondary or non-
specific product formation. 
6.5.6 Primer Design 
Identical PCR primers were used in the multiplexed RT/preamplification round and the 
simplex qPCR round.  The reverse primers functioned as gene-specific RT primers during 
cDNA synthesis.  Primers were at 100 nM final concentration in all reactions.  Primers were 
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designed with Primer3 (MIT); primer sets were also evaluated in silico using NetPrimer 
(Premier Biosoft, Palo Alto, CA) and FastPCR (Institute of Biotechnology, University of 
Helsinki, Finland).  One of the primers in each pair straddled an exon boundary, except in 
the case of the ActB assay, where the primers bracketed a splice junction.  To maximize RT 
efficiency, RNA folding prediction software (Beacon Designer, Premier Biosoft) was used to 
target the assays to regions of mRNA free of secondary structure. Primers were checked for 
high priming efficiency (85%–100%) by qRT-PCR standard-curve analysis using RNA 
standards as template.  Melt-curve analysis was used to disqualify primers with high primer-
dimer potential.  Primer sequences are given in table 6.2.  Primers were synthesized by 
Integrated DNA Technologies (Coralville, IA).   
 
 
 
Table 6.2. Transcript analysis primers 
Target GenBank  ID Forward Primer Reverse Primer 
ActB NM_007393 CAGCTTCTTTGCAGCTCCTT GCAGCGATATCGTCATCCA 
B2M NM_009735 CGGTGACCCTGGTCTTTCT GAATTTGAGGGGTTTTCTGGA 
Rpl5 NM_016980 GGCGAGAGGGTAAAACTGAC TCATCCTATATTTGGGTGTGTT
Rpl19 NM_009078 AGAAGATTGACCGCCATATGTA GGATGCGCTTGTTTTTGAAC 
CD45 NM_011210 GCTGAATACCAGAGACTTCCTT GCTCATCTCCAGTTCATGCTT 
H2K AY989882 ACTATGCTCTGGCTCCAGG GGGTCATGAACCATCACTTTAC 
Primer sets used in RT/preamplification step and SYBR Green qPCR analysis. 
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6.5.7 RNA Standards 
RNA quantitation standards were generated from PCR-product templates with the 
MEGAscript T7 runoff transcription kit (Ambion) and purified with the MEGAclear kit 
(Ambion).  The primers used to make DNA templates are given in table 6.3. PCRs were 
templated with Mouse Thymus PCR-Ready cDNA (Ambion).   RNA was quantitated by UV 
absorbance spectroscopy.  Transcript purity and length were checked with a capillary 
electrophoresis system (Experion, Bio-Rad).  Lysis buffer was spiked with an equimolar 
mixture of RNA standards and 10 µL aliquots were dispensed to 8-tube strips, each tube 
receiving approximately 1000 copies of each of the six target transcripts.  The standards 
strips were stored at -20 °C until needed. 
 
 
Table 6.3. Runoff-transcription template primers 
Target GenBank  ID Forward Primer Reverse Primer 
ActB NM_007393 CCGCGAGCACAGCTTCTTTG AGGAAGAGGATGCGGCAGTG 
B2M NM_009735 CTACTCGGCGCTTCAGTCG CACAGGGTTGGGGGTGAGAA 
Rpl5 NM_016980 CTCTGCAGGTCTGCGTGGAG TCAGCAGCCCTTTCCTGAGC 
Rpl19 NM_009078 CGCTGCGGGAAAAAGAAGGT TGGTCTCCTCCTCCTTGGACA 
CD45 NM_011210 AGCATGGAGGAAGGCACTCG TGCTTTCCTTCGCCCCAGTA 
H2K AY989882 CCCTGGGCTTCTACCCTGCT TCACGCTAGAGAATGAGGGTC
Primer sets used to generate PCR product templates for RNA runoff transcription.  Forward primers 
incorporated a 5’ T7 promoter tail (5’-TAATACGACTCACTATAGGG-3’). 
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6.5.8 Data Analysis 
Threshold cycle (Ct) readings obtained in qPCR reactions were translated to RNA copy 
numbers by reference to parallel reactions on RNA standards.  First, a 1000-copy reference 
Ct was interpolated from the quadruplicate standards Ct values, assuming an average 1000 
template copies per reaction and a nominal PCR efficiency of 0.95.  The transcript copy 
number for lysate-based reactions was computed using the formula N = 1000 · 1.95∆Ct, 
where ∆Ct = Ctref – Ctsample.  The single-cell sorts were ~60% efficient in delivering cells into 
the lysis buffer, negative wells being distinguished by low genomic background signals in 
Rpl5 and Rpl19 assays and negligible amplification in the other four assays.  Samples which 
gave an ActB readout below 20 copies were excluded from the analysis.  For each age 
cohort, cells from three different animals contributed approximately equally to the 
expression data.  Confidence intervals for CV metrics and P values for the age-related noise 
hypothesis were estimated by bootstrap resampling using Resampling Stats for Excel 
(Resampling Stats, Arlington, VA).  Expression data sets were resampled with replacement 
10,000 times. Confidence bounds were established by taking the 2.5th and 97.5th percentile 
values for the CVs calculated on the resampled data.  P values correspond to the fraction of 
resampled data sets which gave lower variability metrics for old-cohort data. Copy number 
readouts of zero were rounded up to 1 copy for GSD calculations; IQR was evaluated after 
normalizing expression values to the data set medians.  Membrane-protein expression 
histograms are based on FACS analyses of samples taken from three different animals within 
each age cohort.  Fluorescence values were normalized to the sample medians before the 
data were pooled.  Each histogram represents data from at least 1405 individual cells.   
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Figure 1. Statistical measures of a digital array with N=765 and 1 ≤ m ≤ 4000 
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Figure 1. Molecule-number expectation bounded by 95% confidence interval 
The above plot shows the expectation value, E(m) in black, bounded by the upper and lower 
bounds to the 95% confidence interval. These values apply to the scenario where N = 765, 
1 ≤ m ≤ 4000, and our a priori knowledge of m makes any value in this interval equally 
probable. 
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Figure 2. CV versus k 
The above plot shows the coefficient of variance, or CV, in the same scenario as in figure 1. 
Its rise to a peak just before hitting the maximum occupancy of k = 765 corresponds to the 
widening of the confidence interval in figure 1 in that region. This increase in uncertainty is 
related to the increased likelihood that a given signal is due to multiple molecules occupying 
a well, instead of just one. 
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